<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Physiol</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Physiol</journal-id>
<journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Physiology</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-042X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30425651</article-id>
<article-id pub-id-type="pmc">6218530</article-id>
<article-id pub-id-type="doi">10.3389/fphys.2018.01517</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Physiology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Proarrhythmic Remodeling of Calcium Homeostasis in Cardiac Disease; Implications for Diabetes and Obesity</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Hamilton</surname>
<given-names>Shanna</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/556771/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Terentyev</surname>
<given-names>Dmitry</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/34372/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Medicine, The Warren Alpert Medical School of Brown University</institution>, <addr-line>Providence, RI</addr-line>, <country>United States</country></aff>
<aff id="aff2"><sup>2</sup><institution>Cardiovascular Research Center, Rhode Island Hospital</institution>, <addr-line>Providence, RI</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: John Pearce Morrow, Columbia University, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Matthew W. Kay, The George Washington University, United States; Xun Ai Ai, Rush University Medical Center, United States</p>
</fn>
<corresp id="c001">*Correspondence: Dmitry Terentyev, <email>dmitry_terentyev@brown.edu</email></corresp>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Cardiac Electrophysiology, a section of the journal Frontiers in Physiology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>30</day>
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>9</volume>
<elocation-id>1517</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>7</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>09</day>
<month>10</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Hamilton and Terentyev.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Hamilton and Terentyev</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>A rapid growth in the incidence of diabetes and obesity has transpired to a major heath issue and economic burden in the postindustrial world, with more than 29 million patients affected in the United States alone. Cardiovascular defects have been established as the leading cause of mortality and morbidity of diabetic patients. Over the last decade, significant progress has been made in delineating mechanisms responsible for the diminished cardiac contractile function and enhanced propensity for malignant cardiac arrhythmias characteristic of diabetic disease. Rhythmic cardiac contractility relies upon the precise interplay between several cellular Ca<sup>2+</sup> transport protein complexes including plasmalemmal L-type Ca<sup>2+</sup> channels (LTCC), Na<sup>+</sup>-Ca<sup>2+</sup> exchanger (NCX1), Sarco/endoplasmic Reticulum (SR) Ca<sup>2+</sup>-ATPase (SERCa2a) and ryanodine receptors (RyR2s), the SR Ca<sup>2+</sup> release channels. Here we provide an overview of changes in Ca<sup>2+</sup> homeostasis in diabetic ventricular myocytes and discuss the therapeutic potential of targeting Ca<sup>2+</sup> handling proteins in the prevention of diabetes-associated cardiomyopathy and arrhythmogenesis.</p>
</abstract>
<kwd-group>
<kwd>Ca<sup>2+</sup>-dependent cardiac arrhythmia</kwd>
<kwd>diabetes</kwd>
<kwd>heart failure</kwd>
<kwd>L-type Ca<sup>2+</sup> channels</kwd>
<kwd>Na<sup>+</sup>-Ca<sup>2+</sup> exchanger type 1</kwd>
<kwd>ryanodine receptor type 2</kwd>
<kwd>sarco/endoplasmic reticulum Ca<sup>2+</sup>-ATPase type 2a</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">American Heart Association<named-content content-type="fundref-id">10.13039/100000968</named-content></funding-source>
<award-id rid="cn001">18POST33960456</award-id>
</award-group>
<award-group>
<funding-source id="cn002">National Institutes of Health<named-content content-type="fundref-id">10.13039/100000002</named-content></funding-source>
<award-id rid="cn002">HL128507</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="0"></fig-count>
<table-count count="4"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="313"></ref-count>
<page-count count="20"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec>
<title>Introduction</title>
<p>Heart failure (HF) and sudden cardiac death (SCD) due to malignant ventricular arrhythmias remain a major cause of mortality and morbidity in the developed world, in part due to alarming growth in the rates of obesity and diabetes (<xref ref-type="bibr" rid="B21">Benjamin et al., 2018</xref>). Diabetic patients have a two-fold increased risk for SCD and approximately 70 % suffer cardiovascular complications (<xref ref-type="bibr" rid="B54">Chugh et al., 2008</xref>; <xref ref-type="bibr" rid="B135">Laakso, 2008</xref>; <xref ref-type="bibr" rid="B239">Spooner, 2008</xref>; <xref ref-type="bibr" rid="B23">Bergner and Goldberger, 2010</xref>; <xref ref-type="bibr" rid="B232">Siscovick et al., 2010</xref>; <xref ref-type="bibr" rid="B265">Vasiliadis et al., 2014</xref>). Defective intracellular Ca<sup>2+</sup> homeostasis has been established as a key contributor to diabetes-related cardiac dysfunction and enhanced arrhythmogenesis independent of coronary heart disease or hypertension (<xref ref-type="bibr" rid="B19">Belke and Dillmann, 2004</xref>; <xref ref-type="bibr" rid="B7">Aneja et al., 2008</xref>; <xref ref-type="bibr" rid="B122">Junttila et al., 2010</xref>; <xref ref-type="bibr" rid="B186">Pappone and Santinelli, 2010</xref>; <xref ref-type="bibr" rid="B12">Axelsen et al., 2015</xref>; <xref ref-type="bibr" rid="B230">Singh et al., 2018</xref>).</p>
<p>Diabetes is a chronic metabolic disorder characterized by hyperglycemia and reduced glucose utilization due to defective insulin secretion or action (<xref ref-type="bibr" rid="B5">American Diabetes Association, 2009</xref>). Type 1 diabetes is caused by the autoimmune destruction of pancreatic β-cells and a deficiency in insulin production. Linked with increasing rates of obesity, the more prevalent Type 2 diabetes is caused by cellular resistance to insulin and the failure of β-cells to compensate. In the diabetic heart, mitochondrial energetics are altered, with a switch of metabolic substrate from glucose to fatty acids (<xref ref-type="bibr" rid="B41">Boudina and Abel, 2010</xref>; <xref ref-type="bibr" rid="B29">Bertero and Maack, 2018</xref>). An imbalance between energy production and substrate utilization results in increased myocardial oxygen consumption and lipotoxicity, leading to mitochondrial dysfunction and reduced cardiac efficiency (<xref ref-type="bibr" rid="B30">Bhatti et al., 2017</xref>; <xref ref-type="bibr" rid="B29">Bertero and Maack, 2018</xref>). Altered mitochondrial energetics also drive changes in morphology and enhance the emission of reactive oxygen species (ROS), resulting in increased oxidative stress of the myocardium (<xref ref-type="bibr" rid="B227">Shen et al., 2004</xref>; <xref ref-type="bibr" rid="B63">Dabkowski et al., 2009</xref>; <xref ref-type="bibr" rid="B121">Joubert et al., 2018</xref>). It is well established that cardiovascular complications are common in both types of diabetes (<xref ref-type="bibr" rid="B135">Laakso, 2008</xref>; <xref ref-type="bibr" rid="B23">Bergner and Goldberger, 2010</xref>).</p>
<p>In the heart the process of excitation-contraction (EC) coupling drives cyclic changes in intracellular Ca<sup>2+</sup> concentration [Ca<sup>2+</sup>], leading to rhythmic contraction and relaxation of cardiomyocytes in response to variable metabolic demand (<xref ref-type="bibr" rid="B24">Bers, 2002</xref>). Cardiac contractility is precisely regulated by ion channels and exchangers that maintain beat-to-beat Ca<sup>2+</sup> concentrations in the steady state, whereby Ca<sup>2+</sup> influx must equal Ca<sup>2+</sup> efflux (Eisner D. et al., 2013). Depolarization of the sarcolemma and activation of voltage-dependent L-type Ca<sup>2+</sup> channels (LTCCs) leads to Ca<sup>2+</sup> influx into the cytosol. This small influx subsequently triggers a much larger Ca<sup>2+</sup>-induced Ca<sup>2+</sup> release (CICR; <xref ref-type="bibr" rid="B83">Fabiato, 1985</xref>) from the sarcoplasmic reticulum (SR) Ca<sup>2+</sup> stores through ryanodine receptors (RyR2s). The significant global increase in cytosolic [Ca<sup>2+</sup>], known as the Ca<sup>2+</sup> transient, activates contractile machinery and leads to muscle contraction. For relaxation to then occur, Ca<sup>2+</sup> must be sequestered and the intracellular [Ca<sup>2+</sup>] decreased. This is primarily by extrusion from the cytosol via the Na<sup>+</sup>/Ca<sup>2+</sup> exchanger (NCX1), or resequestration into the SR via the sarco/endoplasmic reticulum-ATPase (SERCa2a).</p>
<p>Abnormal function of components of Ca<sup>2+</sup> cycling machinery has been implicated in reduced contractility and proarrhythmic electrical instabilities in a variety of inherited and acquired cardiac diseases including HF and diabetic cardiomyopathy (<xref ref-type="bibr" rid="B137">Lagadic-Gossmann et al., 1996</xref>; <xref ref-type="bibr" rid="B7">Aneja et al., 2008</xref>; <xref ref-type="bibr" rid="B116">Jia et al., 2018</xref>). Reduction of SR Ca<sup>2+</sup> release during systole contributes to diminished contraction, while enhancement of spontaneous Ca<sup>2+</sup> release promotes early and delayed after-depolarizations (i.e., EADs and DADs respectively) of sarcolemma implicated in initiation of triggered activity in the heart (<xref ref-type="bibr" rid="B140">Landstrom et al., 2017</xref>). In addition to trigger for arrhythmia initiation, abnormal Ca<sup>2+</sup> cycling contributes to arrhythmia substrate to maintain and perpetuate it via beat-to-beat alternations of electrical activity of the heart, i.e., alternans (<xref ref-type="bibr" rid="B78">Edwards and Blatter, 2014</xref>).</p>
<p>Despite many similarities in diabetes-related remodeling of Ca<sup>2+</sup> homeostasis in comparison to that in HF, there are also some differences. This may also be complicated by the various animal models and species used to study the condition, highlighted in the review of <xref ref-type="bibr" rid="B127">King (2012)</xref>. Models of Type 1 diabetes include chemically induced hyperglycemia by injection of streptozotocin (STZ) or alloxan (<xref ref-type="bibr" rid="B247">Szkudelski, 2001</xref>), as well as animals with genetically induced β-cell destruction (<xref ref-type="bibr" rid="B165">Mathews et al., 2002</xref>). Type 2 diabetes is modeled in both obese and non-obese animals. Genetically obese models include <italic>ob/ob</italic>, <italic>db/db</italic> and Zucker diabetic fatty (ZDF) hyperglycemic rodents, while obesity can also be induced by high fat diet (HFD) or high-sucrose diet (<xref ref-type="bibr" rid="B126">King and Bowe, 2016</xref>). Although larger animal models have been studied more recently (<xref ref-type="bibr" rid="B286">Xie et al., 2013</xref>; <xref ref-type="bibr" rid="B303">Zhang et al., 2017</xref>; <xref ref-type="bibr" rid="B147">Liang et al., 2018</xref>; <xref ref-type="bibr" rid="B291">Yang et al., 2018</xref>), most research investigating diabetes-related ventricular arrhythmias to date has been performed on rodents and remains limited. Conversely, functional alterations of Ca<sup>2+</sup> handling proteins and EC coupling in HF have been extensively researched over several decades, in both small and large animal models as well as failing human cardiomyocytes (<xref ref-type="bibr" rid="B107">Hasenfuss et al., 1994</xref>; <xref ref-type="bibr" rid="B242">Studer et al., 1994</xref>; <xref ref-type="bibr" rid="B216">Schmidt et al., 1999</xref>; <xref ref-type="bibr" rid="B154">Louch et al., 2004</xref>; <xref ref-type="bibr" rid="B238">Sossalla et al., 2010</xref>; <xref ref-type="bibr" rid="B56">Crossman et al., 2011</xref>; <xref ref-type="bibr" rid="B184">Ottolia et al., 2013</xref>; <xref ref-type="bibr" rid="B309">Zima et al., 2014</xref>; <xref ref-type="bibr" rid="B98">Gorski et al., 2015</xref>; <xref ref-type="bibr" rid="B110">Høydal et al., 2018</xref>).</p>
<p>To place defective Ca<sup>2+</sup> homeostasis in the context of our current understanding of EC coupling in cardiac disease, this review summarizes the changes and contribution of major cardiac Ca<sup>2+</sup> handling proteins LTCC, RyR2, SERCa2a, and NCX1 to the reduced cardiac contractility observed in both HF and diabetes. We discuss the role of perturbed EC coupling in arrhythmogenesis in diabetes and the potential of targeting Ca<sup>2+</sup> handling proteins as an anti-arrhythmic strategy.</p>
</sec>
<sec>
<title>L-Type Ca<sup>2+</sup> Channel</title>
<p>Ca<sup>2+</sup> influx though voltage-dependent L-type Ca<sup>2+</sup> channels (LTCC) during action potential initiates Ca<sup>2+</sup> release from the sarcoplasmic reticulum (SR). The LTCC consists of the pore forming subunit α1c, and regulatory subunits α2/δ and β2 (<xref ref-type="bibr" rid="B173">Muralidharan et al., 2017</xref>). C-terminus associated calmodulin (CaM) confers Ca<sup>2+</sup>-dependent inactivation of the channel (<xref ref-type="bibr" rid="B188">Peterson et al., 1999</xref>; <xref ref-type="bibr" rid="B313">Zühlke et al., 1999</xref>). Activity of LTCC can be increased by PKA phosphorylation (<xref ref-type="bibr" rid="B144">Leach et al., 1996</xref>; <xref ref-type="bibr" rid="B46">Bünemann et al., 1999</xref>). Ca<sup>2+</sup>-dependent inactivation of LTCC can be lessened by CaMKII-phosphorylation, a process activated under oxidizing conditions (<xref ref-type="bibr" rid="B287">Xie et al., 2009</xref>). In addition, evidence suggests that the Ca<sup>2+</sup> channel can be directly activated during oxidative stress, and Cysteine 543 of α1c subunit confers redox sensitivity (<xref ref-type="bibr" rid="B173">Muralidharan et al., 2017</xref>; <xref ref-type="bibr" rid="B279">Wilson et al., 2018</xref>). Clusters of ≤10 channels are primarily localized in T-tubules in the sites of contact with junctional SR, i.e., dyads, opposing clusters of RyR2 Ca<sup>2+</sup> release channels (<xref ref-type="bibr" rid="B112">Inoue and Bridge, 2003</xref>). Such distribution ensures efficiency of Ca<sup>2+</sup> release initiation during EC coupling.</p>
<sec>
<title>L-Type Ca<sup>2+</sup> Channel and Cardiac Arrhythmia</title>
<p>Abnormal LTCC function has been implicated in arrhythmogenesis. Gain of function mutations of Cav1.2α1c, as well as loss of function mutation of CaM (reduced Ca<sup>2+</sup> sensitivity) were linked to hereditary Long QT syndrome type 8 and 14 (<xref ref-type="bibr" rid="B266">Venetucci et al., 2012</xref>; <xref ref-type="bibr" rid="B57">Crotti et al., 2013</xref>; <xref ref-type="bibr" rid="B163">Marsman et al., 2014</xref>). Changes in activation and inactivation parameters leading to widening of so called “window” current were linked to enhanced propensity of reactivation during late phases of AP and thereby generation of early after depolarizations (EADs) (<xref ref-type="bibr" rid="B277">Weiss et al., 2010</xref>). Reduction in LTCC expression levels is thought to promote arrhythmogenic Ca<sup>2+</sup> alternans via reduced fidelity of channel coupling with RyR2s (<xref ref-type="bibr" rid="B106">Harvey and Hell, 2013</xref>). Interestingly, reduced LTCC expression levels in disease states are not always reflected by reduced current. For example, in ventricular cardiomyocytes from human failing hearts I<sub>Ca</sub> was similar to controls, despite of a significant decrease in α1c expression levels, likely due to enhanced phosphorylation by PKA (<xref ref-type="bibr" rid="B50">Chen et al., 2002</xref>). Also, fidelity of LTCC-RyR2 coupling can be reduced due to structural remodeling and loss of T-tubules as in hypertrophy, myocardial infarct and HF (<xref ref-type="bibr" rid="B276">Wei et al., 2010</xref>).</p>
</sec>
<sec>
<title>L-Type Ca<sup>2+</sup> Channel in Diabetes</title>
<p>The majority of studies using various models of diabetes did not find statistically significant changes in I<sub>Ca</sub> with a few exceptions (<xref ref-type="bibr" rid="B187">Pereira et al., 2006</xref>; <xref ref-type="bibr" rid="B156">Lu et al., 2007</xref>). <xref ref-type="bibr" rid="B187">Pereira et al. (2006)</xref> showed that in <italic>db/db</italic> mice (Type 2), the decrease in I<sub>Ca</sub> originates from a reduced number of channels in the sarcolemma. Similar results were obtained in the Akita mouse model (Type 1, <xref ref-type="bibr" rid="B156">Lu et al., 2007</xref>). In both models, steady state activation of I<sub>Ca</sub> was shifted to more positive voltages which is expected to reduce ‘window current.’ However, in the latter model steady state inactivation was found shifted even further to the right, resulting in larger “window current.” The information as to whether LTCCs in diabetes undergo posttranslational modifications, or if their distribution with regard to RyR2s is altered, is scarce. While <xref ref-type="bibr" rid="B224">Shao et al. (2012)</xref> saw no T-tubular remodeling in STZ-diabetic rats, diminished T-tubular density was observed in <italic>db/db</italic> mice (<xref ref-type="bibr" rid="B241">Stølen et al., 2009</xref>). These findings, along with changes in LTCC in HF, are summarized in Table <xref ref-type="table" rid="T1">1</xref>.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Changes in LTCC in HF, inherited syndromes and diabetes.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Change in function</th>
<th align="left" colspan="1" rowspan="1" valign="top">Comments</th>
<th align="left" colspan="1" rowspan="1" valign="top">Reference</th>
</tr>
<tr>
<th align="left" colspan="3" rowspan="1" valign="top">
<hr/>
</th>
</tr>
<tr>
<th align="left" colspan="3" rowspan="1" valign="top">L-type Ca<sup>2+</sup> channel (LTCC)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="3" rowspan="1" valign="top">
<italic>Heart failure</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↔</td>
<td align="left" colspan="1" rowspan="1" valign="top">No change in I<sub>Ca</sub><break></break>No change in basal I<sub>Ca</sub> but significant increase in phosphorylation of LTCC to maintain it</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B169">Mewes and Ravens, 1994</xref>; <xref ref-type="bibr" rid="B37">Bodi et al., 2005</xref><break></break><xref ref-type="bibr" rid="B50">Chen et al., 2002</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↑</td>
<td align="left" colspan="1" rowspan="1" valign="top">Changes in window current that drive EADs, less Ca<sup>2+</sup>-dependent inactivation of I<sub>Ca</sub></td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B26">Bers, 2006</xref>; <xref ref-type="bibr" rid="B277">Weiss et al., 2010</xref><break></break></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↓</td>
<td align="left" colspan="1" rowspan="1" valign="top">Impaired trafficking/reduced abundance in T tubules<break></break>LTCC-RyR2 coupling fidelity reduced</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B109">Hong et al., 2012</xref>
<break></break>
<xref ref-type="bibr" rid="B106">Harvey and Hell, 2013</xref>
</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" valign="top">
<italic>Inherited syndromes</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↑</td>
<td align="left" colspan="1" rowspan="1" valign="top">Gain of function mutations in Cav1.2 (Long QT syndrome 8)<break></break>Loss of function CaM mutation reduced Ca<sup>2+</sup> sensitivity (Long QT syndrome 14)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B36">Boczek et al., 2013</xref>; <xref ref-type="bibr" rid="B295">Ye et al., 2018</xref><break></break><xref ref-type="bibr" rid="B57">Crotti et al., 2013</xref>; <xref ref-type="bibr" rid="B163">Marsman et al., 2014</xref></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" valign="top">
<italic>Type 1 diabetes</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↔</td>
<td align="left" colspan="1" rowspan="1" valign="top">No change in I<sub>Ca</sub> in STZ-induced diabetic rats</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B234">Smail et al., 2016</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↓</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced I<sub>Ca</sub> in Akita(ins2) mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B156">Lu et al., 2007</xref>
</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" valign="top">
<italic>Type 2 diabetes</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↔</td>
<td align="left" colspan="1" rowspan="1" valign="top">No change in I<sub>Ca</sub> in Goto-Kakizaki rats</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B211">Salem et al., 2013</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↓</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced number of LTCC channels in sarcolemma in <italic>db/db</italic> mice<break></break>Reduced I<sub>Ca</sub> in <italic>db/db</italic> mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B187">Pereira et al., 2006</xref>
<break></break>
<xref ref-type="bibr" rid="B155">Lu et al., 2011</xref>
</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec>
<title>The Ryanodine Receptor</title>
<p>The cardiac SR Ca<sup>2+</sup> release channel, RyR2, is a large 2.2 MDa homotetramer consisting of four 565 kDa subunits (<xref ref-type="bibr" rid="B261">Tunwell et al., 1996</xref>). While a variety of physiological ligands can modulate RyR2 channel activity including Mg<sup>2+</sup> and ATP, Ca<sup>2+</sup> is the primary effector of function (<xref ref-type="bibr" rid="B24">Bers, 2002</xref>; <xref ref-type="bibr" rid="B89">Fill and Copello, 2002</xref>). During EC coupling, the LTCC-mediated influx of cytosolic Ca<sup>2+</sup> and increase in [Ca<sup>2+</sup>] drives activation of other RyR2 channels within the cardiomyocyte via CICR (<xref ref-type="bibr" rid="B83">Fabiato, 1985</xref>). Activation of single RyR2 clusters consisting of 8–100 channels (<xref ref-type="bibr" rid="B13">Baddeley et al., 2009</xref>) generates a local increase in the concentration of cytosolic Ca<sup>2+</sup>, known as a Ca<sup>2+</sup> spark (<xref ref-type="bibr" rid="B51">Cheng et al., 1996</xref>). The summation of Ca<sup>2+</sup> sparks produced by activated RyR2 clusters throughout the cardiomyocyte leads to a global Ca<sup>2+</sup> transient that initiates muscle contraction (<xref ref-type="bibr" rid="B51">Cheng et al., 1996</xref>).</p>
<p>The positive feedback nature of CICR means it is a self-regenerating process that would be inherently unstable without some mechanism for termination of RyR2-mediated Ca<sup>2+</sup> release (<xref ref-type="bibr" rid="B89">Fill and Copello, 2002</xref>; <xref ref-type="bibr" rid="B133">Kunitomo and Terentyev, 2011</xref>). Several candidate mechanisms have been proposed. While it was originally thought that the binding of Ca<sup>2+</sup> to cytosolic low affinity sites on the channel during Ca<sup>2+</sup> release inactivated RyR2 channels (<xref ref-type="bibr" rid="B83">Fabiato, 1985</xref>), it is now apparent that cytosolic Ca<sup>2+</sup> plays a limited role in the termination of CICR. There is an accumulation of evidence that demonstrates RyR2 responds to luminal Ca<sup>2+</sup> concentrations (<xref ref-type="bibr" rid="B233">Sitsapesan and Williams, 1994</xref>; <xref ref-type="bibr" rid="B158">Lukyanenko et al., 1996</xref>; <xref ref-type="bibr" rid="B101">Györke and Györke, 1998</xref>; <xref ref-type="bibr" rid="B252">Terentyev et al., 2002</xref>), with Ca<sup>2+</sup> spark termination occurring when SR [Ca<sup>2+</sup>] falls to a certain level (<xref ref-type="bibr" rid="B44">Brochet et al., 2005</xref>; <xref ref-type="bibr" rid="B250">Terentyev et al., 2008</xref>; <xref ref-type="bibr" rid="B311">Zima et al., 2008</xref>). Depletion may cause unbinding of Ca<sup>2+</sup> from luminal activation sites and drive closing of the channel [i.e., deactivation (<xref ref-type="bibr" rid="B117">Jiang et al., 2007</xref>; <xref ref-type="bibr" rid="B250">Terentyev et al., 2008</xref>)]. More recently, in a hypothesis termed ‘induction decay’ or ‘pernicious attrition’ (<xref ref-type="bibr" rid="B95">Gillespie and Fill, 2013</xref>; <xref ref-type="bibr" rid="B142">Laver et al., 2013</xref>), it was hypothesized that by decreasing local concentrations of cytosolic Ca<sup>2+</sup>, a reduction in unitary current via RyR2 breaks the positive-feedback loop of CICR within a cluster. Another phenomenon related to termination is refractoriness of SR Ca<sup>2+</sup> release, a period after RyR2 activation and deactivation during which another Ca<sup>2+</sup> release event cannot occur (<xref ref-type="bibr" rid="B221">Sham et al., 1998</xref>; <xref ref-type="bibr" rid="B245">Szentesi et al., 2004</xref>; <xref ref-type="bibr" rid="B103">Györke and Terentyev, 2008</xref>). While it was thought that the refractory state persists until SR [Ca<sup>2+</sup>] is recovered to a critical level, SR Ca<sup>2+</sup> load was shown to recover to pre-release levels long before spontaneous Ca<sup>2+</sup> wave initiation (<xref ref-type="bibr" rid="B17">Belevych et al., 2012</xref>). Mechanisms that determine the refractoriness of CICR remain incompletely understood.</p>
<p>While RyR2 channels open and release Ca<sup>2+</sup> from the SR in response to LTCC-mediated Ca<sup>2+</sup> influx, channels are not completely closed and have a finite open probability, leading to substantial Ca<sup>2+</sup> leak during diastole (<xref ref-type="bibr" rid="B27">Bers, 2014</xref>; <xref ref-type="bibr" rid="B81">Eisner et al., 2017</xref>). This Ca<sup>2+</sup> leak, measurable as Ca<sup>2+</sup> sparks, plays an important physiological role in determining the appropriate SR Ca<sup>2+</sup> load of cardiomyocytes and threshold for SR Ca<sup>2+</sup> release (<xref ref-type="bibr" rid="B51">Cheng et al., 1996</xref>; <xref ref-type="bibr" rid="B81">Eisner et al., 2017</xref>).</p>
<p>Multiple accessory proteins have been shown to coimmunoprecipitate with RyR2, indicative that the channels exist as large macromolecular complexes (<xref ref-type="bibr" rid="B25">Bers, 2004</xref>; <xref ref-type="bibr" rid="B167">Meissner, 2017</xref>). The Ca<sup>2+</sup> binding protein calmodulin (CaM) directly associates with and regulates RyR2 channels (<xref ref-type="bibr" rid="B212">Samsó and Wagenknecht, 2002</xref>; <xref ref-type="bibr" rid="B25">Bers, 2004</xref>), while auxilliary proteins CSQ, triadin (TRDN) and junctin (JUN) form the luminal Ca<sup>2+</sup> sensor of RyR2 within the SR (<xref ref-type="bibr" rid="B102">Györke et al., 2004</xref>; <xref ref-type="bibr" rid="B103">Györke and Terentyev, 2008</xref>). FK506 binding protein 12.6 (FKBP12.6) is also an accessory protein of RyR2, and the interaction was proposed to stabilize the channel, preventing spontaneous Ca<sup>2+</sup> release and SR Ca<sup>2+</sup> leak, although this phenomenon was not observed by many others (<xref ref-type="bibr" rid="B164">Marx et al., 2000</xref>; <xref ref-type="bibr" rid="B197">Prestle et al., 2001</xref>; <xref ref-type="bibr" rid="B94">George et al., 2003</xref>; <xref ref-type="bibr" rid="B97">Goonasekera et al., 2005</xref>; <xref ref-type="bibr" rid="B272">Wehrens et al., 2005</xref>).</p>
<p>During β-adrenergic stimulation as part of the ‘fight or flight’ response, several EC coupling proteins are targets for posttranslational modification, with phosphorylation well established as a regulatory mechanism modulates ion channel activity with positive chronotropic and inotropic effects to enhance cardiac function (<xref ref-type="bibr" rid="B24">Bers, 2002</xref>). The RyR2 channel complex includes a network of associated kinases (protein kinase A (PKA) and Ca<sup>2+</sup>-calmodulin dependent protein kinase II (CaMKII)) and phosphatases (PP1, PP2A, and PP2B) that dynamically and reversibly modulate its phosphorylation state (<xref ref-type="bibr" rid="B16">Belevych et al., 2011a</xref>; <xref ref-type="bibr" rid="B177">Niggli et al., 2013</xref>; <xref ref-type="bibr" rid="B249">Terentyev and Hamilton, 2016</xref>). Three major phosphorylation sites have been identified – PKA-specific Serine 2808 (S2808) and Serine 2031 (S2031), and CaMKII-specific Serine 2814 (S2814) (<xref ref-type="bibr" rid="B282">Witcher et al., 1991</xref>; <xref ref-type="bibr" rid="B275">Wehrens et al., 2004b</xref>; <xref ref-type="bibr" rid="B284">Xiao et al., 2005</xref>).</p>
<p>Another major posttranslational modification of RyR2 function is oxidation (<xref ref-type="bibr" rid="B310">Zima and Mazurek, 2016</xref>). To maintain a fine-tuned balance of reduced and oxidized proteins within the cardiomyocytes, there are multiple sources of ROS as well as antioxidant defense components (<xref ref-type="bibr" rid="B289">Xu et al., 1998</xref>). There are approximately 21 cysteine residues within RyR2 that are reduced under physiological conditions, and the channel is known to be susceptible to reversible redox modification (<xref ref-type="bibr" rid="B289">Xu et al., 1998</xref>; <xref ref-type="bibr" rid="B77">Dulhunty et al., 2000</xref>). At the single channel level, oxidation of RyR2 increases channel open probability and increases the sensitivity to activating Ca<sup>2+</sup>, while reducing agents have opposite effects (<xref ref-type="bibr" rid="B40">Boraso and Williams, 1994</xref>; <xref ref-type="bibr" rid="B289">Xu et al., 1998</xref>; <xref ref-type="bibr" rid="B210">Salama et al., 2000</xref>).</p>
<sec>
<title>The Ryanodine Receptor and Cardiac Arrhythmia</title>
<p>Under pathophysiological conditions, diastolic Ca<sup>2+</sup> leak from the SR is increased, thus exceeding the critical threshold level and increasing RyR2 channel activation, which in turn activates other channels and results in proarrhythmic diastolic Ca<sup>2+</sup> waves (<xref ref-type="bibr" rid="B51">Cheng et al., 1996</xref>). This subsequently activates NCX1, driving a net inward current that gives rise to delayed after depolarizations (DADs) and arrhythmias (<xref ref-type="bibr" rid="B88">Ferrier et al., 1973</xref>; <xref ref-type="bibr" rid="B166">Mechmann and Pott, 1986</xref>; <xref ref-type="bibr" rid="B140">Landstrom et al., 2017</xref>). Evidence suggests that increased refractory period shortening, thus increased RyR2-mediated SR Ca<sup>2+</sup> leak, promotes Ca<sup>2+</sup>-dependent arrhythmias in failing hearts (<xref ref-type="bibr" rid="B17">Belevych et al., 2012</xref>; <xref ref-type="bibr" rid="B45">Brunello et al., 2013</xref>; <xref ref-type="bibr" rid="B55">Cooper et al., 2013</xref>).</p>
<p>Abnormal Ca<sup>2+</sup> release is the driving force for arrhythmia observed in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT), a condition characterized by pathogenic mutations in RyR2 (<xref ref-type="bibr" rid="B199">Priori et al., 2002</xref>; <xref ref-type="bibr" rid="B198">Priori and Chen, 2011</xref>), as well as in associated accessory proteins including CSQ (<xref ref-type="bibr" rid="B251">Terentyev et al., 2006</xref>; <xref ref-type="bibr" rid="B179">Nyegaard et al., 2012</xref>; <xref ref-type="bibr" rid="B208">Roux-Buisson et al., 2012</xref>). The condition presents under conditions of enhanced catecholaminergic drive, in the absence of any structural defects in the heart (<xref ref-type="bibr" rid="B199">Priori et al., 2002</xref>; <xref ref-type="bibr" rid="B255">Tester et al., 2005</xref>). Premature ventricular contractions (PVCs) that often manifest during exercise or periods of stress can degenerate into polymorphic or bidirectional ventricular tachycardia (VT) or fibrillation (VF) and subsequently lead to SCD. Mutations in RyR2 associated with CPVT usually cause increased SR Ca<sup>2+</sup> leak that is exacerbated by β-adrenergic stimulation, but both gain- and loss-of-function mutations have been reported (<xref ref-type="bibr" rid="B271">Wehrens et al., 2003</xref>; <xref ref-type="bibr" rid="B151">Loaiza et al., 2013</xref>; <xref ref-type="bibr" rid="B305">Zhao et al., 2015</xref>; <xref ref-type="bibr" rid="B140">Landstrom et al., 2017</xref>; <xref ref-type="bibr" rid="B264">Uehara et al., 2017</xref>). Mutations in CSQ cause reduction or complete loss of protein expression, and without CSQ-mediated Ca<sup>2+</sup> buffering within the SR, RyR2 channels are prone to spontaneous activation, offering a trigger for arrhythmia (<xref ref-type="bibr" rid="B292">Yano and Zarain-Herzberg, 1994</xref>; <xref ref-type="bibr" rid="B138">Lahat et al., 2001</xref>; <xref ref-type="bibr" rid="B130">Knollmann et al., 2006</xref>; <xref ref-type="bibr" rid="B84">Faggioni et al., 2012</xref>).</p>
<p>The significance of altered PKA-mediated phosphorylation of RyR2 function in the pathogenesis of cardiac arrhythmia remains controversial. Hyperphosphorylation of RyR2 at S2808 was originally hypothesized to cause dissociation of FKBP12.6, destabilizing the channel and thus increasing open channel probability (<xref ref-type="bibr" rid="B164">Marx et al., 2000</xref>). However, the significance of both phosphorylation at this site and the role of PKA-mediated phosphorylation on the function of RyR2 remains a disputed subject (<xref ref-type="bibr" rid="B118">Jiang et al., 2002</xref>; <xref ref-type="bibr" rid="B22">Benkusky et al., 2007</xref>; <xref ref-type="bibr" rid="B59">Curran et al., 2007</xref>; <xref ref-type="bibr" rid="B18">Belevych et al., 2011b</xref>; <xref ref-type="bibr" rid="B43">Bovo et al., 2017</xref>). The role of CaMKII-mediated Ry2 phosphorylation in modulating channel function is more strongly supported, with consensus that activation of CaMKII as opposed to PKA increases SR Ca<sup>2+</sup> leak (<xref ref-type="bibr" rid="B1">Ai et al., 2005</xref>; <xref ref-type="bibr" rid="B59">Curran et al., 2007</xref>; <xref ref-type="bibr" rid="B177">Niggli et al., 2013</xref>), although this is not universal (<xref ref-type="bibr" rid="B273">Wehrens et al., 2006</xref>; <xref ref-type="bibr" rid="B290">Yang et al., 2007</xref>). It is also well established that chronic CaMKII activity in cardiac disease is a major regulator of RyR2 function with arrhythmogenic consequences (<xref ref-type="bibr" rid="B1">Ai et al., 2005</xref>; <xref ref-type="bibr" rid="B301">Zhang et al., 2005</xref>; <xref ref-type="bibr" rid="B248">Terentyev et al., 2009</xref>; <xref ref-type="bibr" rid="B17">Belevych et al., 2012</xref>; <xref ref-type="bibr" rid="B205">Respress et al., 2012</xref>; <xref ref-type="bibr" rid="B263">Uchinoumi et al., 2016</xref>). Additionally, oxidation as a posttranslational modification may alter RyR2 function in cardiac disease. In the healthy heart, oxidation may serve to transiently enhance Ca<sup>2+</sup> release, increasing cardiac output (<xref ref-type="bibr" rid="B177">Niggli et al., 2013</xref>). However, in conditions of severe oxidative stress such as HF, increased RyR2 oxidation by ROS can lead to RyR2 activation and increased proarrhythmic SR Ca<sup>2+</sup> leak (<xref ref-type="bibr" rid="B172">Mochizuki et al., 2007</xref>; <xref ref-type="bibr" rid="B16">Belevych et al., 2011a</xref>,<xref ref-type="bibr" rid="B18">b</xref>). Modulation of RyR2 activity by ROS can also be indirect, via the oxidation of CaMKII and subsequent increased CaMKII-mediated phosphorylation of the channel (<xref ref-type="bibr" rid="B49">Chelu et al., 2009</xref>; <xref ref-type="bibr" rid="B6">Anderson, 2015</xref>).</p>
<p>The SR Ca<sup>2+</sup> load is thought to be a critical factor of cardiac alternans, a repetitive beat-to-beat fluctuation in cellular repolarization at a constant heart rate that closely linked to development of ventricular arrhythmias (<xref ref-type="bibr" rid="B78">Edwards and Blatter, 2014</xref>). Any impairment in the refractoriness of RyR2-mediated Ca<sup>2+</sup> release or the recovery after channel inactivation may facilitate the onset of alternans, due to a reduction in the subsequent Ca<sup>2+</sup> transient amplitude (<xref ref-type="bibr" rid="B78">Edwards and Blatter, 2014</xref>). These properties of RyR2 have been shown to be a major component underlying generation of alternans in both computational and experimental studies (<xref ref-type="bibr" rid="B235">Sobie et al., 2006</xref>; <xref ref-type="bibr" rid="B178">Nivala and Qu, 2012</xref>; <xref ref-type="bibr" rid="B228">Shkryl et al., 2012</xref>; <xref ref-type="bibr" rid="B4">Alvarez-Lacalle et al., 2013</xref>; <xref ref-type="bibr" rid="B244">Sun et al., 2018</xref>).</p>
</sec>
<sec>
<title>The Ryanodine Receptor in Diabetes</title>
<p>It is well established that increased SR Ca<sup>2+</sup> leak due to enhanced RyR2 channel activity significantly contributes to arrhythmogenic potential in diabetic cardiomyopathy.</p>
<p>Injection of STZ destroys insulin-producing β cells and has long been used for the generation of Type 1 diabetes phenotypes. Early studies of RyR2-mediated Ca<sup>2+</sup> release in diabetes utilized STZ-diabetic rat models. Work of <xref ref-type="bibr" rid="B297">Yu et al. (1994)</xref> showed that cardiomyocytes from STZ-diabetic rats had reduced maximum rates of shortening and relengthening, as well as depressed SR Ca<sup>2+</sup> content. Using [<sup>3</sup>H] ryanodine binding assay as an indication of RyR2 channel functionality, isolated SR membranes from diabetic rats showed reduced high-affinity binding sites. <xref ref-type="bibr" rid="B31">Bidasee et al. (2001)</xref> also reported decreased [<sup>3</sup>H] ryanodine binding in 6-week post STZ injection, but posited this was due to dysfunctional RyR2 rather than a decrease in protein expression or mRNA level as observed in <xref ref-type="bibr" rid="B254">Teshima et al. (2000)</xref> and <xref ref-type="bibr" rid="B52">Choi et al. (2002)</xref>. Interestingly, <xref ref-type="bibr" rid="B304">Zhao et al. (2014)</xref> found that Ca<sup>2+</sup> spark frequency showed a gradual decline in correlation with progression of STZ-diabetes, with significant differences between 4-week and 12-week post-injection groups.</p>
<p><xref ref-type="bibr" rid="B294">Yaras et al. (2005)</xref> importantly showed increased Ca<sup>2+</sup> spark frequency in cardiomyocytes from STZ-diabetic rat, with a reduced Ca<sup>2+</sup> transient amplitude and depressed SR Ca<sup>2+</sup> loading. This was accompanied by significantly increased phosphorylation of RyR2 at S2808 and a ∼40% decrease in FKBP12.6 association. Similar findings were reported by other groups, where these phenomena were suggested to underscore depressed SR Ca<sup>2+</sup> release in STZ-diabetic cardiomyocytes (<xref ref-type="bibr" rid="B223">Shao et al., 2007</xref>, <xref ref-type="bibr" rid="B225">2009</xref>; <xref ref-type="bibr" rid="B260">Tuncay et al., 2014</xref>), indicative that Ca<sup>2+</sup> leak via hyperactive RyR2 contributes to the disease phenotype. Later work showed that exercise training for 4 weeks could attenuate this, reducing S2808 phosphorylation and increase levels of FKBP12.6 expression (<xref ref-type="bibr" rid="B225">Shao et al., 2009</xref>). However, the functional role of PKA-mediated RyR2 phosphorylation remains controversial and many studies have shown phosphorylation at the S2808 site does not modulate channel activity in other cardiac disease states (<xref ref-type="bibr" rid="B285">Xiao et al., 2004</xref>; <xref ref-type="bibr" rid="B100">Guo et al., 2010</xref>). An increase in endogenous CaMKII-mediated phosphorylation of RyR2 has also been implicated in the aberrant Ca<sup>2+</sup> handling observed in STZ-diabetic rats (<xref ref-type="bibr" rid="B176">Netticadan et al., 2001</xref>) and <italic>db/db</italic> mice (<xref ref-type="bibr" rid="B241">Stølen et al., 2009</xref>). Conversely, <xref ref-type="bibr" rid="B256">Tian et al. (2011)</xref> posited that gain-of-function changes in RyR2 function observed in single channel recordings were independent of phosphorylation at either S2808 or S2814 sites. Instead, the increase in open channel probability and 20% reduction in conductance was attributed to increased responsiveness to cytoplasmic activators including Ca<sup>2+</sup>, alterations in the threshold for activation by luminal Ca<sup>2+</sup>, and a blunted response to physiological inhibitors.</p>
<p>Other posttranslational modifications of RyR2 in Type 1 diabetes have also been suggested to underscore channel dysfunction. <xref ref-type="bibr" rid="B32">Bidasee et al. (2003a)</xref> suggested RyR2 dysfunction, evidenced by decreased [<sup>3</sup>H] ryanodine binding in STZ-diabetic rats, was in part due to formation of disulfide bonds between adjacent sulfhydryl groups. The same group also showed that non-cross-linking advanced glycation end products (AGEs) on RyR2 are significantly increased in diabetic heart tissue, and this increase could be partially attenuated with insulin treatment (<xref ref-type="bibr" rid="B33">Bidasee et al., 2003b</xref>). Extensive carbonylation of RyR2 by increased reactive carbonyl species (RCS) in STZ- diabetic rats was suggested to reduce the responsiveness of RyR2 to cytoplasmic Ca<sup>2+</sup>. While expression levels of RyR2 remained unchanged, there was an increase in non-functional RyR2 channels, but also an increase in the activity of others. The increased heterogeneity of RyR2 channels was posited to increase spontaneous and dyssynchronous SR Ca<sup>2+</sup> release in isolated cardiomyocytes, thus providing a trigger for arrhythmia. Treatment of diabetic rats with RCS scavengers attenuated spontaneous SR Ca<sup>2+</sup> release, reduced RyR2 carbonylation and normalized channel functionality.</p>
<p>Fewer studies have investigated changes in RyR2-mediated Ca<sup>2+</sup> handling in models of Type 2 diabetes. In the non-failing myocardium of type 2 diabetic patients RyR2 protein expression was decreased, while mRNA levels were decreased in the Goto-Kakizaki model (<xref ref-type="bibr" rid="B206">Reuter et al., 2008</xref>; <xref ref-type="bibr" rid="B91">Gaber et al., 2014</xref>). In a prediabetic model of metabolic syndrome, whereby dogs were chronically fed a high fat diet (HFD), phosphorylation of RyR2 at S2808 was significantly elevated and the channel’s ability to bind [<sup>3</sup>H] ryanodine significantly depressed in the ventricles compared to healthy controls, while no changes in RyR2 mRNA or protein expression were observed (<xref ref-type="bibr" rid="B72">Dinçer et al., 2006</xref>). <xref ref-type="bibr" rid="B181">Okatan et al. (2016)</xref> also observed increased RyR2 phosphorylation at S2808 in rats with high sucrose diet-induced metabolic syndrome, accompanied by reduced FKBP12.6 expression. Through studies of electric-field stimulated intracellular Ca<sup>2+</sup> handling, cardiomyocytes isolated from rats with metabolic syndrome showed significantly increased SR Ca<sup>2+</sup> leak, depressed SR Ca<sup>2+</sup> loading and reduced Ca<sup>2+</sup> transient amplitude vs. controls. This data is suggestive that alterations in RyR2 function and SR Ca<sup>2+</sup> release may be an important mechanism of early cardiac dysfunction in insulin resistance and diabetes development.</p>
<p>Abnormal intracellular lipid concentration is a hallmark of both obesity and diabetes, and <xref ref-type="bibr" rid="B119">Joseph et al. (2016)</xref> recently studied Ca<sup>2+</sup> handling in cardiomyocytes from a transgenic model of cardiac lipid overload, with peroxisome proliferator-activated receptor-γ (PPARg) overexpression. This revealed increased Ca<sup>2+</sup> spark activity compared to controls that could be reduced by application of antioxidant mitoTEMPO. A significant increase in mitochondrial oxidative stress was suggested to increase RyR2 oxidation and subsequent SR Ca<sup>2+</sup> release. In 8-week mice with HFD-induced obesity, <xref ref-type="bibr" rid="B213">Sánchez et al. (2018)</xref> reported a shift in the distribution of single RyR2 channel responsiveness to activating cytosolic [Ca<sup>2+</sup>], whereby channels were much more active to those isolated from control mice. No changes were observed in RyR2 expression levels or phosphorylation status at S2808 or S2814 sites. Instead, this phenomenon was attributed to significantly increased RyR2 oxidation in HFD-mice, implicating the diabetes-related increase in oxidative stress in abnormal Ca<sup>2+</sup> handling. Changes in RyR2 in HF and diabetes are summarized in Table <xref ref-type="table" rid="T2">2</xref>.</p>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p>Changes in RyR2 in HF, inherited syndromes and diabetes.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Change in function</th>
<th align="left" colspan="1" rowspan="1" valign="top">Comments</th>
<th align="left" colspan="1" rowspan="1" valign="top">Reference</th>
</tr>
<tr>
<th align="left" colspan="3" rowspan="1" valign="top">
<hr/>
</th>
</tr>
<tr>
<th align="left" colspan="3" rowspan="1" valign="top">
<bold>Ryanodine Receptor (RyR2)</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="3" rowspan="1" valign="top">
<italic>Heart failure</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↑</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increases diastolic SR Ca<sup>2+</sup> leak, resulting in diastolic Ca<sup>2+</sup> waves<break></break>Increased phosphorylation (S2808)<break></break>Decreased FKBP12.6 association<break></break>Increased phosphorylation (S2031)<break></break>Increased phosphorylation (S2814)<break></break><break></break>Increased oxidation<break></break><break></break>Other posttranslational modifications</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B18">Belevych et al., 2011b</xref>; <xref ref-type="bibr" rid="B51">Cheng et al., 1996</xref><break></break><xref ref-type="bibr" rid="B164">Marx et al., 2000</xref><break></break><xref ref-type="bibr" rid="B164">Marx et al., 2000</xref>; <xref ref-type="bibr" rid="B271">Wehrens et al., 2003</xref>; <xref ref-type="bibr" rid="B272">Wehrens et al., 2005</xref><break></break><xref ref-type="bibr" rid="B284">Xiao et al., 2005</xref><break></break><xref ref-type="bibr" rid="B1">Ai et al., 2005</xref>; <xref ref-type="bibr" rid="B59">Curran et al., 2007</xref>; <xref ref-type="bibr" rid="B248">Terentyev et al., 2009</xref>; <xref ref-type="bibr" rid="B238">Sossalla et al., 2010</xref>; <xref ref-type="bibr" rid="B18">Belevych et al., 2011b</xref>; <xref ref-type="bibr" rid="B205">Respress et al., 2012</xref>; <xref ref-type="bibr" rid="B76">Dries et al., 2018</xref><break></break><xref ref-type="bibr" rid="B172">Mochizuki et al., 2007</xref>; <xref ref-type="bibr" rid="B250">Terentyev et al., 2008</xref>;<break></break><xref ref-type="bibr" rid="B18">Belevych et al., 2011b</xref>
<break></break><xref ref-type="bibr" rid="B289">Xu et al., 1998</xref>; <xref ref-type="bibr" rid="B15">Barouch et al., 2002</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Inherited syndromes</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↑</td>
<td align="left" colspan="1" rowspan="1" valign="top">CPVT; mostly gain of function RyR2 mutations, or mutations in accessory proteins</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B292">Yano and Zarain-Herzberg, 1994</xref>; <xref ref-type="bibr" rid="B138">Lahat et al., 2001</xref>; <xref ref-type="bibr" rid="B199">Priori et al., 2002</xref>; <xref ref-type="bibr" rid="B251">Terentyev et al., 2006</xref>; <xref ref-type="bibr" rid="B208">Roux-Buisson et al., 2012</xref></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" valign="top">
<italic>Type 1 diabetes</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↑</td>
<td align="left" colspan="1" rowspan="1" valign="top">Decreased protein expression/mRNA level in STZ-diabetic rats (increased activity due to posttranslational modification)<break></break>Increased PKA-mediated phosphorylation (S2808) in STZ-diabetic rats<break></break><break></break>Decreased FKBP12.6 association in STZ-diabetic rats<break></break><break></break>Increased CaMKII-mediated phosphorylation (S2814) in STZ-diabetic rats<break></break>Other posttranslational modification in STZ-diabetic rats (oxidation, carbonylation, AGEs)<break></break>Change in sensitivity to cytosolic or luminal Ca<sup>2+</sup> activation in STZ diabetic rats</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B254">Teshima et al., 2000</xref>; <xref ref-type="bibr" rid="B294">Yaras et al., 2005</xref>; <xref ref-type="bibr" rid="B304">Zhao et al., 2014</xref>; <xref ref-type="bibr" rid="B53">Chou et al., 2017</xref><break></break><xref ref-type="bibr" rid="B176">Netticadan et al., 2001</xref>; <xref ref-type="bibr" rid="B294">Yaras et al., 2005</xref>; <xref ref-type="bibr" rid="B223">Shao et al., 2007</xref>, <xref ref-type="bibr" rid="B225">2009</xref><break></break><xref ref-type="bibr" rid="B294">Yaras et al., 2005</xref>; <xref ref-type="bibr" rid="B223">Shao et al., 2007</xref>, <xref ref-type="bibr" rid="B225">2009</xref>; <xref ref-type="bibr" rid="B260">Tuncay et al., 2014</xref>; <xref ref-type="bibr" rid="B304">Zhao et al., 2014</xref><break></break><xref ref-type="bibr" rid="B176">Netticadan et al., 2001</xref>; <xref ref-type="bibr" rid="B225">Shao et al., 2009</xref><break></break><xref ref-type="bibr" rid="B32">Bidasee et al., 2003a</xref>,<xref ref-type="bibr" rid="B33">b</xref>; <xref ref-type="bibr" rid="B224">Shao et al., 2012</xref><break></break><break></break><xref ref-type="bibr" rid="B256">Tian et al., 2011</xref>; <xref ref-type="bibr" rid="B224">Shao et al., 2012</xref></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" valign="top">
<italic>Type 2 diabetes</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↑</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced protein expression in nonfailing diabetic human myocardium, with increased phosphorylation<break></break>Reduced mRNA levels in Goto-Kakizaki rats<break></break>Reduced protein expression levels in PPARg mice with lipid overload<break></break>Increased PKA-mediated phosphorylation (S2808) in high-sucrose diet rats and HFD dogs<break></break>Increased oxidation in PPARg mice with lipid overload and HFD mice<break></break>Change in sensitivity to cytosolic or luminal Ca<sup>2+</sup> activation in HFD mice</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B206">Reuter et al., 2008</xref><break></break><break></break><xref ref-type="bibr" rid="B91">Gaber et al., 2014</xref><break></break><xref ref-type="bibr" rid="B119">Joseph et al., 2016</xref><break></break><xref ref-type="bibr" rid="B72">Dinçer et al., 2006</xref>; <xref ref-type="bibr" rid="B181">Okatan et al., 2016</xref><break></break><break></break><xref ref-type="bibr" rid="B119">Joseph et al., 2016</xref>; <xref ref-type="bibr" rid="B213">Sánchez et al., 2018</xref><break></break><xref ref-type="bibr" rid="B213">Sánchez et al., 2018</xref></td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec>
<title>Sarco/Endoplasmic Reticulum Ca<sup>2+</sup>-Atpase</title>
<p>For relaxation to occur, intracellular [Ca<sup>2+</sup>] is decreased primarily via sequestration into the SR by SERCa2a, the primary cardiac SERCa isoform (<xref ref-type="bibr" rid="B24">Bers, 2002</xref>). While SERCa2a interacts with multiple proteins (including calreticulin, HRC, PP1, S100A, sarcolipin, SUMO), the most important regulator of function is phospholamban (PLB) (<xref ref-type="bibr" rid="B132">Kranias and Hajjar, 2012</xref>). Unphosphorylated PLB has an inhibitory effect on SERCa2a activity, lowering affinity of the pump for Ca<sup>2+</sup>. Conversely phosphorylation of PLB, either by PKA at Serine 16 (S16) or CaMKII at Threonine 17 (T17), relieves SERCa2a inhibition and increases activity (<xref ref-type="bibr" rid="B229">Simmerman et al., 1986</xref>). Oxidative thiol modification of SERCa2a at Cysteine 674 also enhances function (<xref ref-type="bibr" rid="B139">Lancel et al., 2009</xref>). Upregulated SERCa2a function is the primary mechanism for positive lusitropic (accelerated relaxation) and inotropic (increased contraction) responses during β-adrenergic stimulation (<xref ref-type="bibr" rid="B86">Fearnley et al., 2011</xref>; <xref ref-type="bibr" rid="B267">Vervliet et al., 2018</xref>).</p>
<sec>
<title>Sarco/Endoplasmic Reticulum Ca<sup>2+</sup>-ATPase and Cardiac Arrhythmia</title>
<p>In HF, impaired SERCa2a expression and activity blunts Ca<sup>2+</sup> transient amplitude and rate of decay (<xref ref-type="bibr" rid="B281">Winslow et al., 1999</xref>). Reduced sequestration of Ca<sup>2+</sup> into the SR drives Ca<sup>2+</sup> extrusion from the cardiomyocyte via NCX1. This generates a net inward depolarizing current that can prolong action potential and thus facilitate triggered activity (<xref ref-type="bibr" rid="B183">O’Rourke et al., 1999</xref>; <xref ref-type="bibr" rid="B28">Bers et al., 2002</xref>). Diminished SR Ca<sup>2+</sup> uptake by SERCa2a is also associated with the initiation of cardiac alternans (<xref ref-type="bibr" rid="B168">Merchant and Armoundas, 2012</xref>; <xref ref-type="bibr" rid="B178">Nivala and Qu, 2012</xref>).</p>
<p>While it may seem counterintuitive to increase SR Ca<sup>2+</sup> uptake as a therapeutic strategy, given that SR Ca<sup>2+</sup> overload may exacerbate SR Ca<sup>2+</sup> leak through RyR2, accumulated evidence suggests the contrary. Upregulation of SERCa2a in small and large animal studies has been shown to protect against development of arrhythmias, improve contractile function and normalize intracellular Ca<sup>2+</sup> handling (<xref ref-type="bibr" rid="B171">Meyer and Dillmann, 1998</xref>; <xref ref-type="bibr" rid="B65">del Monte et al., 2001</xref>, <xref ref-type="bibr" rid="B67">2004</xref>; <xref ref-type="bibr" rid="B243">Suarez et al., 2004</xref>; <xref ref-type="bibr" rid="B201">Prunier et al., 2008</xref>; <xref ref-type="bibr" rid="B159">Lyon et al., 2011</xref>; <xref ref-type="bibr" rid="B87">Fernandez-Tenorio and Niggli, 2018</xref>). Multicenter SERCa2a gene therapy trials in humans with HF have been completed, but with limited success (<xref ref-type="bibr" rid="B114">Jaski et al., 2009</xref>; <xref ref-type="bibr" rid="B115">Jessup et al., 2011</xref>; <xref ref-type="bibr" rid="B312">Zsebo et al., 2014</xref>; <xref ref-type="bibr" rid="B99">Greenberg et al., 2016</xref>). Increased SERCa2a activity also suppressed cardiac alternans in both computational models and experimental studies (<xref ref-type="bibr" rid="B61">Cutler et al., 2009</xref>; <xref ref-type="bibr" rid="B240">Stary et al., 2016</xref>).</p>
</sec>
<sec>
<title>Sarco/Endoplasmic Reticulum Ca<sup>2+</sup>-ATPase in Diabetes</title>
<p>Diminished SR Ca<sup>2+</sup> uptake has been identified as a primary mechanism for decreased cardiac contractility observed in diabetic cardiomyopathy (<xref ref-type="bibr" rid="B92">Ganguly et al., 1983</xref>). Dysfunction of SERCa2a has been established at early stages of type 1 diabetes development and is primarily ascribed to decreased mRNA levels or expression of the protein, resulting in reduced Ca<sup>2+</sup> transient amplitudes and a slower rate of transient decay (<xref ref-type="bibr" rid="B92">Ganguly et al., 1983</xref>; <xref ref-type="bibr" rid="B257">Trost et al., 2002</xref>; <xref ref-type="bibr" rid="B34">Bidasee et al., 2004</xref>; <xref ref-type="bibr" rid="B111">Hu et al., 2005</xref>; <xref ref-type="bibr" rid="B136">Lacombe et al., 2007</xref>). Increased oxidative stress and intracellular ROS concentrations in diabetic hearts can reduce SERCa2a activity by oxidizing Cysteine 674, as well as interfering with the ATP binding site (<xref ref-type="bibr" rid="B288">Xu et al., 1997</xref>; <xref ref-type="bibr" rid="B296">Ying et al., 2008</xref>). Other molecular mechanisms suggested to drive SERCa2a downregulation include increased carbonylation, glycation and O-GlcNAcylation (<xref ref-type="bibr" rid="B34">Bidasee et al., 2004</xref>; <xref ref-type="bibr" rid="B111">Hu et al., 2005</xref>; <xref ref-type="bibr" rid="B222">Shao et al., 2011</xref>). Changes in PLB expression and phosphorylation have also been reported in STZ-diabetic rats, but this finding is not universal (<xref ref-type="bibr" rid="B283">Wold et al., 2005</xref>). Gene therapy with recombinant PLB antibody, which could mimic PLB phosphorylation thus activate SERCa2a, was also shown to increase the rate of whole heart relaxation, contraction and pressure development in a diabetic mouse model and cardiomyopathic hamsters (<xref ref-type="bibr" rid="B170">Meyer et al., 2004</xref>; <xref ref-type="bibr" rid="B70">Dieterle et al., 2005</xref>).</p>
<p>The pathophysiological role of SERCa2a in cardiomyopathy observed in type 2 diabetes remains to be fully elucidated, although activity is mostly reduced in various models (<xref ref-type="bibr" rid="B298">Zarain-Herzberg et al., 2014</xref>). Decreased SERCa2a mRNA levels were observed in the obese <italic>fa/fa</italic> rats while levels of protein, but not mRNA, were reduced in Otsuka Long-Evans Tokushima Fatty (OLETF) rats. No changes in protein expression were observed in the <italic>db/db</italic> mouse, but rather an increased PLB expression was posited to account for diminished SR Ca<sup>2+</sup> uptake in this model. <xref ref-type="bibr" rid="B241">Stølen et al. (2009)</xref> reported reduced SERCa2a protein expression, increased PLB phosphorylation and overall reduced SERCa2a Ca<sup>2+</sup> uptake in <italic>db/db</italic> mice. Conversely, increased expression of SERCa2a and reduced PLB mRNA was observed in ZDF rats, which could be further increased with insulin treatment in a concentration-dependent manner (<xref ref-type="bibr" rid="B90">Fredersdorf et al., 2012</xref>). Upregulation of SR Ca<sup>2+</sup> uptake via SERCa2a may offer protection in early phases of disease development, countering volume overload and impaired relaxation (<xref ref-type="bibr" rid="B90">Fredersdorf et al., 2012</xref>; <xref ref-type="bibr" rid="B298">Zarain-Herzberg et al., 2014</xref>). Changes in SERCa2a expression and function in both HF and diabetes are summarized in Table <xref ref-type="table" rid="T3">3</xref>.</p>
<table-wrap id="T3" position="float">
<label>Table 3</label>
<caption>
<p>Changes in SERCa2a in HF, inherited syndromes and diabetes.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Change in function</th>
<th align="left" colspan="1" rowspan="1" valign="top">Comments</th>
<th align="left" colspan="1" rowspan="1" valign="top">Reference</th>
</tr>
<tr>
<th align="left" colspan="3" rowspan="1" valign="top">
<hr/>
</th>
</tr>
<tr>
<th align="left" colspan="3" rowspan="1" valign="top">
<bold>Sarco/endoplasmic reticulum Ca<sup>2+</sup> ATPase (SERCa2a)</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="3" rowspan="1" valign="top">
<italic>Heart failure</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↓</td>
<td align="left" colspan="1" rowspan="1" valign="top">Depressed activity<break></break><break></break>Reduced mRNA levels/protein expression<break></break><break></break>Decreased PLB expression<break></break><break></break>Decreased PLB phosphorylation<break></break>Increased PLB phosphorylation<break></break>Dissociation of SUMO1</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B192">Pieske et al., 1995</xref>; <xref ref-type="bibr" rid="B215">Schmidt et al., 1998</xref>, <xref ref-type="bibr" rid="B216">1999</xref>; <xref ref-type="bibr" rid="B60">Currie and Smith, 1999</xref>; <xref ref-type="bibr" rid="B118">Jiang et al., 2002</xref><break></break><xref ref-type="bibr" rid="B128">Kiss et al., 1995</xref>; <xref ref-type="bibr" rid="B60">Currie and Smith, 1999</xref>; <xref ref-type="bibr" rid="B9">Armoundas et al., 2007</xref><break></break><xref ref-type="bibr" rid="B183">O’Rourke et al., 1999</xref>; <xref ref-type="bibr" rid="B118">Jiang et al., 2002</xref>; <xref ref-type="bibr" rid="B9">Armoundas et al., 2007</xref><break></break><xref ref-type="bibr" rid="B218">Schwinger et al., 1998</xref>, <xref ref-type="bibr" rid="B219">1999</xref><break></break><xref ref-type="bibr" rid="B60">Currie and Smith, 1999</xref><break></break><xref ref-type="bibr" rid="B216">Schmidt et al., 1999</xref></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" valign="top">
<italic>Inherited syndromes</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↓</td>
<td align="left" colspan="1" rowspan="1" valign="top">PLB mutation, reduced SERCa2a activity</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B217">Schmitt et al., 2003</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↑</td>
<td align="left" colspan="1" rowspan="1" valign="top">PLB deletion mutation, enhanced SERCa2a activity</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B105">Haghighi et al., 2003</xref>, <xref ref-type="bibr" rid="B104">2006</xref></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" valign="top">
<italic>Type 1 diabetes</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↓</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced SERCa2a activity in alloxan and STZ-induced diabetic rats<break></break>Decreased mRNA levels/protein expression levels in STZ-diabetic rats<break></break><break></break><break></break>Decreased SERCa2a expression, increased CaMKII phosphorylation of SERCa2a and PLB in STZ-diabetic rats<break></break>Increased oxidation in diabetic pig aorta<break></break>Increased carbonylation, glycation and O-GlcNAcylation in STZ-diabetic rats</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B152">Lopaschuk et al., 1983</xref>; <xref ref-type="bibr" rid="B3">Allo et al., 1991</xref><break></break><xref ref-type="bibr" rid="B254">Teshima et al., 2000</xref>; <xref ref-type="bibr" rid="B52">Choi et al., 2002</xref>; <xref ref-type="bibr" rid="B257">Trost et al., 2002</xref>; <xref ref-type="bibr" rid="B34">Bidasee et al., 2004</xref>; <xref ref-type="bibr" rid="B111">Hu et al., 2005</xref>; <xref ref-type="bibr" rid="B136">Lacombe et al., 2007</xref><break></break><xref ref-type="bibr" rid="B176">Netticadan et al., 2001</xref><break></break><break></break><xref ref-type="bibr" rid="B296">Ying et al., 2008</xref><break></break><xref ref-type="bibr" rid="B34">Bidasee et al., 2004</xref>; <xref ref-type="bibr" rid="B111">Hu et al., 2005</xref>; <xref ref-type="bibr" rid="B222">Shao et al., 2011</xref></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" valign="top">
<italic>Type 2 diabetes</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↑</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased SERCa2a expression but reduced PLB mRNA in Zucker rats</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B90">Fredersdorf et al., 2012</xref>
<break></break>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↓</td>
<td align="left" colspan="1" rowspan="1" valign="top">Slowed SR Ca<sup>2+</sup> uptake without changes in SERCa2a expression but increased PLB phosphorylation in rats fed high starch/sucrose<break></break>Decreased mRNA levels/protein expression levels in obese <italic>fa/fa</italic> and OLETF rats<break></break>No change in SERCa2a expression but increased PLB expression in <italic>db/db</italic> mouse<break></break>Reduced SERCa2a expression but increased in phosphorylation of PLB in PPARg mice<break></break>Reduced SERCa2a expression but enhanced CaMKII-mediated phosphorylation of PLB in <italic>ob/ob</italic> mice.</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B283">Wold et al., 2005</xref>
<break></break>
<break></break>
<xref ref-type="bibr" rid="B298">Zarain-Herzberg et al., 2014</xref>
<break></break>
<xref ref-type="bibr" rid="B298">Zarain-Herzberg et al., 2014</xref>
<break></break>
<xref ref-type="bibr" rid="B119">Joseph et al., 2016</xref>
<break></break>
<xref ref-type="bibr" rid="B241">Stølen et al., 2009</xref>
</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec>
<title>Na<sup>+</sup>/Ca<sup>2+</sup> Exchanger</title>
<p>To maintain the cardiac contraction cycle, equal amount of Ca<sup>2+</sup> that enters the cell though LTCCs must be removed to the extracellular milieu. The Na<sup>+</sup>/Ca<sup>2+</sup> exchanger is the main route for Ca<sup>2+</sup> extrusion from myocytes. Cardiac NCX (NCX1, 110 kDa) is activated by intracellular Ca<sup>2+</sup> in submicromolar range transporting one Ca<sup>2+</sup> ion in exchange to thee Na<sup>2+</sup> ions (<xref ref-type="bibr" rid="B68">Despa and Bers, 2013</xref>). In the early phases of action potential at voltages more positive than reversal potential of NCX1, a small amount of Ca<sup>2+</sup> enters the cell. This “primes” RyR2 clusters for activation during subsequent openings of LTCCs, enhancing efficiency of CICR (<xref ref-type="bibr" rid="B175">Neco et al., 2010</xref>). At later stages of action potential during the Ca<sup>2+</sup> transient, NCX1 works in a forward mode extruding Ca<sup>2+</sup>, and, since it is electrogenic, contributes to depolarization. Increase in intracellular [Na<sup>2+</sup>] can significantly increase NCX1-mediated Ca<sup>2+</sup> influx and reduce removal. Although NCX1 activity was demonstrated being increased in the presence of oxidants (<xref ref-type="bibr" rid="B134">Kuster et al., 2010</xref>), evidence also exists that enhanced production of ROS leads to NCX1 inhibition (<xref ref-type="bibr" rid="B149">Liu and O’Rourke, 2013</xref>).</p>
<sec>
<title>Na<sup>+</sup>/Ca<sup>2+</sup> Exchanger and Cardiac Arrhythmia</title>
<p>Enhanced expression and activity of NCX1 is thought to be one of the major causes of increased arrhythmogenesis in HF (<xref ref-type="bibr" rid="B193">Pogwizd et al., 1999</xref>; <xref ref-type="bibr" rid="B28">Bers et al., 2002</xref>). NCX1 translates intracellular [Ca<sup>2+</sup>] during spontaneous Ca<sup>2+</sup> waves into depolarizations, i.e., DADs, which can lead to activation of Na<sup>2+</sup> channels and extrasystolic action potentials. During systole enhanced NCX1 prolongs APD allowing LTCCs to reactivate thereby contributing to generation of EADs. Increased NCX1-mediated Ca<sup>2+</sup> influx during reverse mode due to increased intracellular [Na<sup>2+</sup>] characteristic of HF or ischemia may increase cytosolic Ca<sup>2+</sup> and thereby activity of RyR2s (<xref ref-type="bibr" rid="B214">Satoh et al., 2000</xref>; <xref ref-type="bibr" rid="B246">Szepesi et al., 2015</xref>). Pharmacological inhibition of NCX1 substantially reduced triggered activity in various models of ventricular arrhythmia with perturbed Ca<sup>2+</sup> homeostasis (<xref ref-type="bibr" rid="B42">Bourgonje et al., 2013</xref>; <xref ref-type="bibr" rid="B120">Jost et al., 2013</xref>; <xref ref-type="bibr" rid="B174">Nagy et al., 2014</xref>; <xref ref-type="bibr" rid="B306">Zhong et al., 2018</xref>). Experiments using mouse ventricular myocytes with reduced NCX1 demonstrated that genetic inhibition of NCX1 suppressed arrhythmogenic after depolarizations (<xref ref-type="bibr" rid="B38">Bögeholz et al., 2015</xref>), while transgenic overexpression promoted generation of EADs due to prolonged repolarization and spontaneous action potentials (<xref ref-type="bibr" rid="B196">Pott et al., 2012</xref>).</p>
</sec>
<sec>
<title>Na<sup>+</sup>/Ca<sup>2+</sup> Exchanger in Diabetes</title>
<p>The levels and activity of NCX1 vary in different diabetes models. Alloxan or STZ- injected mice with diabetes type 1 showed reduction in NCX1 activity, reduced expression and mRNA levels (<xref ref-type="bibr" rid="B160">Makino et al., 1987</xref>; <xref ref-type="bibr" rid="B191">Pierce et al., 1990</xref>; <xref ref-type="bibr" rid="B96">Golfman et al., 1998</xref>; <xref ref-type="bibr" rid="B108">Hattori et al., 2000</xref>). A number of studies shows increased intracellular [Na<sup>+</sup>] in myocytes from diabetic hearts which enhances NCX1-mediated Ca<sup>2+</sup> influx and reduces extrusion (<xref ref-type="bibr" rid="B73">Doliba et al., 2000</xref>; <xref ref-type="bibr" rid="B278">Wickley et al., 2007</xref>), but reduced NCX1 expression levels have also been reported (<xref ref-type="bibr" rid="B35">Bilginoglu et al., 2013</xref>). <xref ref-type="bibr" rid="B20">Belke et al. (2004)</xref> using the diabetes type 2 <italic>db/db</italic> mouse model showed no difference in NCX1 activity. In <italic>db/db</italic> mice, <xref ref-type="bibr" rid="B241">Stølen et al. (2009)</xref> reported increased NCX1 function. Insulin-resistant sucrose-fed rats with diastolic dysfunction showed normal expression and function of NCX1 (<xref ref-type="bibr" rid="B283">Wold et al., 2005</xref>). No changes in I<sub>NCX</sub> were reported in high fat diet mouse model (<xref ref-type="bibr" rid="B207">Ricci et al., 2006</xref>). An increase in mRNA levels of NCX1 was shown in human patients with diabetes type 2 (<xref ref-type="bibr" rid="B10">Ashrafi et al., 2017</xref>). A similar increase was demonstrated in the mouse model with lipid overload (<xref ref-type="bibr" rid="B119">Joseph et al., 2016</xref>) and diabetes type 1 Akita(ins2) mouse model of cardiomyopathy (<xref ref-type="bibr" rid="B141">LaRocca et al., 2012</xref>). Alterations in NCX1 expression and function in HF and diabetes are summarized in Table <xref ref-type="table" rid="T4">4</xref>.</p>
<table-wrap id="T4" position="float">
<label>Table 4</label>
<caption>
<p>Changes in NCX1 in HF, inherited syndromes and diabetes.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Change in function</th>
<th align="left" colspan="1" rowspan="1" valign="top">Comments</th>
<th align="left" colspan="1" rowspan="1" valign="top">Reference</th>
</tr>
<tr>
<th align="left" colspan="3" rowspan="1" valign="top">
<hr/>
</th>
</tr>
<tr>
<th align="left" colspan="3" rowspan="1" valign="top">
<bold>Na<sup>+</sup>/Ca<sup>2+</sup>-exchanger (NCX1)</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="3" rowspan="1" valign="top">
<italic>Heart failure</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↔</td>
<td align="left" colspan="1" rowspan="1" valign="top">No change in NCX1 function in end-stage human HF</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B189">Piacentino et al., 2003</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↑</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased protein expression and enhanced activity<break></break><break></break>Enhanced reverse mode activity, with Ca<sup>2+</sup> entry into<break></break>the myocyte</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B193">Pogwizd et al., 1999</xref>, <xref ref-type="bibr" rid="B194">2001</xref>; <xref ref-type="bibr" rid="B183">O’Rourke et al., 1999</xref>; <xref ref-type="bibr" rid="B28">Bers et al., 2002</xref>; <xref ref-type="bibr" rid="B184">Ottolia et al., 2013</xref><break></break><xref ref-type="bibr" rid="B69">Despa et al., 2002</xref>; <xref ref-type="bibr" rid="B270">Weber et al., 2003</xref></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" valign="top">
<italic>Inherited syndromes</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" valign="top">
<italic>Type 1 diabetes</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↑</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased activity<break></break>Increased mRNA levels in Akita(ins2) mice</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B73">Doliba et al., 2000</xref>; <xref ref-type="bibr" rid="B278">Wickley et al., 2007</xref><break></break><xref ref-type="bibr" rid="B141">LaRocca et al., 2012</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↓</td>
<td align="left" colspan="1" rowspan="1" valign="top">Depressed activity in STZ-diabetic rats<break></break><break></break>Reduced mRNA levels/protein expression in STZ-diabetic rats</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B191">Pierce et al., 1990</xref>; <xref ref-type="bibr" rid="B3">Allo et al., 1991</xref>; <xref ref-type="bibr" rid="B108">Hattori et al., 2000</xref><break></break><xref ref-type="bibr" rid="B108">Hattori et al., 2000</xref></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" valign="top">
<italic>Type 2 diabetes</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↔</td>
<td align="left" colspan="1" rowspan="1" valign="top">No change in NCX1 activity/protein expression in <italic>db/db</italic> mice, high-sucrose diet rats, HFD mice</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B20">Belke et al., 2004</xref>; <xref ref-type="bibr" rid="B283">Wold et al., 2005</xref>; <xref ref-type="bibr" rid="B207">Ricci et al., 2006</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">↑</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased mRNA levels in human left ventricle<break></break>Increased mRNA levels in PPAR mice with lipid overload<break></break>Increased activity in <italic>db/db</italic> mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B10">Ashrafi et al., 2017</xref>
<break></break>
<xref ref-type="bibr" rid="B119">Joseph et al., 2016</xref>
<break></break>
<xref ref-type="bibr" rid="B241">Stølen et al., 2009</xref>
</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec>
<title>Mechanisms of Ca<sup>2+</sup> Dependent Arrhythmia in Diabetes</title>
<p>The enhanced propensity to ventricular tachyarrhythmias in diabetic and obese patients is well established (<xref ref-type="bibr" rid="B258">Tse et al., 2016</xref>). The arrhythmic potential increases relatively early in the course of development of diabetic cardiomyopathy before the onset of systolic dysfunction. <xref ref-type="bibr" rid="B136">Lacombe et al. (2007)</xref> showed dramatic increase in EADs and DADs in ventricular myocytes from diabetic rats with diastolic dysfunction 8 weeks after STZ injection. <xref ref-type="bibr" rid="B236">Sommese et al. (2016)</xref> demonstrated enhanced arrhythmogenesis <italic>in vivo</italic> in fructose rich diet (FRD) prediabetic mice. The authors showed increased activity of RyR2 manifested in enhanced frequency of spontaneous Ca<sup>2+</sup> waves in field-stimulated myocytes. Mice expressing SR-targeted CaMKII inhibitor peptide AIP showed less ectopic activity that WT FRD mice, and in rats FRD-mediated increase in pro-arrhythmic spontaneous Ca<sup>2+</sup> release was eliminated by incubation of myocytes with pharmacological inhibitor of CaMKII KN93 or antioxidant Tempol. The authors conclude that RyR2 phosphorylation by ROS-activated CaMKII at CaMKII site S2814 plays a major role in diabetes-related arrhythmogenesis. Interestingly, the authors did not find changes in RyR2 phosphorylation at PKA site S2808. Earlier work by <xref ref-type="bibr" rid="B82">Erickson et al. (2013)</xref> linked diabetic hyperglycemia-mediated activation of CaMKII with Ca<sup>2+</sup>-dependent triggered activity in rats. The authors proposed that acute hyperglycemia causes covalent modification of CaMKII by O-linked <italic>N</italic>-acetylglucosamine (O-GlcNAc), resulting in prolonged activation of CaMKII and subsequent increase in RyR2 CaMKII phosphorylation and thereby its activity.</p>
<p>Diabetes is associated with oxidative stress and mitochondrial dysfunction plays significant role in enhanced production of ROS (<xref ref-type="bibr" rid="B2">Akar, 2013</xref>; <xref ref-type="bibr" rid="B286">Xie et al., 2013</xref>; <xref ref-type="bibr" rid="B253">Teshima et al., 2014</xref>). It is postulated that a micro-domain between the SR and mitochondria allows for control by Ca<sup>2+</sup> of mitochondrial function and SR Ca<sup>2+</sup> handling machinery by mitochondrial ROS (<xref ref-type="bibr" rid="B209">Ruiz-Meana et al., 2010</xref>; <xref ref-type="bibr" rid="B80">Eisner V. et al., 2013</xref>; <xref ref-type="bibr" rid="B153">Lopez-Cristosto et al., 2017</xref>). The close proximity of mitochondria to SR Ca<sup>2+</sup> release sites (∼37–270 nm; <xref ref-type="bibr" rid="B226">Sharma et al., 2000</xref>) facilitates not only mitochondrial Ca<sup>2+</sup> uptake and subsequent alterations in mitochondrial function (<xref ref-type="bibr" rid="B58">Csordás et al., 2001</xref>; <xref ref-type="bibr" rid="B74">Dorn and Maack, 2013</xref>), but also ROS-mediated modification of RyR2 and SERCa2a, both of which are redox sensitive (<xref ref-type="bibr" rid="B308">Zima and Blatter, 2006</xref>). In the PPARg overexpression mouse, it was demonstrated that oxidative stress due to mitochondrial dysfunction causes increased SR Ca<sup>2+</sup> leak by oxidizing RyR2 channels (<xref ref-type="bibr" rid="B119">Joseph et al., 2016</xref>). This promoted ventricular ectopy, which was significantly reduced <italic>in vivo</italic> by a mitochondrial-targeted antioxidant mitoTEMPO. <xref ref-type="bibr" rid="B213">Sánchez et al. (2018)</xref> reported increased incidences of PVCs and non-sustained VT in HFD-mice vs. controls and this phenomenon was attributed to significantly increased RyR2 oxidation. When antioxidant apocynin was provided in the drinking water, appearance of ventricular arrhythmias in this model was completely abolished. Interestingly, results from <xref ref-type="bibr" rid="B85">Fauconnier et al. (2007)</xref> and <xref ref-type="bibr" rid="B150">Llano-Diez et al. (2016)</xref> suggest that in <italic>ob/ob</italic> and HFD mice at certain stages of disease development, mitochondrial ROS emission is reduced. <xref ref-type="bibr" rid="B85">Fauconnier et al. (2007)</xref> proposed that during prolonged exposure to increased fatty acid levels due to the switch in mitochondrial substrate utilization, cardiomyocytes from the <italic>ob/ob</italic> mouse adapt to preferential use of fatty acids for metabolism, so further exposure to fatty acids improved intracellular Ca<sup>2+</sup> homeostasis in this model.</p>
<p>Increased NCX1 activity has also been identified as a mechanism promoting arrhythmia via enhancement of depolarization during spontaneous SR Ca<sup>2+</sup> release events (<xref ref-type="bibr" rid="B195">Pott et al., 2011</xref>). <xref ref-type="bibr" rid="B119">Joseph et al. (2016)</xref> showed that in the PPARg overexpression model, NCX1 was upregulated. Importantly, in left ventricular tissue samples from type 2 diabetes human patients NCX1 expression was found significantly higher than in control patients with hypertrophy (<xref ref-type="bibr" rid="B10">Ashrafi et al., 2017</xref>).</p>
<p>Direct evidence that diabetes-related aberrant Ca<sup>2+</sup> homeostasis can contribute to reentrant mechanisms of arrhythmia was obtained by <xref ref-type="bibr" rid="B53">Chou et al. (2017)</xref> who showed that optically mapped hearts from obese <italic>db/db</italic> mice exhibit concordant Ca<sup>2+</sup>/Vm alternans at lower stimulation frequencies than controls. The authors attributed it to lower expression levels of RyR2 and enhanced activity of CaMKII. Interestingly, previous studies using this model showed that the expression levels of LTCCs are substantially reduced (<xref ref-type="bibr" rid="B187">Pereira et al., 2006</xref>), while RyR2- mediated leak enhanced; and SERCA2a function severely depressed because of enhanced expression of PLB (<xref ref-type="bibr" rid="B20">Belke et al., 2004</xref>). Indeed, reduced fidelity of LTCC/RyR2 coupling and impaired ability to re-sequester Ca<sup>2+</sup> into the SR are thought to be major underlying causes for beat-to-beat alternations of intracellular Ca<sup>2+</sup> transient amplitude (<xref ref-type="bibr" rid="B78">Edwards and Blatter, 2014</xref>).</p>
</sec>
<sec>
<title>Therapeutic Strategies to Improve Ca<sup>2+</sup> Homeostasis in Diabetes</title>
<p>Profound changes in cardiac Ca<sup>2+</sup> homeostasis were reported in multiple animal models of diabetes at various states of disease progression, yet mechanisms underlying Ca<sup>2+</sup> mishandling remain to be fully understood. While many experimental studies have sought to elucidate mechanisms underlying the enhanced propensity for arrhythmia in insulin-dependent models of type 1 diabetes, those driving arrhythmogenesis in type 2 diabetes are far less investigated. Given the prevalence of acquired diabetes is drastically increasing due to higher rates of obesity in the developed world, future studies are necessary to understand this complex phenotype.</p>
<sec>
<title>Insulin Replacement</title>
<p>Strategies to manage diabetes include insulin replacement and aerobic exercise regimes (<xref ref-type="bibr" rid="B280">Winnick et al., 2008</xref>). Insulin elicits positive inotropic effects on the myocardium, inducing SERCa2a activity (<xref ref-type="bibr" rid="B190">Pierce et al., 1985</xref>), while endurance exercise has been shown to improve intracellular Ca<sup>2+</sup> cycling and protect against oxidative stress in diabetic animal models (<xref ref-type="bibr" rid="B125">Kim et al., 1996</xref>; <xref ref-type="bibr" rid="B225">Shao et al., 2009</xref>; <xref ref-type="bibr" rid="B241">Stølen et al., 2009</xref>). Combined therapy was shown to increase expression of Ca<sup>2+</sup> handling proteins, restore Ca<sup>2+</sup> handling and improve basal cardiac function in type 1 diabetic rats (<xref ref-type="bibr" rid="B143">Le Douairon Lahaye et al., 2012</xref>; <xref ref-type="bibr" rid="B62">da Silva et al., 2015</xref>). However, due to the multifaceted nature of the disease, diabetes remains a prime risk factor for cardiovascular disease despite beneficial effects of these frontline treatments (<xref ref-type="bibr" rid="B145">Leon and Maddox, 2015</xref>).</p>
</sec>
<sec>
<title>Inhibition of the Renin-Angiotensin System</title>
<p>During the progression of diabetic cardiomyopathy, hyperglycemia is known to increase activity of the renin-angiotensin system (RAS) (<xref ref-type="bibr" rid="B220">Sechi et al., 1994</xref>; <xref ref-type="bibr" rid="B180">Ohishi, 2018</xref>). Angiotensin II has been shown to have direct effects on cardiomyocytes, with activation of its receptor (AT1) increasing generation of oxidants and increasing intracellular [Ca<sup>2+</sup>], as well as activating protein kinase C (PKC) and PKA (<xref ref-type="bibr" rid="B161">Malhotra et al., 1997</xref>; <xref ref-type="bibr" rid="B64">de Lannoy et al., 1998</xref>; <xref ref-type="bibr" rid="B75">Dostal, 2000</xref>; <xref ref-type="bibr" rid="B202">Raimondi et al., 2004</xref>). Angiotensin-converting enzyme (ACE) inhibitors and AT1 blockers are used to prevent hypertension and cardiovascular disease in diabetic patients (<xref ref-type="bibr" rid="B162">Mancia et al., 2013</xref>; <xref ref-type="bibr" rid="B230">Singh et al., 2018</xref>). Antagonism of angiotensin II was demonstrated to alleviate diminished SERCa2a activity in HF models (<xref ref-type="bibr" rid="B182">Okuda et al., 2004</xref>; <xref ref-type="bibr" rid="B93">Gassanov et al., 2006</xref>), while administration of AT1 blockers to STZ-diabetic rat cardiomyocytes reduced cellular oxidative stress as well as phosphorylation levels of RyR2, improving Ca<sup>2+</sup> homeostasis (<xref ref-type="bibr" rid="B200">Privratsky et al., 2003</xref>; <xref ref-type="bibr" rid="B293">Yaras et al., 2007</xref>; <xref ref-type="bibr" rid="B185">Ozdemir et al., 2009</xref>).</p>
</sec>
<sec>
<title>β-Blockade</title>
<p>Current and conventional treatments of diabetes are limited in terms of preventing ventricular arrhythmias and SCD. Blockade of the β-adrenergic stimulation cascade remains a primary treatment of HF in a bid to reduce arrhythmogenic responses, including those of Ca<sup>2+</sup> handling proteins (<xref ref-type="bibr" rid="B129">Klapholz, 2009</xref>; <xref ref-type="bibr" rid="B204">Rehsia and Dhalla, 2010</xref>). However, use of antagonists in diabetic patients remains controversial, given β-blockers have been associated with increased risk for cardiovascular events in diabetic patients and can have hypoglycemic side effects (<xref ref-type="bibr" rid="B47">Casiglia and Tikhonoff, 2017</xref>; <xref ref-type="bibr" rid="B259">Tsujimoto et al., 2017</xref>).</p>
</sec>
<sec>
<title>Targeting LTCC or NCX1</title>
<p>As it stands, inhibition of LTCC or NCX1 does not appear to be an appropriate strategy in ameliorating Ca<sup>2+</sup> mishandling in diabetic hearts. Current density of LTCC is reported as unaltered or reduced in diabetic models (<xref ref-type="bibr" rid="B187">Pereira et al., 2006</xref>; <xref ref-type="bibr" rid="B156">Lu et al., 2007</xref>). A reduction of I<sub>Ca</sub> in this setting would diminish the trigger for RyR2-mediated Ca<sup>2+</sup> release and thereby may exacerbate systolic dysfunction and increase propensity to Ca<sup>2+</sup> alternans. Pharmacological inhibition of NCX1 is generally viewed as beneficial since it reduces Ca<sup>2+</sup> influx during reverse mode limiting Ca<sup>2+</sup> overload and attenuates depolarization during forward mode reducing triggered activity (<xref ref-type="bibr" rid="B8">Antoons et al., 2012</xref>). However, if NCX1 is already diminished as shown in many models of diabetes (<xref ref-type="bibr" rid="B160">Makino et al., 1987</xref>; <xref ref-type="bibr" rid="B191">Pierce et al., 1990</xref>; <xref ref-type="bibr" rid="B96">Golfman et al., 1998</xref>; <xref ref-type="bibr" rid="B108">Hattori et al., 2000</xref>) additional inhibition was proven to be detrimental leading to adverse accumulation of Ca<sup>2+</sup> in cytosol and cell death (<xref ref-type="bibr" rid="B39">Bögeholz et al., 2017</xref>).</p>
</sec>
<sec>
<title>Targeting SERCa2a</title>
<p>SERCa2a overexpression and/or enhancement may be a more suitable approach to ameliorate reduced contractility in diabetic cardiomyopathy, given the majority of studies report diminished pump activity. Insulin treatment has been shown to restore SERCa2a expression levels and improve Ca<sup>2+</sup> homeostasis in obese type 2 diabetic rats (<xref ref-type="bibr" rid="B90">Fredersdorf et al., 2012</xref>). Transgenic overexpression of SERCa2a (or SERCa1a) in diabetic models increased SR Ca<sup>2+</sup> uptake and attenuated diminished contractile function (<xref ref-type="bibr" rid="B257">Trost et al., 2002</xref>; <xref ref-type="bibr" rid="B268">Vetter et al., 2002</xref>; <xref ref-type="bibr" rid="B269">Waller et al., 2015</xref>). As previously discussed, studies using adenoviral mediated SERCa2a gene transfer in both small and large animal models of HF demonstrated similar results (<xref ref-type="bibr" rid="B65">del Monte et al., 2001</xref>, <xref ref-type="bibr" rid="B67">2004</xref>; <xref ref-type="bibr" rid="B159">Lyon et al., 2011</xref>). While gene transfer via adeno-associated virus showed promise in the first human trial, it has shown limited success in others. Improvements and advances in gene therapy technology are likely to facilitate efficient and effective strategies to treat cardiac disease in the future (<xref ref-type="bibr" rid="B113">Ishikawa and Hajjar, 2017</xref>).</p>
<p>To enhance SERCa2a activity one could also modulate the inhibitory action of the accessory protein PLB. Ablation or knockdown of PLB has been demonstrated to suppress pro-arrhythmic Ca<sup>2+</sup> waves generation in a model of CPVT (<xref ref-type="bibr" rid="B14">Bai et al., 2013</xref>), improve mortality rates in CSQ-transgenic mice [severe HF model, (<xref ref-type="bibr" rid="B123">Kaneko et al., 2016</xref>)] and importantly, improve contractile function in failing human cardiomyocytes (<xref ref-type="bibr" rid="B66">del Monte et al., 2002</xref>). However, ablation has not alleviated HF development in all models and a mutant form of PLB unable to inhibit SERCa has been linked to lethal dilated cardiomyopathy in humans (<xref ref-type="bibr" rid="B105">Haghighi et al., 2003</xref>; <xref ref-type="bibr" rid="B237">Song et al., 2003</xref>; <xref ref-type="bibr" rid="B231">Sipido and Vangheluwe, 2010</xref>; <xref ref-type="bibr" rid="B302">Zhang et al., 2010</xref>).</p>
</sec>
<sec>
<title>Targeting RyR2</title>
<p>Abnormally high activity of RyR2 is the most universal finding demonstrated across several models of diabetes. Compounds thought to modulate RyR2 including JTV-519 (K201), carvedilol, dantrolene and tetracaine analogs have previously been tested for therapeutic potential (<xref ref-type="bibr" rid="B124">Kaneko et al., 1997</xref>; <xref ref-type="bibr" rid="B274">Wehrens et al., 2004a</xref>; <xref ref-type="bibr" rid="B131">Kobayashi et al., 2010</xref>; <xref ref-type="bibr" rid="B307">Zhou et al., 2011</xref>; <xref ref-type="bibr" rid="B299">Zhang et al., 2015</xref>). However, there remains a need for drugs without off-target effects and significant effort is currently being made to identify small novel modulators of the channel that will prevent arrhythmogenic Ca<sup>2+</sup> leak (<xref ref-type="bibr" rid="B146">Li et al., 2017</xref>; <xref ref-type="bibr" rid="B203">Rebbeck et al., 2017</xref>).</p>
<p>Stabilization of RyR2-mediated Ca release can be achieved indirectly by targeting CaMKII, given chronic activity in cardiac disease has been linked to RyR2 channel dysfunction (<xref ref-type="bibr" rid="B1">Ai et al., 2005</xref>; <xref ref-type="bibr" rid="B263">Uchinoumi et al., 2016</xref>; <xref ref-type="bibr" rid="B300">Zhang, 2017</xref>). It has been demonstrated that blockade of CaMKII and inhibition of RyR2 phosphorylation in cardiac disease improves intracellular Ca<sup>2+</sup> homeostasis and attenuates arrhythmogenesis (<xref ref-type="bibr" rid="B11">Ather et al., 2013</xref>; <xref ref-type="bibr" rid="B262">Tzimas et al., 2015</xref>; <xref ref-type="bibr" rid="B263">Uchinoumi et al., 2016</xref>), including in a rat model of type 2 diabetes (<xref ref-type="bibr" rid="B236">Sommese et al., 2016</xref>), but this is also not a universal finding (<xref ref-type="bibr" rid="B48">Chakraborty et al., 2014</xref>). Alternatively, stabilization could be achieved by a reduction of RyR2 oxidation. In mouse and rat models of type 2 diabetes, it was demonstrated that treatment with ROS scavengers protects against spontaneous Ca<sup>2+</sup> release events, blunting diastolic dysfunction and arrhythmogenesis <italic>in vivo</italic> (<xref ref-type="bibr" rid="B222">Shao et al., 2011</xref>; <xref ref-type="bibr" rid="B119">Joseph et al., 2016</xref>; <xref ref-type="bibr" rid="B236">Sommese et al., 2016</xref>; <xref ref-type="bibr" rid="B213">Sánchez et al., 2018</xref>). Antioxidants may also reduce ROS-dependent CaMKII activation, hence reduce RyR2 phosphorylation and elevated SR Ca<sup>2+</sup> leak (<xref ref-type="bibr" rid="B157">Luczak and Anderson, 2014</xref>; <xref ref-type="bibr" rid="B236">Sommese et al., 2016</xref>; <xref ref-type="bibr" rid="B263">Uchinoumi et al., 2016</xref>). While increased oxidative stress and ROS concentrations are a hallmark of multiple cardiac disease states including diabetes, usage of ROS scavengers as a therapeutic strategy is not straightforward because certain levels of intracellular ROS are essential for many physiological processes and the ability to target antioxidants to specific subcellular compartments remains limited (<xref ref-type="bibr" rid="B309">Zima et al., 2014</xref>; <xref ref-type="bibr" rid="B71">Dietl and Maack, 2017</xref>).</p>
<p>Targeting accessory proteins of RyR2 also offers therapeutic potential. Adenoviral overexpression of sorcin in the hearts of diabetic mice improved contractile function and increased the Ca<sup>2+</sup> transient amplitude of isolated rat cardiomyocytes (<xref ref-type="bibr" rid="B243">Suarez et al., 2004</xref>). In recent work of <xref ref-type="bibr" rid="B148">Liu et al. (2018)</xref> it was demonstrated that gene transfer of modified CaM prolonged refractoriness of RyR2-mediated SR Ca<sup>2+</sup> release, abolishing ventricular arrhythmias observed in a mouse model of CPVT.</p>
</sec>
</sec>
<sec>
<title>Conclusion</title>
<p>In conclusion, changes in cardiac Ca<sup>2+</sup> homeostasis vary across different models of diabetes and obesity. Diabetes is a progressive disease and therefore results from different laboratories using the same model can differ. Longitudinal studies are warranted to resolve the ongoing discrepancies. Although there are many similarities with HF, there are substantial differences in Ca<sup>2+</sup> handling in diabetic cardiomyopathy so the treatment strategies could be different.</p>
<p>Abnormalities in Ca<sup>2+</sup> cycling sufficient to increase arrhythmic potential appear very early during disease progression of diabetes. The most consistent finding even at very early stages of disease is enhanced RyR2 activity, making it an attractive therapeutic target. Future studies are needed to identify the most suitable approaches for RyR2 stabilization in diabetes. SERCa2a is also attractive target, especially at the later stages of disease progression and cardiomyopathy development. However, it remains unclear whether SERCa2a function is depressed at the early stages when arrhythmic risk is already high. The emerging concept of a mitochondria-SR microdomain and its potential as a therapeutic target may warrant investigation, given mitochondrial dysfunction is a well-established in diabetes. However, levels of mitochondrial ROS emission should be confirmed at different stages of disease, given work of some laboratories suggesting there may be an adaptive improvement in metabolism of fatty acids and thus a reduction in ROS emission. Furthermore, there remains a need for studies using larger animal models of type 2 diabetes with physiology more analogous to that of humans.</p>
</sec>
<sec>
<title>Author Contributions</title>
<p>SH and DT obtained funding, conceived of, and wrote the manuscript.</p>
</sec>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported by American Heart Association Grant #18POST33960456 to SH and NIH Grant HL128507 to DT.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ai</surname><given-names>X.</given-names></name><name><surname>Curran</surname><given-names>J. W.</given-names></name><name><surname>Shannon</surname><given-names>T. R.</given-names></name><name><surname>Bers</surname><given-names>D. M.</given-names></name><name><surname>Pogwizd</surname><given-names>S. M.</given-names></name></person-group> (<year>2005</year>). <article-title>Ca2 + /calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2 + leak in heart failure.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>97</volume>
<fpage>1314</fpage>–<lpage>1322</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000194329.41863.89</pub-id>
<pub-id pub-id-type="pmid">16269653</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akar</surname><given-names>F. G.</given-names></name></person-group> (<year>2013</year>). <article-title>Mitochondrial targets for arrhythmia suppression: is there a role for pharmacological intervention?</article-title>
<source/><italic>J. Interv. Card Electrophysiol.</italic>
<volume>37</volume>
<fpage>249</fpage>–<lpage>258</lpage>. <pub-id pub-id-type="doi">10.1007/s10840-013-9809-3</pub-id>
<pub-id pub-id-type="pmid">23824789</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allo</surname><given-names>S. N.</given-names></name><name><surname>Lincoln</surname><given-names>T. M.</given-names></name><name><surname>Wilson</surname><given-names>G. L.</given-names></name><name><surname>Green</surname><given-names>F. J.</given-names></name><name><surname>Watanabe</surname><given-names>A. M.</given-names></name><name><surname>Schaffer</surname><given-names>S. W.</given-names></name></person-group> (<year>1991</year>). <article-title>Non-insulin-dependent diabetes-induced defects in cardiac cellular calcium regulation.</article-title>
<source/><italic>Am. J. Physiol.</italic>
<volume>260</volume>
<fpage>C1165</fpage>–<lpage>C1171</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.1991.260.6.C1165</pub-id>
<pub-id pub-id-type="pmid">1829324</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarez-Lacalle</surname><given-names>E.</given-names></name><name><surname>Cantalapiedra</surname><given-names>I. R.</given-names></name><name><surname>Peñaranda</surname><given-names>A.</given-names></name><name><surname>Cinca</surname><given-names>J.</given-names></name><name><surname>Hove-Madsen</surname><given-names>L.</given-names></name><name><surname>Echebarria</surname><given-names>B.</given-names></name></person-group> (<year>2013</year>). <article-title>Dependency of calcium alternans on ryanodine receptor refractoriness.</article-title>
<source/><italic>PLoS One</italic>
<volume>8</volume>:<issue>e55042</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0055042</pub-id>
<pub-id pub-id-type="pmid">23390511</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><collab>American Diabetes Association.</collab> (<year>2009</year>). <article-title>Diagnosis, and classification of diabetes mellitus.</article-title>
<source/><italic>Diabetes Care</italic>
<volume>32</volume>(Suppl. 1), <fpage>S62</fpage>–<lpage>S67</lpage>. <pub-id pub-id-type="doi">10.2337/dc09-S062</pub-id>
<pub-id pub-id-type="pmid">19118289</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>M. E.</given-names></name></person-group> (<year>2015</year>). <article-title>Oxidant stress promotes disease by activating CaMKII.</article-title>
<source/><italic>J. Mol. Cell. Cardiol.</italic>
<volume>89</volume>
<fpage>160</fpage>–<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2015.10.014</pub-id>
<pub-id pub-id-type="pmid">26475411</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aneja</surname><given-names>A.</given-names></name><name><surname>Tang</surname><given-names>W. H.</given-names></name><name><surname>Bansilal</surname><given-names>S.</given-names></name><name><surname>Garcia</surname><given-names>M. J.</given-names></name><name><surname>Farkouh</surname><given-names>M. E.</given-names></name></person-group> (<year>2008</year>). <article-title>Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options.</article-title>
<source/><italic>Am. J. Med.</italic>
<volume>121</volume>
<fpage>748</fpage>–<lpage>757</lpage>. <pub-id pub-id-type="doi">10.1016/j.amjmed.2008.03.046</pub-id>
<pub-id pub-id-type="pmid">18724960</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antoons</surname><given-names>G.</given-names></name><name><surname>Willems</surname><given-names>R.</given-names></name><name><surname>Sipido</surname><given-names>K. R.</given-names></name></person-group> (<year>2012</year>). <article-title>Alternative strategies in arrhythmia therapy: evaluation of Na/Ca exchange as an anti-arrhythmic target.</article-title>
<source/><italic>Pharmacol. Ther.</italic>
<volume>134</volume>
<fpage>26</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2011.12.001</pub-id>
<pub-id pub-id-type="pmid">22197992</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armoundas</surname><given-names>A. A.</given-names></name><name><surname>Rose</surname><given-names>J.</given-names></name><name><surname>Aggarwal</surname><given-names>R.</given-names></name><name><surname>Stuyvers</surname><given-names>B. D.</given-names></name><name><surname>O’Rourke</surname><given-names>B.</given-names></name><name><surname>Kass</surname><given-names>D. A.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Cellular and molecular determinants of altered Ca2 + handling in the failing rabbit heart: primary defects in SR Ca2 + uptake and release mechanisms.</article-title>
<source/><italic>Am. J. Physiol. Heart Circ. Physiol.</italic>
<volume>292</volume>
<fpage>H1607</fpage>–<lpage>H1618</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00525.2006</pub-id>
<pub-id pub-id-type="pmid">17122195</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashrafi</surname><given-names>R.</given-names></name><name><surname>Modi</surname><given-names>P.</given-names></name><name><surname>Oo</surname><given-names>A. Y.</given-names></name><name><surname>Pullan</surname><given-names>D. M.</given-names></name><name><surname>Jian</surname><given-names>K.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Arrhythmogenic gene remodelling in elderly patients with type 2 diabetes with aortic stenosis and normal left ventricular ejection fraction.</article-title>
<source/><italic>Exp. Physiol.</italic>
<volume>102</volume>
<fpage>1424</fpage>–<lpage>1434</lpage>. <pub-id pub-id-type="doi">10.1113/EP086412</pub-id>
<pub-id pub-id-type="pmid">28804970</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ather</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Anderson</surname><given-names>M. E.</given-names></name><name><surname>Wehrens</surname><given-names>X. H.</given-names></name></person-group> (<year>2013</year>). <article-title>Inhibition of CaMKII phosphorylation of RyR2 prevents inducible ventricular arrhythmias in mice with Duchenne muscular dystrophy.</article-title>
<source/><italic>Heart Rhythm.</italic>
<volume>10</volume>
<fpage>592</fpage>–<lpage>599</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2012.12.016</pub-id>
<pub-id pub-id-type="pmid">23246599</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Axelsen</surname><given-names>L. N.</given-names></name><name><surname>Calloe</surname><given-names>K.</given-names></name><name><surname>Braunstein</surname><given-names>T. H.</given-names></name><name><surname>Riemann</surname><given-names>M.</given-names></name><name><surname>Hofgaard</surname><given-names>J. P.</given-names></name><name><surname>Liang</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Diet-induced pre-diabetes slows cardiac conductance and promotes arrhythmogenesis.</article-title>
<source/><italic>Cardiovasc. Diabetol.</italic>
<volume>14</volume>:<issue>87</issue>. <pub-id pub-id-type="doi">10.1186/s12933-015-0246-8</pub-id>
<pub-id pub-id-type="pmid">26169175</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baddeley</surname><given-names>D.</given-names></name><name><surname>Jayasinghe</surname><given-names>I. D.</given-names></name><name><surname>Lam</surname><given-names>L.</given-names></name><name><surname>Rossberger</surname><given-names>S.</given-names></name><name><surname>Cannell</surname><given-names>M. B.</given-names></name><name><surname>Soeller</surname><given-names>C.</given-names></name></person-group> (<year>2009</year>). <article-title>Optical single-channel resolution imaging of the ryanodine receptor distribution in rat cardiac myocytes.</article-title>
<source/><italic>Proc Natl Acad Sci U.S.A.</italic>
<volume>106</volume>
<fpage>22275</fpage>–<lpage>22280</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0908971106</pub-id>
<pub-id pub-id-type="pmid">20018773</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>Y.</given-names></name><name><surname>Jones</surname><given-names>P. P.</given-names></name><name><surname>Guo</surname><given-names>J.</given-names></name><name><surname>Zhong</surname><given-names>X.</given-names></name><name><surname>Clark</surname><given-names>R. B.</given-names></name><name><surname>Zhou</surname><given-names>Q.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Phospholamban knockout breaks arrhythmogenic Ca<sup>2+</sup> waves and suppresses catecholaminergic polymorphic ventricular tachycardia in mice.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>113</volume>
<fpage>517</fpage>–<lpage>526</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.113.301678</pub-id>
<pub-id pub-id-type="pmid">23856523</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barouch</surname><given-names>L. A.</given-names></name><name><surname>Harrison</surname><given-names>R. W.</given-names></name><name><surname>Skaf</surname><given-names>M. W.</given-names></name><name><surname>Rosas</surname><given-names>G. O.</given-names></name><name><surname>Cappola</surname><given-names>T. P.</given-names></name><name><surname>Kobeissi</surname><given-names>Z. A.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms.</article-title>
<source/><italic>Nature</italic>
<volume>416</volume>
<fpage>337</fpage>–<lpage>339</lpage>. <pub-id pub-id-type="doi">10.1038/416337a</pub-id>
<pub-id pub-id-type="pmid">11907582</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belevych</surname><given-names>A. E.</given-names></name><name><surname>Sansom</surname><given-names>S. E.</given-names></name><name><surname>Terentyeva</surname><given-names>R.</given-names></name><name><surname>Ho</surname><given-names>H. T.</given-names></name><name><surname>Nishijima</surname><given-names>Y.</given-names></name><name><surname>Martin</surname><given-names>M. M.</given-names></name><etal></etal></person-group> (<year>2011a</year>). <article-title>MicroRNA-1 and -133 increase arrhythmogenesis in heart failure by dissociating phosphatase activity from RyR2 complex.</article-title>
<source/><italic>PLoS One</italic>
<volume>6</volume>:<issue>e28324</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0028324</pub-id>
<pub-id pub-id-type="pmid">22163007</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belevych</surname><given-names>A. E.</given-names></name><name><surname>Terentyev</surname><given-names>D.</given-names></name><name><surname>Terentyeva</surname><given-names>R.</given-names></name><name><surname>Ho</surname><given-names>H. T.</given-names></name><name><surname>Györke</surname><given-names>I.</given-names></name><name><surname>Bonilla</surname><given-names>I. M.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Shortened Ca2 + signaling refractoriness underlies cellular arrhythmogenesis in a postinfarction model of sudden cardiac death.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>110</volume>
<fpage>569</fpage>–<lpage>577</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.111.260455</pub-id>
<pub-id pub-id-type="pmid">22223353</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belevych</surname><given-names>A. E.</given-names></name><name><surname>Terentyev</surname><given-names>D.</given-names></name><name><surname>Terentyeva</surname><given-names>R.</given-names></name><name><surname>Nishijima</surname><given-names>Y.</given-names></name><name><surname>Sridhar</surname><given-names>A.</given-names></name><name><surname>Hamlin</surname><given-names>R. L.</given-names></name><etal></etal></person-group> (<year>2011b</year>). <article-title>The relationship between arrhythmogenesis and impaired contractility in heart failure: role of altered ryanodine receptor function.</article-title>
<source/><italic>Cardiovasc. Res.</italic>
<volume>90</volume>
<fpage>493</fpage>–<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvr025</pub-id>
<pub-id pub-id-type="pmid">21273243</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belke</surname><given-names>D. D.</given-names></name><name><surname>Dillmann</surname><given-names>W. H.</given-names></name></person-group> (<year>2004</year>). <article-title>Altered cardiac calcium handling in diabetes.</article-title>
<source/><italic>Curr. Hypertens. Rep.</italic>
<volume>6</volume>
<fpage>424</fpage>–<lpage>429</lpage>. <pub-id pub-id-type="doi">10.1007/s11906-004-0035-3</pub-id><pub-id pub-id-type="pmid">15527685</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belke</surname><given-names>D. D.</given-names></name><name><surname>Swanson</surname><given-names>E. A.</given-names></name><name><surname>Dillmann</surname><given-names>W. H.</given-names></name></person-group> (<year>2004</year>). <article-title>Decreased sarcoplasmic reticulum activity and contractility in diabetic <italic>db/db</italic> mouse heart.</article-title>
<source/><italic>Diabetes</italic>
<volume>53</volume>
<fpage>3201</fpage>–<lpage>3208</lpage>. <pub-id pub-id-type="doi">10.2337/diabetes.53.12.3201</pub-id>
<pub-id pub-id-type="pmid">15561951</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjamin</surname><given-names>E. J.</given-names></name><name><surname>Virani</surname><given-names>S. S.</given-names></name><name><surname>Callaway</surname><given-names>C. W.</given-names></name><name><surname>Chamberlain</surname><given-names>A. M.</given-names></name><name><surname>Chang</surname><given-names>A. R.</given-names></name><name><surname>Cheng</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Heart disease and stroke statistics-2018 update: a report from the American heart association.</article-title>
<source/><italic>Circulation</italic>
<volume>137</volume>
<fpage>e67</fpage>–<lpage>e492</lpage>. <pub-id pub-id-type="doi">10.1161/CIR.0000000000000558</pub-id>
<pub-id pub-id-type="pmid">29386200</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benkusky</surname><given-names>N. A.</given-names></name><name><surname>Weber</surname><given-names>C. S.</given-names></name><name><surname>Scherman</surname><given-names>J. A.</given-names></name><name><surname>Farrell</surname><given-names>E. F.</given-names></name><name><surname>Hacker</surname><given-names>T. A.</given-names></name><name><surname>John</surname><given-names>M. C.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Intact beta-adrenergic response and unmodified progression toward heart failure in mice with genetic ablation of a major protein kinase A phosphorylation site in the cardiac ryanodine receptor.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>101</volume>
<fpage>819</fpage>–<lpage>829</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.107.153007</pub-id>
<pub-id pub-id-type="pmid">17717301</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergner</surname><given-names>D. W.</given-names></name><name><surname>Goldberger</surname><given-names>J. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Diabetes mellitus and sudden cardiac death: what are the data?</article-title>
<source/><italic>Cardiol. J.</italic>
<volume>17</volume>
<fpage>117</fpage>–<lpage>129</lpage>.<pub-id pub-id-type="pmid">20544609</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bers</surname><given-names>D. M.</given-names></name></person-group> (<year>2002</year>). <article-title>Cardiac excitation-contraction coupling.</article-title>
<source/><italic>Nature</italic>
<volume>415</volume>
<fpage>198</fpage>–<lpage>205</lpage>. <pub-id pub-id-type="doi">10.1038/415198a</pub-id>
<pub-id pub-id-type="pmid">11805843</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bers</surname><given-names>D. M.</given-names></name></person-group> (<year>2004</year>). <article-title>Macromolecular complexes regulating cardiac ryanodine receptor function.</article-title>
<source/><italic>J. Mol. Cell. Cardiol.</italic>
<volume>37</volume>
<fpage>417</fpage>–<lpage>429</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2004.05.026</pub-id>
<pub-id pub-id-type="pmid">15276012</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bers</surname><given-names>D. M.</given-names></name></person-group> (<year>2006</year>). <article-title>Altered cardiac myocyte Ca regulation in heart failure.</article-title>
<source/><italic>Physiology</italic>
<volume>21</volume>
<fpage>380</fpage>–<lpage>387</lpage>. <pub-id pub-id-type="doi">10.1152/physiol.00019.2006</pub-id>
<pub-id pub-id-type="pmid">17119150</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bers</surname><given-names>D. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Cardiac sarcoplasmic reticulum calcium leak: basis and roles in cardiac dysfunction.</article-title>
<source/><italic>Annu. Rev. Physiol.</italic>
<volume>76</volume>
<fpage>107</fpage>–<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-physiol-020911-153308</pub-id>
<pub-id pub-id-type="pmid">24245942</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bers</surname><given-names>D. M.</given-names></name><name><surname>Pogwizd</surname><given-names>S. M.</given-names></name><name><surname>Schlotthauer</surname><given-names>K.</given-names></name></person-group> (<year>2002</year>). <article-title>Upregulated Na/Ca exchange is involved in both contractile dysfunction and arrhythmogenesis in heart failure.</article-title>
<source/><italic>Basic Res. Cardiol.</italic>
<volume>97</volume>(Suppl. 1), <fpage>I36</fpage>–<lpage>I42</lpage>. <pub-id pub-id-type="doi">10.1007/s003950200027</pub-id>
<pub-id pub-id-type="pmid">12479232</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertero</surname><given-names>E.</given-names></name><name><surname>Maack</surname><given-names>C.</given-names></name></person-group> (<year>2018</year>). <article-title>Metabolic remodelling in heart failure.</article-title>
<source/><italic>Nat. Rev. Cardiol.</italic>
<volume>15</volume>
<fpage>457</fpage>–<lpage>470</lpage>. <pub-id pub-id-type="doi">10.1038/s41569-018-0044-6</pub-id>
<pub-id pub-id-type="pmid">29915254</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhatti</surname><given-names>J. S.</given-names></name><name><surname>Bhatti</surname><given-names>G. K.</given-names></name><name><surname>Reddy</surname><given-names>P. H.</given-names></name></person-group> (<year>2017</year>). <article-title>Mitochondrial dysfunction and oxidative stress in metabolic disorders - A step towards mitochondria based therapeutic strategies.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1863</volume>
<fpage>1066</fpage>–<lpage>1077</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2016.11.010</pub-id>
<pub-id pub-id-type="pmid">27836629</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bidasee</surname><given-names>K. R.</given-names></name><name><surname>Dinçer</surname><given-names>U. D.</given-names></name><name><surname>Besch</surname><given-names>H. R.</given-names><suffix>Jr.</suffix></name></person-group> (<year>2001</year>). <article-title>Ryanodine receptor dysfunction in hearts of streptozotocin-induced diabetic rats.</article-title>
<source/><italic>Mol. Pharmacol.</italic>
<volume>60</volume>
<fpage>1356</fpage>–<lpage>1364</lpage>. <pub-id pub-id-type="doi">10.1124/mol.60.6.1356</pub-id><pub-id pub-id-type="pmid">11723243</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bidasee</surname><given-names>K. R.</given-names></name><name><surname>Nallani</surname><given-names>K.</given-names></name><name><surname>Besch</surname><given-names>H. R.</given-names><suffix>Jr.</suffix></name><name><surname>Dinçer</surname><given-names>U. D.</given-names></name></person-group> (<year>2003a</year>). <article-title>Streptozotocin-induced diabetes increases disulfide bond formation on cardiac ryanodine receptor (RyR2).</article-title>
<source/><italic>J. Pharmacol. Exp. Ther.</italic>
<volume>305</volume>
<fpage>989</fpage>–<lpage>998</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.102.046201</pub-id>
<pub-id pub-id-type="pmid">12606683</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bidasee</surname><given-names>K. R.</given-names></name><name><surname>Nallani</surname><given-names>K.</given-names></name><name><surname>Yu</surname><given-names>Y.</given-names></name><name><surname>Cocklin</surname><given-names>R. R.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2003b</year>). <article-title>Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors/calcium-release channels.</article-title>
<source/><italic>Diabetes</italic>
<volume>52</volume><fpage>1825</fpage>–<lpage>1836</lpage>. <pub-id pub-id-type="pmid">12829653</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bidasee</surname><given-names>K. R.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Shao</surname><given-names>C. H.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Patel</surname><given-names>K. P.</given-names></name><name><surname>Dinçer</surname><given-names>U. D.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Diabetes increases formation of advanced glycation end products on Sarco(endo)plasmic reticulum Ca<sup>2+</sup> -ATPase.</article-title>
<source/><italic>Diabetes</italic>
<volume>53</volume>
<fpage>463</fpage>–<lpage>473</lpage>. <pub-id pub-id-type="doi">10.2337/diabetes.53.2.463</pub-id><pub-id pub-id-type="pmid">14747299</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilginoglu</surname><given-names>A.</given-names></name><name><surname>Kandilci</surname><given-names>H. B.</given-names></name><name><surname>Turan</surname><given-names>B.</given-names></name></person-group> (<year>2013</year>). <article-title>Intracellular levels of Na(+) and TTX-sensitive Na(+) channel current in diabetic rat ventricular cardiomyocytes.</article-title>
<source/><italic>Cardiovasc. Toxicol.</italic>
<volume>13</volume>
<fpage>138</fpage>–<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1007/s12012-012-9192-9</pub-id>
<pub-id pub-id-type="pmid">23225150</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boczek</surname><given-names>N. J.</given-names></name><name><surname>Best</surname><given-names>J. M.</given-names></name><name><surname>Tester</surname><given-names>D. J.</given-names></name><name><surname>Giudicessi</surname><given-names>J. R.</given-names></name><name><surname>Middha</surname><given-names>S.</given-names></name><name><surname>Evans</surname><given-names>J. M.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Exome sequencing and systems biology converge to identify novel mutations in the L-type calcium channel, CACNA1C, linked to autosomal dominant long QT syndrome.</article-title>
<source/><italic>Circ. Cardiovasc. Genet.</italic>
<volume>6</volume>
<fpage>279</fpage>–<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCGENETICS.113.000138</pub-id>
<pub-id pub-id-type="pmid">23677916</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bodi</surname><given-names>I.</given-names></name><name><surname>Mikala</surname><given-names>G.</given-names></name><name><surname>Koch</surname><given-names>S. E.</given-names></name><name><surname>Akhter</surname><given-names>S. A.</given-names></name><name><surname>Schwartz</surname><given-names>A.</given-names></name></person-group> (<year>2005</year>). <article-title>The L-type calcium channel in the heart: the beat goes on.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>115</volume>
<fpage>3306</fpage>–<lpage>3317</lpage>. <pub-id pub-id-type="doi">10.1172/JCI27167</pub-id>
<pub-id pub-id-type="pmid">16322774</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bögeholz</surname><given-names>N.</given-names></name><name><surname>Pauls</surname><given-names>P.</given-names></name><name><surname>Bauer</surname><given-names>B. K.</given-names></name><name><surname>Schulte</surname><given-names>J. S.</given-names></name><name><surname>Dechering</surname><given-names>D. G.</given-names></name><name><surname>Frommeyer</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Suppression of early and late afterdepolarizations by heterozygous knockout of the Na + /Ca2 + exchanger in a murine model.</article-title>
<source/><italic>Circ. Arrhythm. Electrophysiol.</italic>
<volume>8</volume>
<fpage>1210</fpage>–<lpage>1218</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCEP.115.002927</pub-id>
<pub-id pub-id-type="pmid">26338832</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bögeholz</surname><given-names>N.</given-names></name><name><surname>Schulte</surname><given-names>J. S.</given-names></name><name><surname>Kaese</surname><given-names>S.</given-names></name><name><surname>Bauer</surname><given-names>B. K.</given-names></name><name><surname>Pauls</surname><given-names>P.</given-names></name><name><surname>Dechering</surname><given-names>D. G.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>The effects of SEA0400 on Ca2 + transient amplitude and proarrhythmia depend on the Na + /Ca2 + exchanger expression level in murine models.</article-title>
<source/><italic>Front. Pharmacol.</italic>
<volume>21</volume>:<issue>649</issue>. <pub-id pub-id-type="doi">10.3389/fphar.2017.00649</pub-id>
<pub-id pub-id-type="pmid">28983248</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boraso</surname><given-names>A.</given-names></name><name><surname>Williams</surname><given-names>A. J.</given-names></name></person-group> (<year>1994</year>). <article-title>Modification of the gating of the cardiac sarcoplasmic reticulum Ca(2 + )-release channel by H2O2 and dithiothreitol.</article-title>
<source/><italic>Am. J. Physiol.</italic>
<volume>267</volume>(3 Pt 2), <fpage>H1010</fpage>–<lpage>H1016</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.1994.267.3.H1010</pub-id>
<pub-id pub-id-type="pmid">8092267</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boudina</surname><given-names>S.</given-names></name><name><surname>Abel</surname><given-names>E. D.</given-names></name></person-group> (<year>2010</year>). <article-title>Diabetic cardiomyopathy, causes and effects.</article-title>
<source/><italic>Rev. Endocr. Metab. Disord.</italic>
<volume>11</volume>
<fpage>31</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1007/s11154-010-9131-7</pub-id>
<pub-id pub-id-type="pmid">20180026</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourgonje</surname><given-names>V. J.</given-names></name><name><surname>Vos</surname><given-names>M. A.</given-names></name><name><surname>Ozdemir</surname><given-names>S.</given-names></name><name><surname>Doisne</surname><given-names>N.</given-names></name><name><surname>Acsai</surname><given-names>K.</given-names></name><name><surname>Varro</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Combined Na( + )/Ca(2 + ) exchanger and L-type calcium channel block as a potential strategy to suppress arrhythmias and maintain ventricular function.</article-title>
<source/><italic>Circ. Arrhythm. Electrophysiol.</italic>
<volume>6</volume>
<fpage>371</fpage>–<lpage>379</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCEP.113.000322</pub-id>
<pub-id pub-id-type="pmid">23515266</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bovo</surname><given-names>E.</given-names></name><name><surname>Huke</surname><given-names>S.</given-names></name><name><surname>Blatter</surname><given-names>L. A.</given-names></name><name><surname>Zima</surname><given-names>A. V.</given-names></name></person-group> (<year>2017</year>). <article-title>The effect of PKA-mediated phosphorylation of ryanodine receptor on SR Ca2 + leak in ventricular myocytes.</article-title>
<source/><italic>J. Mol. Cell. Cardiol.</italic>
<volume>104</volume>
<fpage>9</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2017.01.015</pub-id>
<pub-id pub-id-type="pmid">28131630</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brochet</surname><given-names>D. X.</given-names></name><name><surname>Yang</surname><given-names>D.</given-names></name><name><surname>Di Maio</surname><given-names>A.</given-names></name><name><surname>Lederer</surname><given-names>W. J.</given-names></name><name><surname>Franzini-Armstrong</surname><given-names>C.</given-names></name><name><surname>Cheng</surname><given-names>H.</given-names></name></person-group> (<year>2005</year>). <article-title>Ca2 + blinks: rapid nanoscopic store calcium signaling.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>102</volume>
<fpage>3099</fpage>–<lpage>3104</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0500059102</pub-id>
<pub-id pub-id-type="pmid">15710901</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunello</surname><given-names>L.</given-names></name><name><surname>Slabaugh</surname><given-names>J. L.</given-names></name><name><surname>Radwanski</surname><given-names>P. B.</given-names></name><name><surname>Ho</surname><given-names>H. T.</given-names></name><name><surname>Belevych</surname><given-names>A. E.</given-names></name><name><surname>Lou</surname><given-names>Q.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Decreased RyR2 refractoriness determines myocardial synchronization of aberrant Ca2 + release in a genetic model of arrhythmia.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>110</volume>
<fpage>10312</fpage>–<lpage>10317</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1300052110</pub-id>
<pub-id pub-id-type="pmid">23733959</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bünemann</surname><given-names>M.</given-names></name><name><surname>Gerhardstein</surname><given-names>B. L.</given-names></name><name><surname>Gao</surname><given-names>T.</given-names></name><name><surname>Hosey</surname><given-names>M. M.</given-names></name></person-group> (<year>1999</year>). <article-title>Functional regulation of L-type calcium channels via protein kinase A-mediated phosphorylation of the beta(2) subunit.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>26</volume>
<fpage>33851</fpage>–<lpage>33854</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.274.48.33851</pub-id>
<pub-id pub-id-type="pmid">10567342</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casiglia</surname><given-names>E.</given-names></name><name><surname>Tikhonoff</surname><given-names>V.</given-names></name></person-group> (<year>2017</year>). <article-title>Long-standing problem of β-blocker-elicited hypoglycemia in diabetes mellitus.</article-title>
<source/><italic>Hypertension</italic>
<volume>70</volume>
<fpage>42</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.117.09378</pub-id>
<pub-id pub-id-type="pmid">28559390</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakraborty</surname><given-names>A.</given-names></name><name><surname>Pasek</surname><given-names>D. A.</given-names></name><name><surname>Huang</surname><given-names>T. Q.</given-names></name><name><surname>Gomez</surname><given-names>A. C.</given-names></name><name><surname>Yamaguchi</surname><given-names>N.</given-names></name><name><surname>Anderson</surname><given-names>M. E.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Inhibition of CaMKII does not attenuate cardiac hypertrophy in mice with dysfunctional ryanodine receptor.</article-title>
<source/><italic>PLoS One</italic>
<volume>9</volume>:<issue>e104338</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0104338</pub-id>
<pub-id pub-id-type="pmid">25093823</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chelu</surname><given-names>M. G.</given-names></name><name><surname>Sarma</surname><given-names>S.</given-names></name><name><surname>Sood</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>van Oort</surname><given-names>R. J.</given-names></name><name><surname>Skapura</surname><given-names>D. G.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2 + leak promotes atrial fibrillation in mice.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>119</volume>
<fpage>1940</fpage>–<lpage>1951</lpage>. <pub-id pub-id-type="doi">10.1172/JCI37059</pub-id>
<pub-id pub-id-type="pmid">19603549</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Piacentino</surname><given-names>V.</given-names><suffix>III</suffix></name><name><surname>Furukawa</surname><given-names>S.</given-names></name><name><surname>Goldman</surname><given-names>B.</given-names></name><name><surname>Margulies</surname><given-names>K. B.</given-names></name><name><surname>Houser</surname><given-names>S. R.</given-names></name></person-group> (<year>2002</year>). <article-title>L-type Ca2 + channel density and regulation are altered in failing human ventricular myocytes and recover after support with mechanical assist devices.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>20</volume>
<fpage>517</fpage>–<lpage>524</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000033988.13062.7C</pub-id>
<pub-id pub-id-type="pmid">12242270</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>H.</given-names></name><name><surname>Lederer</surname><given-names>M. R.</given-names></name><name><surname>Lederer</surname><given-names>W. J.</given-names></name><name><surname>Cannell</surname><given-names>M. B.</given-names></name></person-group> (<year>1996</year>). <article-title>Calcium sparks and [Ca2 + ]i waves in cardiac myocytes.</article-title>
<source/><italic>Am. J. Physiol.</italic>
<volume>270</volume>(1 Pt 1), <fpage>C148</fpage>–<lpage>C159</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.1996.270.1.C148</pub-id>
<pub-id pub-id-type="pmid">8772440</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>K. M.</given-names></name><name><surname>Zhong</surname><given-names>Y.</given-names></name><name><surname>Hoit</surname><given-names>B. D.</given-names></name><name><surname>Grupp</surname><given-names>I. L.</given-names></name><name><surname>Hahn</surname><given-names>H.</given-names></name><name><surname>Dilly</surname><given-names>K. W.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Defective intracellular Ca(2 + ) signaling contributes to cardiomyopathy in Type 1 diabetic rats.</article-title>
<source/><italic>Am. J. Physiol. Heart Circ. Physiol.</italic>
<volume>283</volume>
<fpage>H1398</fpage>–<lpage>H1408</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00313.2002</pub-id>
<pub-id pub-id-type="pmid">12234790</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chou</surname><given-names>C. C.</given-names></name><name><surname>Ho</surname><given-names>C. T.</given-names></name><name><surname>Lee</surname><given-names>H. L.</given-names></name><name><surname>Chu</surname><given-names>Y.</given-names></name><name><surname>Yen</surname><given-names>T. H.</given-names></name><name><surname>Wen</surname><given-names>M. S.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Roles of impaired intracellular calcium cycling in arrhythmogenicity of diabetic mouse model.</article-title>
<source/><italic>Pacing Clin. Electrophysiol.</italic>
<volume>40</volume>
<fpage>1087</fpage>–<lpage>1095</lpage>. <pub-id pub-id-type="doi">10.1111/pace.13166</pub-id>
<pub-id pub-id-type="pmid">28842915</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chugh</surname><given-names>S. S.</given-names></name><name><surname>Reinier</surname><given-names>K.</given-names></name><name><surname>Teodorescu</surname><given-names>C.</given-names></name><name><surname>Evanado</surname><given-names>A.</given-names></name><name><surname>Kehr</surname><given-names>E.</given-names></name><name><surname>Al Samara</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Epidemiology of sudden cardiac death: clinical and research implications.</article-title>
<source/><italic>Prog. Cardiovasc. Dis.</italic>
<volume>51</volume>
<fpage>213</fpage>–<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1016/j.pcad.2008.06.003</pub-id>
<pub-id pub-id-type="pmid">19026856</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>L. L.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Centracchio</surname><given-names>J.</given-names></name><name><surname>Terentyeva</surname><given-names>R.</given-names></name><name><surname>Koren</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Redox modification of ryanodine receptors by mitochondria-derived reactive oxygen species contributes to aberrant Ca2 + handling in ageing rabbit hearts.</article-title>
<source/><italic>J. Physiol.</italic>
<volume>591</volume>
<fpage>5895</fpage>–<lpage>5911</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2013.260521</pub-id>
<pub-id pub-id-type="pmid">24042501</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crossman</surname><given-names>D. J.</given-names></name><name><surname>Ruygrok</surname><given-names>P. N.</given-names></name><name><surname>Soeller</surname><given-names>C.</given-names></name><name><surname>Cannell</surname><given-names>M. B.</given-names></name></person-group> (<year>2011</year>). <article-title>Changes in the organization of excitation-contraction coupling structures in failing human heart.</article-title>
<source/><italic>PLoS One</italic>
<volume>6</volume>:<issue>e17901</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0017901</pub-id>
<pub-id pub-id-type="pmid">21408028</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crotti</surname><given-names>L.</given-names></name><name><surname>Johnson</surname><given-names>C. N.</given-names></name><name><surname>Graf</surname><given-names>E.</given-names></name><name><surname>De Ferrari</surname><given-names>G. M.</given-names></name><name><surname>Cuneo</surname><given-names>B. F.</given-names></name><name><surname>Ovadia</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Calmodulin mutations associated with recurrent cardiac arrest in infants.</article-title>
<source/><italic>Circulation</italic>
<volume>127</volume>
<fpage>1009</fpage>–<lpage>1017</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.112.001216</pub-id>
<pub-id pub-id-type="pmid">23388215</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Csordás</surname><given-names>G.</given-names></name><name><surname>Thomas</surname><given-names>A. P.</given-names></name><name><surname>Hajnóczky</surname><given-names>G.</given-names></name></person-group> (<year>2001</year>). <article-title>Calcium signal transmission between ryanodine receptors and mitochondria in cardiac muscle.</article-title>
<source/><italic>Trends Cardiovasc. Med.</italic>
<volume>11</volume>
<fpage>269</fpage>–<lpage>275</lpage>. <pub-id pub-id-type="doi">10.1016/S1050-1738(01)00123-2</pub-id><pub-id pub-id-type="pmid">11709280</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curran</surname><given-names>J.</given-names></name><name><surname>Hinton</surname><given-names>M. J.</given-names></name><name><surname>Ríos</surname><given-names>E.</given-names></name><name><surname>Bers</surname><given-names>D. M.</given-names></name><name><surname>Shannon</surname><given-names>T. R.</given-names></name></person-group> (<year>2007</year>). <article-title>Beta-adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes is mediated by calcium/calmodulin-dependent protein kinase.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>100</volume>
<fpage>391</fpage>–<lpage>398</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000258172.74570.e6</pub-id>
<pub-id pub-id-type="pmid">17234966</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Currie</surname><given-names>S.</given-names></name><name><surname>Smith</surname><given-names>G. L.</given-names></name></person-group> (<year>1999</year>). <article-title>Enhanced phosphorylation of phospholamban and downregulation of sarco/endoplasmic reticulum Ca2 + ATPase type 2 (SERCA 2) in cardiac sarcoplasmic reticulum from rabbits with heart failure.</article-title>
<source/><italic>Cardiovasc. Res.</italic>
<volume>41</volume>
<fpage>135</fpage>–<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1016/S0008-6363(98)00241-7</pub-id>
<pub-id pub-id-type="pmid">10325961</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cutler</surname><given-names>M. J.</given-names></name><name><surname>Wan</surname><given-names>X.</given-names></name><name><surname>Laurita</surname><given-names>K. R.</given-names></name><name><surname>Hajjar</surname><given-names>R. J.</given-names></name><name><surname>Rosenbaum</surname><given-names>D. S.</given-names></name></person-group> (<year>2009</year>). <article-title>Targeted SERCA2a gene expression identifies molecular mechanism and therapeutic target for arrhythmogenic cardiac alternans.</article-title>
<source/><italic>Circ. Arrhythm. Electrophysiol.</italic>
<volume>2</volume>
<fpage>686</fpage>–<lpage>694</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCEP.109.863118</pub-id>
<pub-id pub-id-type="pmid">19948504</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Silva</surname><given-names>M. F.</given-names></name><name><surname>Natali</surname><given-names>A. J.</given-names></name><name><surname>da Silva</surname><given-names>E.</given-names></name><name><surname>Gomes</surname><given-names>G. J.</given-names></name><name><surname>Teodoro</surname><given-names>B. G.</given-names></name><name><surname>Cunha</surname><given-names>D. N.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Attenuation of Ca2 + homeostasis, oxidative stress, and mitochondrial dysfunctions in diabetic rat heart: insulin therapy or aerobic exercise?</article-title>
<source/><italic>J. Appl. Physiol.</italic>
<volume>119</volume>
<fpage>148</fpage>–<lpage>156</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.00915.2014</pub-id>
<pub-id pub-id-type="pmid">25997948</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dabkowski</surname><given-names>E. R.</given-names></name><name><surname>Williamson</surname><given-names>C. L.</given-names></name><name><surname>Bukowski</surname><given-names>V. C.</given-names></name><name><surname>Chapman</surname><given-names>R. S.</given-names></name><name><surname>Leonard</surname><given-names>S. S.</given-names></name><name><surname>Peer</surname><given-names>C. J.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Diabetic cardiomyopathy-associated dysfunction in spatially distinct mitochondrial subpopulations.</article-title>
<source/><italic>Am. J. Physiol. Heart Circ. Physiol.</italic>
<volume>296</volume>
<fpage>H359</fpage>–<lpage>H369</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00467.2008</pub-id>
<pub-id pub-id-type="pmid">19060128</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Lannoy</surname><given-names>L. M.</given-names></name><name><surname>Danser</surname><given-names>A. H.</given-names></name><name><surname>Bouhuizen</surname><given-names>A. M.</given-names></name><name><surname>Saxena</surname><given-names>P. R.</given-names></name><name><surname>Schalekamp</surname><given-names>M. A.</given-names></name></person-group> (<year>1998</year>). <article-title>Localization and production of angiotensin II in the isolated perfused rat heart.</article-title>
<source/><italic>Hypertension</italic>
<volume>31</volume>
<fpage>1111</fpage>–<lpage>1117</lpage>. <pub-id pub-id-type="doi">10.1161/01.HYP.31.5.1111</pub-id><pub-id pub-id-type="pmid">9576122</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>del Monte</surname><given-names>F.</given-names></name><name><surname>Hajjar</surname><given-names>R. J.</given-names></name><name><surname>Harding</surname><given-names>S. E.</given-names></name></person-group> (<year>2001</year>). <article-title>Overwhelming evidence of the beneficial effects of SERCA gene transfer in heart failure.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>88</volume>
<fpage>E66</fpage>–<lpage>E67</lpage>. <pub-id pub-id-type="doi">10.1161/hh1101.092004</pub-id>
<pub-id pub-id-type="pmid">11397790</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>del Monte</surname><given-names>F.</given-names></name><name><surname>Harding</surname><given-names>S. E.</given-names></name><name><surname>Dec</surname><given-names>G. W.</given-names></name><name><surname>Gwathmey</surname><given-names>J. K.</given-names></name><name><surname>Hajjar</surname><given-names>R. J.</given-names></name></person-group> (<year>2002</year>). <article-title>Targeting phospholamban by gene transfer in human heart failure.</article-title>
<source/><italic>Circulation</italic>
<volume>105</volume>
<fpage>904</fpage>–<lpage>907</lpage>. <pub-id pub-id-type="doi">10.1161/hc0802.105564</pub-id><pub-id pub-id-type="pmid">11864915</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>del Monte</surname><given-names>F.</given-names></name><name><surname>Lebeche</surname><given-names>D.</given-names></name><name><surname>Guerrero</surname><given-names>J. L.</given-names></name><name><surname>Tsuji</surname><given-names>T.</given-names></name><name><surname>Doye</surname><given-names>A. A.</given-names></name><name><surname>Gwathmey</surname><given-names>J. K.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>101</volume>
<fpage>5622</fpage>–<lpage>5627</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0305778101</pub-id>
<pub-id pub-id-type="pmid">15044708</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Despa</surname><given-names>S.</given-names></name><name><surname>Bers</surname><given-names>D. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Na<sup>+</sup> transport in the normal and failing heart - remember the balance.</article-title>
<source/><italic>J. Mol. Cell. Cardiol.</italic>
<volume>61</volume>
<fpage>2</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2013.04.011</pub-id>
<pub-id pub-id-type="pmid">23608603</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Despa</surname><given-names>S.</given-names></name><name><surname>Islam</surname><given-names>M. A.</given-names></name><name><surname>Weber</surname><given-names>C. R.</given-names></name><name><surname>Pogwizd</surname><given-names>S. M.</given-names></name><name><surname>Bers</surname><given-names>D. M.</given-names></name></person-group> (<year>2002</year>). <article-title>Intracellular Na( + ) concentration is elevated in heart failure but Na/K pump function is unchanged.</article-title>
<source/><italic>Circulation</italic>
<volume>105</volume>
<fpage>2543</fpage>–<lpage>2548</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.0000016701.85760.97</pub-id>
<pub-id pub-id-type="pmid">12034663</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dieterle</surname><given-names>T.</given-names></name><name><surname>Meyer</surname><given-names>M.</given-names></name><name><surname>Gu</surname><given-names>Y.</given-names></name><name><surname>Belke</surname><given-names>D. D.</given-names></name><name><surname>Swanson</surname><given-names>E.</given-names></name><name><surname>Iwatate</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Gene transfer of a phospholamban-targeted antibody improves calcium handling and cardiac function in heart failure.</article-title>
<source/><italic>Cardiovasc. Res.</italic>
<volume>67</volume>
<fpage>678</fpage>–<lpage>688</lpage>. <pub-id pub-id-type="doi">10.1016/j.cardiores.2005.04.029</pub-id>
<pub-id pub-id-type="pmid">15927173</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dietl</surname><given-names>A.</given-names></name><name><surname>Maack</surname><given-names>C.</given-names></name></person-group> (<year>2017</year>). <article-title>Targeting mitochondrial calcium handling and reactive oxygen species in heart failure.</article-title>
<source/><italic>Curr. Heart Fail. Rep.</italic>
<volume>14</volume>
<fpage>338</fpage>–<lpage>349</lpage>. <pub-id pub-id-type="doi">10.1007/s11897-017-0347-7</pub-id>
<pub-id pub-id-type="pmid">28656516</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinçer</surname><given-names>U. D.</given-names></name><name><surname>Araiza</surname><given-names>A.</given-names></name><name><surname>Knudson</surname><given-names>J. D.</given-names></name><name><surname>Shao</surname><given-names>C. H.</given-names></name><name><surname>Bidasee</surname><given-names>K. R.</given-names></name><name><surname>Tune</surname><given-names>J. D.</given-names></name></person-group> (<year>2006</year>). <article-title>Dysfunction of cardiac ryanodine receptors in the metabolic syndrome.</article-title>
<source/><italic>J. Mol. Cell. Cardiol.</italic>
<volume>41</volume>
<fpage>108</fpage>–<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2006.04.018</pub-id>
<pub-id pub-id-type="pmid">16793060</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doliba</surname><given-names>N. M.</given-names></name><name><surname>Babsky</surname><given-names>A. M.</given-names></name><name><surname>Wehrli</surname><given-names>S. L.</given-names></name><name><surname>Ivanics</surname><given-names>T. M.</given-names></name><name><surname>Friedman</surname><given-names>M. F.</given-names></name><name><surname>Osbakken</surname><given-names>M. D.</given-names></name></person-group> (<year>2000</year>). <article-title>Metabolic control of sodium transport in streptozotocin-induced diabetic rat hearts.</article-title>
<source/><italic>Biochemistry</italic>
<volume>65</volume>
<fpage>502</fpage>–<lpage>508</lpage>. <pub-id pub-id-type="pmid">10810190</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorn</surname><given-names>G. W.</given-names></name><name><surname>Maack</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>SR and mitochondria: calcium cross-talk between kissing cousins.</article-title>
<source/><italic>J. Mol. Cell. Cardiol.</italic>
<volume>55</volume>
<fpage>42</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2012.07.015</pub-id>
<pub-id pub-id-type="pmid">22902320</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dostal</surname><given-names>D. E.</given-names></name></person-group> (<year>2000</year>). <article-title>The cardiac renin-angiotensin system: novel signaling mechanisms related to cardiac growth and function.</article-title>
<source/><italic>Regul. Pept.</italic>
<volume>28</volume>
<fpage>1</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/S0167-0115(99)00123-8</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dries</surname><given-names>E.</given-names></name><name><surname>Santiago</surname><given-names>D. J.</given-names></name><name><surname>Gilbert</surname><given-names>G.</given-names></name><name><surname>Lenaerts</surname><given-names>I.</given-names></name><name><surname>Vandenberk</surname><given-names>B.</given-names></name><name><surname>Nagaraju</surname><given-names>C. K.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Hyperactive ryanodine receptors in human heart failure and ischaemic cardiomyopathy reside outside of couplons.</article-title>
<source/><italic>Cardiovasc. Res.</italic>
<volume>114</volume>
<fpage>1512</fpage>–<lpage>1524</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvy088</pub-id>
<pub-id pub-id-type="pmid">29668881</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dulhunty</surname><given-names>A.</given-names></name><name><surname>Haarmann</surname><given-names>C.</given-names></name><name><surname>Green</surname><given-names>D.</given-names></name><name><surname>Hart</surname><given-names>J.</given-names></name></person-group> (<year>2000</year>). <article-title>How many cysteine residues regulate ryanodine receptor channel activity?</article-title>
<source/><italic>Antioxid. Redox Signal.</italic>
<volume>2</volume>
<fpage>27</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2000.2.1-27</pub-id>
<pub-id pub-id-type="pmid">11232596</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>J. N.</given-names></name><name><surname>Blatter</surname><given-names>L. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Cardiac alternans and intracellular calcium cycling.</article-title>
<source/><italic>Clin. Exp. Pharmacol. Physiol.</italic>
<volume>41</volume>
<fpage>524</fpage>–<lpage>532</lpage>. <pub-id pub-id-type="doi">10.1111/1440-1681.12231</pub-id>
<pub-id pub-id-type="pmid">25040398</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisner</surname><given-names>D.</given-names></name><name><surname>Bode</surname><given-names>E.</given-names></name><name><surname>Venetucci</surname><given-names>L.</given-names></name><name><surname>Trafford</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Calcium flux balance in the heart.</article-title>
<source/><italic>J. Mol. Cell. Cardiol.</italic>
<volume>58</volume>
<fpage>110</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2012.11.017</pub-id>
<pub-id pub-id-type="pmid">23220128</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisner</surname><given-names>V.</given-names></name><name><surname>Csordás</surname><given-names>G.</given-names></name><name><surname>Hajnóczky</surname><given-names>G.</given-names></name></person-group> (<year>2013</year>). <article-title>Interactions between sarco-endoplasmic reticulum and mitochondria in cardiac and skeletal muscle - pivotal roles in Ca<sup>2+</sup> and reactive oxygen species signaling.</article-title>
<source/><italic>J. Cell. Sci.</italic>
<volume>126</volume>(Pt 14), <fpage>2965</fpage>–<lpage>2978</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.093609</pub-id>
<pub-id pub-id-type="pmid">23843617</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisner</surname><given-names>D. A.</given-names></name><name><surname>Caldwell</surname><given-names>J. L.</given-names></name><name><surname>Kistamás</surname><given-names>K.</given-names></name><name><surname>Trafford</surname><given-names>A. W.</given-names></name></person-group> (<year>2017</year>). <article-title>Calcium and excitation-contraction coupling in the heart.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>121</volume>
<fpage>181</fpage>–<lpage>195</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.310230</pub-id>
<pub-id pub-id-type="pmid">28684623</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erickson</surname><given-names>J. R.</given-names></name><name><surname>Pereira</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Han</surname><given-names>G.</given-names></name><name><surname>Ferguson</surname><given-names>A.</given-names></name><name><surname>Dao</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation.</article-title>
<source/><italic>Nature</italic>
<volume>502</volume>
<fpage>372</fpage>–<lpage>376</lpage>. <pub-id pub-id-type="doi">10.1038/nature12537</pub-id>
<pub-id pub-id-type="pmid">24077098</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fabiato</surname><given-names>A.</given-names></name></person-group> (<year>1985</year>). <article-title>Time and calcium dependence of activation and inactivation of calcium-induced release of calcium from the sarcoplasmic reticulum of a skinned canine cardiac Purkinje cell.</article-title>
<source/><italic>J. Gen. Physiol.</italic>
<volume>85</volume>
<fpage>247</fpage>–<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.85.2.247</pub-id>
<pub-id pub-id-type="pmid">2580043</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faggioni</surname><given-names>M.</given-names></name><name><surname>Kryshtal</surname><given-names>D. O.</given-names></name><name><surname>Knollmann</surname><given-names>B. C.</given-names></name></person-group> (<year>2012</year>). <article-title>Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia.</article-title>
<source/><italic>Pediatr. Cardiol.</italic>
<volume>33</volume>
<fpage>959</fpage>–<lpage>967</lpage>. <pub-id pub-id-type="doi">10.1007/s00246-012-0256-1</pub-id>
<pub-id pub-id-type="pmid">22421959</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fauconnier</surname><given-names>J.</given-names></name><name><surname>Andersson</surname><given-names>D. C.</given-names></name><name><surname>Zhang</surname><given-names>S. J.</given-names></name><name><surname>Lanner</surname><given-names>J. T.</given-names></name><name><surname>Wibom</surname><given-names>R.</given-names></name><name><surname>Katz</surname><given-names>A.</given-names></name></person-group> (<year>2007</year>). <article-title>Effects of palmitate on Ca(2 + ) handling in adult control and ob/ob cardiomyocytes: impact of mitochondrial reactive oxygen species.</article-title>
<source/><italic>Diabetes</italic>
<volume>56</volume>
<fpage>1136</fpage>–<lpage>1142</lpage>. <pub-id pub-id-type="doi">10.2337/db06-0739</pub-id>
<pub-id pub-id-type="pmid">17229941</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fearnley</surname><given-names>C. J.</given-names></name><name><surname>Roderick</surname><given-names>H. L.</given-names></name><name><surname>Bootman</surname><given-names>M. D.</given-names></name></person-group> (<year>2011</year>). <article-title>Calcium signaling in cardiac myocytes.</article-title>
<source/><italic>Cold Spring Harb Perspect. Biol.</italic>
<volume>3</volume>:<issue>a004242</issue>. <pub-id pub-id-type="doi">10.1101/cshperspect.a004242</pub-id>
<pub-id pub-id-type="pmid">21875987</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez-Tenorio</surname><given-names>M.</given-names></name><name><surname>Niggli</surname><given-names>E.</given-names></name></person-group> (<year>2018</year>). <article-title>Stabilization of Ca2 + signaling in cardiac muscle by stimulation of SERCA.</article-title>
<source/><italic>J. Mol. Cell. Cardiol.</italic>
<volume>119</volume>
<fpage>87</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2018.04.015</pub-id>
<pub-id pub-id-type="pmid">29715473</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrier</surname><given-names>G. R.</given-names></name><name><surname>Saunders</surname><given-names>J. H.</given-names></name><name><surname>Mendez</surname><given-names>C.</given-names></name></person-group> (<year>1973</year>). <article-title>A cellular mechanism for the generation of ventricular arrhythmias by acetylstrophanthidin.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>32</volume>
<fpage>600</fpage>–<lpage>609</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.32.5.600</pub-id>
<pub-id pub-id-type="pmid">4713202</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fill</surname><given-names>M.</given-names></name><name><surname>Copello</surname><given-names>J. A.</given-names></name></person-group> (<year>2002</year>). <article-title>Ryanodine receptor calcium release channels.</article-title>
<source/><italic>Physiol. Rev.</italic>
<volume>82</volume>
<fpage>893</fpage>–<lpage>922</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00013.2002</pub-id>
<pub-id pub-id-type="pmid">12270947</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fredersdorf</surname><given-names>S.</given-names></name><name><surname>Thumann</surname><given-names>C.</given-names></name><name><surname>Zimmermann</surname><given-names>W. H.</given-names></name><name><surname>Vetter</surname><given-names>R.</given-names></name><name><surname>Graf</surname><given-names>T.</given-names></name><name><surname>Luchner</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Increased myocardial SERCA expression in early type 2 diabetes mellitus is insulin dependent: In vivo and in vitro data.</article-title>
<source/><italic>Cardiovasc. Diabetol.</italic>
<volume>11</volume>:<issue>57</issue>. <pub-id pub-id-type="doi">10.1186/1475-2840-11-57</pub-id>
<pub-id pub-id-type="pmid">22621761</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaber</surname><given-names>E. M.</given-names></name><name><surname>Jayaprakash</surname><given-names>P.</given-names></name><name><surname>Qureshi</surname><given-names>M. A.</given-names></name><name><surname>Parekh</surname><given-names>K.</given-names></name><name><surname>Oz</surname><given-names>M.</given-names></name><name><surname>Adrian</surname><given-names>T. E.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Effects of a sucrose-enriched diet on the pattern of gene expression, contraction and Ca(2 + ) transport in Goto-Kakizaki type 2 diabetic rat heart.</article-title>
<source/><italic>Exp. Physiol.</italic>
<volume>99</volume>
<fpage>881</fpage>–<lpage>893</lpage>. <pub-id pub-id-type="doi">10.1113/expphysiol.2013.077594</pub-id>
<pub-id pub-id-type="pmid">24681897</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganguly</surname><given-names>P. K.</given-names></name><name><surname>Pierce</surname><given-names>G. N.</given-names></name><name><surname>Dhalla</surname><given-names>K. S.</given-names></name><name><surname>Dhalla</surname><given-names>N. S.</given-names></name></person-group> (<year>1983</year>). <article-title>Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy.</article-title>
<source/><italic>Am. J. Physiol.</italic>
<volume>244</volume>
<fpage>E528</fpage>–<lpage>E535</lpage>. <pub-id pub-id-type="doi">10.1152/ajpendo.1983.244.6.E528</pub-id>
<pub-id pub-id-type="pmid">6134470</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gassanov</surname><given-names>N.</given-names></name><name><surname>Brandt</surname><given-names>M. C.</given-names></name><name><surname>Michels</surname><given-names>G.</given-names></name><name><surname>Lindner</surname><given-names>M.</given-names></name><name><surname>Er</surname><given-names>F.</given-names></name><name><surname>Hoppe</surname><given-names>U. C.</given-names></name></person-group> (<year>2006</year>). <article-title>Angiotensin II-induced changes of calcium sparks and ionic currents in human atrial myocytes: potential role for early remodeling in atrial fibrillation.</article-title>
<source/><italic>Cell Calcium</italic>
<volume>39</volume>
<fpage>175</fpage>–<lpage>186</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceca.2005.10.008</pub-id>
<pub-id pub-id-type="pmid">16303176</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>George</surname><given-names>C. H.</given-names></name><name><surname>Sorathia</surname><given-names>R.</given-names></name><name><surname>Bertrand</surname><given-names>B. M.</given-names></name><name><surname>Lai</surname><given-names>F. A.</given-names></name></person-group> (<year>2003</year>). <article-title>In situ modulation of the human cardiac ryanodine receptor (hRyR2) by FKBP12.6.</article-title>
<source/><italic>Biochem. J.</italic>
<volume>370</volume>(Pt 2), <fpage>579</fpage>–<lpage>589</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20021433</pub-id>
<pub-id pub-id-type="pmid">12443530</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillespie</surname><given-names>D.</given-names></name><name><surname>Fill</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Pernicious attrition and inter-RyR2 CICR current control in cardiac muscle.</article-title>
<source/><italic>J. Mol. Cell. Cardiol.</italic>
<volume>58</volume>
<fpage>53</fpage>–<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2013.01.011</pub-id>
<pub-id pub-id-type="pmid">23369697</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golfman</surname><given-names>L.</given-names></name><name><surname>Dixon</surname><given-names>I. M.</given-names></name><name><surname>Takeda</surname><given-names>N.</given-names></name><name><surname>Lukas</surname><given-names>A.</given-names></name><name><surname>Dakshinamurti</surname><given-names>K.</given-names></name><name><surname>Dhalla</surname><given-names>N. S.</given-names></name></person-group> (<year>1998</year>). <article-title>Cardiac sarcolemmal Na( + )-Ca2 + exchange and Na( + )-K + ATPase activities and gene expression in alloxan-induced diabetes in rats.</article-title>
<source/><italic>Mol. Cell. Biochem.</italic>
<volume>188</volume>
<fpage>91</fpage>–<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1023/A:1006824623496</pub-id>
<pub-id pub-id-type="pmid">9823015</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goonasekera</surname><given-names>S. A.</given-names></name><name><surname>Chen</surname><given-names>S. R.</given-names></name><name><surname>Dirksen</surname><given-names>R. T.</given-names></name></person-group> (<year>2005</year>). <article-title>Reconstitution of local Ca2 + signaling between cardiac L-type Ca2 + channels and ryanodine receptors: insights into regulation by FKBP12.6.</article-title>
<source/><italic>Am. J. Physiol. Cell Physiol.</italic>
<volume>289</volume>
<fpage>C1476</fpage>–<lpage>C1484</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00250.2005</pub-id>
<pub-id pub-id-type="pmid">16049053</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorski</surname><given-names>P. A.</given-names></name><name><surname>Ceholski</surname><given-names>D. K.</given-names></name><name><surname>Hajjar</surname><given-names>R. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Altered myocardial calcium cycling and energetics in heart failure–a rational approach for disease treatment.</article-title>
<source/><italic>Cell Metab.</italic>
<volume>21</volume>
<fpage>183</fpage>–<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2015.01.005</pub-id>
<pub-id pub-id-type="pmid">25651173</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenberg</surname><given-names>B.</given-names></name><name><surname>Butler</surname><given-names>J.</given-names></name><name><surname>Felker</surname><given-names>G. M.</given-names></name><name><surname>Ponikowski</surname><given-names>P.</given-names></name><name><surname>Voors</surname><given-names>A. A.</given-names></name><name><surname>Desai</surname><given-names>A. S.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial.</article-title>
<source/><italic>Lancet</italic>
<volume>387</volume>
<fpage>1178</fpage>–<lpage>1186</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(16)00082-9</pub-id>
<pub-id pub-id-type="pmid">26803443</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>T.</given-names></name><name><surname>Cornea</surname><given-names>R. L.</given-names></name><name><surname>Huke</surname><given-names>S.</given-names></name><name><surname>Camors</surname><given-names>E.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Picht</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Kinetics of FKBP12.6 binding to ryanodine receptors in permeabilized cardiac myocytes and effects on Ca sparks.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>106</volume>
<fpage>1743</fpage>–<lpage>1752</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.110.219816</pub-id>
<pub-id pub-id-type="pmid">20431056</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Györke</surname><given-names>I.</given-names></name><name><surname>Györke</surname><given-names>S.</given-names></name></person-group> (<year>1998</year>). <article-title>Regulation of the cardiac ryanodine receptor channel by luminal Ca2 + involves luminal Ca2 + sensing sites.</article-title>
<source/><italic>Biophys. J.</italic>
<volume>75</volume>
<fpage>2801</fpage>–<lpage>2810</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-3495(98)77723-9</pub-id><pub-id pub-id-type="pmid">9826602</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Györke</surname><given-names>I.</given-names></name><name><surname>Hester</surname><given-names>N.</given-names></name><name><surname>Jones</surname><given-names>L. R.</given-names></name><name><surname>Györke</surname><given-names>S.</given-names></name></person-group> (<year>2004</year>). <article-title>The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium.</article-title>
<source/><italic>Biophys. J.</italic>
<volume>86</volume>
<fpage>2121</fpage>–<lpage>2128</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-3495(04)74271-X</pub-id>
<pub-id pub-id-type="pmid">15041652</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Györke</surname><given-names>S.</given-names></name><name><surname>Terentyev</surname><given-names>D.</given-names></name></person-group> (<year>2008</year>). <article-title>Modulation of ryanodine receptor by luminal calcium and accessory proteins in health and cardiac disease.</article-title>
<source/><italic>Cardiovasc. Res.</italic>
<volume>77</volume>
<fpage>245</fpage>–<lpage>255</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvm038</pub-id>
<pub-id pub-id-type="pmid">18006456</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haghighi</surname><given-names>K.</given-names></name><name><surname>Kolokathis</surname><given-names>F.</given-names></name><name><surname>Gramolini</surname><given-names>A. O.</given-names></name><name><surname>Waggoner</surname><given-names>J. R.</given-names></name><name><surname>Pater</surname><given-names>L.</given-names></name><name><surname>Lynch</surname><given-names>R. A.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>103</volume>
<fpage>1388</fpage>–<lpage>1393</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0510519103</pub-id>
<pub-id pub-id-type="pmid">16432188</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haghighi</surname><given-names>K.</given-names></name><name><surname>Kolokathis</surname><given-names>F.</given-names></name><name><surname>Pater</surname><given-names>L.</given-names></name><name><surname>Lynch</surname><given-names>R. A.</given-names></name><name><surname>Asahi</surname><given-names>M.</given-names></name><name><surname>Gramolini</surname><given-names>A. O.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>111</volume>
<fpage>869</fpage>–<lpage>876</lpage>. <pub-id pub-id-type="doi">10.1172/JCI17892</pub-id>
<pub-id pub-id-type="pmid">12639993</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harvey</surname><given-names>R. D.</given-names></name><name><surname>Hell</surname><given-names>J. W.</given-names></name></person-group> (<year>2013</year>). <article-title>CaV1.2 signaling complexes in the heart.</article-title>
<source/><italic>J. Mol. Cell. Cardiol.</italic>
<volume>58</volume>
<fpage>143</fpage>–<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2012.12.006</pub-id>
<pub-id pub-id-type="pmid">23266596</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasenfuss</surname><given-names>G.</given-names></name><name><surname>Reinecke</surname><given-names>H.</given-names></name><name><surname>Studer</surname><given-names>R.</given-names></name><name><surname>Meyer</surname><given-names>M.</given-names></name><name><surname>Pieske</surname><given-names>B.</given-names></name><name><surname>Holtz</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>1994</year>). <article-title>Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2 + )-ATPase in failing and nonfailing human myocardium.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>75</volume>
<fpage>434</fpage>–<lpage>442</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.75.3.434</pub-id><pub-id pub-id-type="pmid">8062417</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hattori</surname><given-names>Y.</given-names></name><name><surname>Matsuda</surname><given-names>N.</given-names></name><name><surname>Kimura</surname><given-names>J.</given-names></name><name><surname>Ishitani</surname><given-names>T.</given-names></name><name><surname>Tamada</surname><given-names>A.</given-names></name><name><surname>Gando</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Diminished function and expression of the cardiac Na + -Ca2 + exchanger in diabetic rats: implication in Ca2 + overload.</article-title>
<source/><italic>J. Physiol.</italic>
<volume>15</volume>(527 Pt 1), <fpage>85</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7793.2000.00085.x</pub-id>
<pub-id pub-id-type="pmid">10944172</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>T. T.</given-names></name><name><surname>Smyth</surname><given-names>J. W.</given-names></name><name><surname>Chu</surname><given-names>K. Y.</given-names></name><name><surname>Vogan</surname><given-names>J. M.</given-names></name><name><surname>Fong</surname><given-names>T. S.</given-names></name><name><surname>Jensen</surname><given-names>B. C.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>BIN1 is reduced and Cav1.2 trafficking is impaired in human failing cardiomyocytes.</article-title>
<source/><italic>Heart Rhythm.</italic>
<volume>9</volume>
<fpage>812</fpage>–<lpage>820</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2011.11.055</pub-id>
<pub-id pub-id-type="pmid">22138472</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Høydal</surname><given-names>M. A.</given-names></name><name><surname>Kirkeby-Garstad</surname><given-names>I.</given-names></name><name><surname>Karevold</surname><given-names>A.</given-names></name><name><surname>Wiseth</surname><given-names>R.</given-names></name><name><surname>Haaverstad</surname><given-names>R.</given-names></name><name><surname>Wahba</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Human cardiomyocyte calcium handling and transverse tubules in mid-stage of post-myocardial-infarction heart failure.</article-title>
<source/><italic>ESC Heart Fail.</italic>
<volume>5</volume>
<fpage>332</fpage>–<lpage>342</lpage>. <pub-id pub-id-type="doi">10.1002/ehf2.12271</pub-id>
<pub-id pub-id-type="pmid">29431258</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Belke</surname><given-names>D.</given-names></name><name><surname>Suarez</surname><given-names>J.</given-names></name><name><surname>Swanson</surname><given-names>E.</given-names></name><name><surname>Clark</surname><given-names>R.</given-names></name><name><surname>Hoshijima</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Adenovirus-mediated overexpression of O-GlcNAcase improves contractile function in the diabetic heart.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>96</volume>
<fpage>1006</fpage>–<lpage>1013</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000165478.06813.58</pub-id>
<pub-id pub-id-type="pmid">15817886</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>M.</given-names></name><name><surname>Bridge</surname><given-names>J. H.</given-names></name></person-group> (<year>2003</year>). <article-title>Ca2 + sparks in rabbit ventricular myocytes evoked by action potentials: involvement of clusters of L-type Ca2 + channels.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>92</volume>
<fpage>532</fpage>–<lpage>538</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000064175.70693.EC</pub-id>
<pub-id pub-id-type="pmid">12609971</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishikawa</surname><given-names>K.</given-names></name><name><surname>Hajjar</surname><given-names>R. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Current methods in cardiac gene therapy: overview.</article-title>
<source/><italic>Methods Mol. Biol.</italic>
<volume>1521</volume>
<fpage>3</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-6588-5_1</pub-id>
<pub-id pub-id-type="pmid">27910038</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaski</surname><given-names>B. E.</given-names></name><name><surname>Jessup</surname><given-names>M. L.</given-names></name><name><surname>Mancini</surname><given-names>D. M.</given-names></name><name><surname>Cappola</surname><given-names>T. P.</given-names></name><name><surname>Pauly</surname><given-names>D. F.</given-names></name><name><surname>Greenberg</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial.</article-title>
<source/><italic>J. Card Fail.</italic>
<volume>15</volume>
<fpage>171</fpage>–<lpage>181</lpage>. <pub-id pub-id-type="doi">10.1016/j.cardfail.2009.01.013</pub-id>
<pub-id pub-id-type="pmid">19327618</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jessup</surname><given-names>M.</given-names></name><name><surname>Greenberg</surname><given-names>B.</given-names></name><name><surname>Mancini</surname><given-names>D.</given-names></name><name><surname>Cappola</surname><given-names>T.</given-names></name><name><surname>Pauly</surname><given-names>D. F.</given-names></name><name><surname>Jaski</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2 + -ATPase in patients with advanced heart failure.</article-title>
<source/><italic>Circulation</italic>
<volume>124</volume>
<fpage>304</fpage>–<lpage>313</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.111.022889</pub-id>
<pub-id pub-id-type="pmid">21709064</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>G.</given-names></name><name><surname>Hill</surname><given-names>M. A.</given-names></name><name><surname>Sowers</surname><given-names>J. R.</given-names></name></person-group> (<year>2018</year>). <article-title>Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>122</volume>
<fpage>624</fpage>–<lpage>638</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.311586</pub-id>
<pub-id pub-id-type="pmid">29449364</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>R.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>S. R.</given-names></name></person-group> (<year>2007</year>). <article-title>Loss of luminal Ca2 + activation in the cardiac ryanodine receptor is associated with ventricular fibrillation and sudden death.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>104</volume>
<fpage>18309</fpage>–<lpage>18314</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0706573104</pub-id>
<pub-id pub-id-type="pmid">17984046</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>M. T.</given-names></name><name><surname>Lokuta</surname><given-names>A. J.</given-names></name><name><surname>Farrell</surname><given-names>E. F.</given-names></name><name><surname>Wolff</surname><given-names>M. R.</given-names></name><name><surname>Haworth</surname><given-names>R. A.</given-names></name><name><surname>Valdivia</surname><given-names>H. H.</given-names></name></person-group> (<year>2002</year>). <article-title>Abnormal Ca2 + release, but normal ryanodine receptors, in canine and human heart failure.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>29</volume>
<fpage>1015</fpage>–<lpage>1022</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000043663.08689.05</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joseph</surname><given-names>L. C.</given-names></name><name><surname>Subramanyam</surname><given-names>P.</given-names></name><name><surname>Radlicz</surname><given-names>C.</given-names></name><name><surname>Trent</surname><given-names>C. M.</given-names></name><name><surname>Iyer</surname><given-names>V.</given-names></name><name><surname>Colecraft</surname><given-names>H. M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Mitochondrial oxidative stress during cardiac lipid overload causes intracellular calcium leak and arrhythmia.</article-title>
<source/><italic>Heart Rhythm.</italic>
<volume>13</volume>
<fpage>1699</fpage>–<lpage>1706</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2016.05.002</pub-id>
<pub-id pub-id-type="pmid">27154230</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jost</surname><given-names>N.</given-names></name><name><surname>Nagy</surname><given-names>N.</given-names></name><name><surname>Corici</surname><given-names>C.</given-names></name><name><surname>Kohajda</surname><given-names>Z.</given-names></name><name><surname>Horváth</surname><given-names>A.</given-names></name><name><surname>Acsai</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>ORM-10103, a novel specific inhibitor of the Na + /Ca2 + exchanger, decreases early and delayed afterdepolarizations in the canine heart.</article-title>
<source/><italic>Br J Pharmacol.</italic>
<volume>170</volume>
<fpage>768</fpage>–<lpage>778</lpage>. <pub-id pub-id-type="doi">10.1111/bph.12228</pub-id>
<pub-id pub-id-type="pmid">23647096</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joubert</surname><given-names>M.</given-names></name><name><surname>Manrique</surname><given-names>A.</given-names></name><name><surname>Cariou</surname><given-names>B.</given-names></name><name><surname>Prieur</surname><given-names>X.</given-names></name></person-group> (<year>2018</year>). <article-title>Diabetes-related cardiomyopathy: The sweet story of glucose overload from epidemiology to cellular pathways.</article-title>
<source/><italic>Diabetes Metab.</italic>
<pub-id pub-id-type="doi">10.1016/j.diabet.2018.07.003</pub-id> [Epub ahead of print]. <pub-id pub-id-type="pmid">30078623</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Junttila</surname><given-names>M. J.</given-names></name><name><surname>Barthel</surname><given-names>P.</given-names></name><name><surname>Myerburg</surname><given-names>R. J.</given-names></name><name><surname>Mäkikallio</surname><given-names>T. H.</given-names></name><name><surname>Bauer</surname><given-names>A.</given-names></name><name><surname>Ulm</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Sudden cardiac death after myocardial infarction in patients with type 2 diabetes.</article-title>
<source/><italic>Heart Rhythm.</italic>
<volume>7</volume>
<fpage>1396</fpage>–<lpage>1403</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2010.07.031</pub-id>
<pub-id pub-id-type="pmid">20682359</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaneko</surname><given-names>M.</given-names></name><name><surname>Hashikami</surname><given-names>K.</given-names></name><name><surname>Yamamoto</surname><given-names>S.</given-names></name><name><surname>Matsumoto</surname><given-names>H.</given-names></name><name><surname>Nishimoto</surname><given-names>T.</given-names></name></person-group> (<year>2016</year>). <article-title>Phospholamban ablation using CRISPR/Cas9 system improves mortality in a murine heart failure model.</article-title>
<source/><italic>PLoS One</italic>
<volume>11</volume>:<issue>e0168486</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0168486</pub-id>
<pub-id pub-id-type="pmid">27992596</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaneko</surname><given-names>N.</given-names></name><name><surname>Matsuda</surname><given-names>R.</given-names></name><name><surname>Toda</surname><given-names>M.</given-names></name><name><surname>Shimamoto</surname><given-names>K.</given-names></name></person-group> (<year>1997</year>). <article-title>Inhibition of annexin V-dependent Ca2 + movement in large unilamellar vesicles by K201, a new 1,4-benzothiazepine derivative.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>13</volume>
<fpage>1</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/S0005-2736(97)00132-6</pub-id>
<pub-id pub-id-type="pmid">9375807</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J. D.</given-names></name><name><surname>Yu</surname><given-names>B. P.</given-names></name><name><surname>McCarter</surname><given-names>R. J.</given-names></name><name><surname>Lee</surname><given-names>S. Y.</given-names></name><name><surname>Herlihy</surname><given-names>J. T.</given-names></name></person-group> (<year>1996</year>). <article-title>Exercise and diet modulate cardiac lipid peroxidation and antioxidant defenses.</article-title>
<source/><italic>Free Radic. Biol. Med.</italic>
<volume>20</volume>
<fpage>83</fpage>–<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1016/0891-5849(95)02023-3</pub-id>
<pub-id pub-id-type="pmid">8903682</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>A.</given-names></name><name><surname>Bowe</surname><given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>Animal models for diabetes: understanding the pathogenesis and finding new treatments.</article-title>
<source/><italic>Biochem. Pharmacol.</italic>
<volume>99</volume>
<fpage>1</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2015.08.108</pub-id>
<pub-id pub-id-type="pmid">26432954</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>A. J. F.</given-names></name></person-group> (<year>2012</year>). <article-title>The use of animal models in diabetes research.</article-title>
<source/><italic>Br. J. Pharmacol.</italic>
<volume>166</volume>
<fpage>877</fpage>–<lpage>894</lpage>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.2012.01911.x</pub-id>
<pub-id pub-id-type="pmid">22352879</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiss</surname><given-names>E.</given-names></name><name><surname>Ball</surname><given-names>N. A.</given-names></name><name><surname>Kranias</surname><given-names>E. G.</given-names></name><name><surname>Walsh</surname><given-names>R. A.</given-names></name></person-group> (<year>1995</year>). <article-title>Differential changes in cardiac phospholamban and sarcoplasmic reticular Ca(2 + )-ATPase protein levels. Effects on Ca2 + transport and mechanics in compensated pressure-overload hypertrophy and congestive heart failure.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>77</volume>
<fpage>759</fpage>–<lpage>764</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.77.4.759</pub-id>
<pub-id pub-id-type="pmid">7554123</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klapholz</surname><given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>Beta-blocker use for the stages of heart failure.</article-title>
<source/><italic>Mayo Clin. Proc.</italic>
<volume>84</volume>
<fpage>718</fpage>–<lpage>729</lpage>. <pub-id pub-id-type="doi">10.4065/84.8.718</pub-id>
<pub-id pub-id-type="pmid">19648389</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knollmann</surname><given-names>B. C.</given-names></name><name><surname>Chopra</surname><given-names>N.</given-names></name><name><surname>Hlaing</surname><given-names>T.</given-names></name><name><surname>Akin</surname><given-names>B.</given-names></name><name><surname>Yang</surname><given-names>T.</given-names></name><name><surname>Ettensohn</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2 + release, and catecholaminergic polymorphic ventricular tachycardia.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>116</volume>
<fpage>2510</fpage>–<lpage>2520</lpage>. <pub-id pub-id-type="doi">10.1172/JCI29128</pub-id>
<pub-id pub-id-type="pmid">16932808</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>S.</given-names></name><name><surname>Yano</surname><given-names>M.</given-names></name><name><surname>Uchinoumi</surname><given-names>H.</given-names></name><name><surname>Suetomi</surname><given-names>T.</given-names></name><name><surname>Susa</surname><given-names>T.</given-names></name><name><surname>Ono</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Dantrolene, a therapeutic agent for malignant hyperthermia, inhibits catecholaminergic polymorphic ventricular tachycardia in a RyR2(R2474S/ + ) knock-in mouse model.</article-title>
<source/><italic>Circ. J.</italic>
<volume>74</volume>
<fpage>2579</fpage>–<lpage>2584</lpage>. <pub-id pub-id-type="doi">10.1253/circj.CJ-10-0680</pub-id>
<pub-id pub-id-type="pmid">20944434</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kranias</surname><given-names>E. G.</given-names></name><name><surname>Hajjar</surname><given-names>R. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>110</volume>
<fpage>1646</fpage>–<lpage>1660</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.111.259754</pub-id>
<pub-id pub-id-type="pmid">22679139</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunitomo</surname><given-names>Y.</given-names></name><name><surname>Terentyev</surname><given-names>D.</given-names></name></person-group> (<year>2011</year>). <article-title>How to stop the fire? Control of Ca<sup>2+</sup>-induced Ca<sup>2+</sup> release in cardiac muscle.</article-title>
<source/><italic>J. Physiol.</italic>
<volume>589</volume>(Pt 24), <fpage>5899</fpage>–<lpage>5900</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2011.222554</pub-id><pub-id pub-id-type="pmid">22174133</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuster</surname><given-names>G. M.</given-names></name><name><surname>Lancel</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Communal</surname><given-names>C.</given-names></name><name><surname>Trucillo</surname><given-names>M. P.</given-names></name><name><surname>Lim</surname><given-names>C. C.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Redox-mediated reciprocal regulation of SERCA and Na + -Ca2 + exchanger contributes to sarcoplasmic reticulum Ca2 + depletion in cardiac myocytes.</article-title>
<source/><italic>Free Radic. Biol Med.</italic>
<volume>48</volume>
<fpage>1182</fpage>–<lpage>1187</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2010.01.038</pub-id>
<pub-id pub-id-type="pmid">20132882</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laakso</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>Diabetes as a ’cardiovascular disease equivalent’: implications for treatment.</article-title>
<source/><italic>Nat. Clin. Pract. Cardiovasc. Med.</italic>
<volume>5</volume>
<fpage>682</fpage>–<lpage>683</lpage>. <pub-id pub-id-type="doi">10.1038/ncpcardio1344</pub-id>
<pub-id pub-id-type="pmid">18797431</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lacombe</surname><given-names>V. A.</given-names></name><name><surname>Viatchenko-Karpinski</surname><given-names>S.</given-names></name><name><surname>Terentyev</surname><given-names>D.</given-names></name><name><surname>Sridhar</surname><given-names>A.</given-names></name><name><surname>Emani</surname><given-names>S.</given-names></name><name><surname>Bonagura</surname><given-names>J. D.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes.</article-title>
<source/><italic>Am. J. Physiol. Regul. Integr. Comp. Physiol.</italic>
<volume>293</volume>
<fpage>R1787</fpage>–<lpage>R1797</lpage>. <pub-id pub-id-type="doi">10.1152/ajpregu.00059.2007</pub-id>
<pub-id pub-id-type="pmid">17761517</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lagadic-Gossmann</surname><given-names>D.</given-names></name><name><surname>Buckler</surname><given-names>K. J.</given-names></name><name><surname>Le Prigent</surname><given-names>K.</given-names></name><name><surname>Feuvray</surname><given-names>D.</given-names></name></person-group> (<year>1996</year>). <article-title>Altered Ca2 + handling in ventricular myocytes isolated from diabetic rats.</article-title>
<source/><italic>Am. J. Physiol.</italic>
<volume>270</volume>(5 Pt 2), <fpage>H1529</fpage>–<lpage>H1537</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.1996.270.5.H1529</pub-id>
<pub-id pub-id-type="pmid">8928857</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lahat</surname><given-names>H.</given-names></name><name><surname>Pras</surname><given-names>E.</given-names></name><name><surname>Olender</surname><given-names>T.</given-names></name><name><surname>Avidan</surname><given-names>N.</given-names></name><name><surname>Ben-Asher</surname><given-names>E.</given-names></name><name><surname>Man</surname><given-names>O.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>69</volume>
<fpage>1378</fpage>–<lpage>1384</lpage>. <pub-id pub-id-type="doi">10.1086/324565</pub-id>
<pub-id pub-id-type="pmid">11704930</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lancel</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Evangelista</surname><given-names>A.</given-names></name><name><surname>Trucillo</surname><given-names>M. P.</given-names></name><name><surname>Tong</surname><given-names>X.</given-names></name><name><surname>Siwik</surname><given-names>D. A.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Nitroxyl activates SERCA in cardiac myocytes via glutathiolation of cysteine 674.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>104</volume>
<fpage>720</fpage>–<lpage>723</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.108.188441</pub-id>
<pub-id pub-id-type="pmid">19265039</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landstrom</surname><given-names>A. P.</given-names></name><name><surname>Dobrev</surname><given-names>D.</given-names></name><name><surname>Wehrens</surname><given-names>X. H. T.</given-names></name></person-group> (<year>2017</year>). <article-title>Calcium signaling and cardiac arrhythmias.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>120</volume>
<fpage>1969</fpage>–<lpage>1993</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.310083</pub-id>
<pub-id pub-id-type="pmid">28596175</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LaRocca</surname><given-names>T. J.</given-names></name><name><surname>Fabris</surname><given-names>F.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Benhayon</surname><given-names>D.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>McCollum</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Na + /Ca2 + exchanger-1 protects against systolic failure in the Akitains2 model of diabetic cardiomyopathy via a CXCR4/NF-κB pathway.</article-title>
<source/><italic>Am. J. Physiol. Heart Circ. Physiol.</italic>
<volume>303</volume>
<fpage>H353</fpage>–<lpage>H367</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.01198.2011</pub-id>
<pub-id pub-id-type="pmid">22610174</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laver</surname><given-names>D. R.</given-names></name><name><surname>Kong</surname><given-names>C. H.</given-names></name><name><surname>Imtiaz</surname><given-names>M. S.</given-names></name><name><surname>Cannell</surname><given-names>M. B.</given-names></name></person-group> (<year>2013</year>). <article-title>Termination of calcium-induced calcium release by induction decay: an emergent property of stochastic channel gating and molecular scale architecture.</article-title>
<source/><italic>J. Mol. Cell. Cardiol.</italic>
<volume>54</volume>
<fpage>98</fpage>–<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2012.10.009</pub-id>
<pub-id pub-id-type="pmid">23123322</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Douairon Lahaye</surname><given-names>S.</given-names></name><name><surname>Gratas-Delamarche</surname><given-names>A.</given-names></name><name><surname>Malardé</surname><given-names>L.</given-names></name><name><surname>Zguira</surname><given-names>S.</given-names></name><name><surname>Vincent</surname><given-names>S.</given-names></name><name><surname>Lemoine Morel</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Combined insulin treatment and intense exercise training improved basal cardiac function and Ca(2 + )-cycling proteins expression in type 1 diabetic rats.</article-title>
<source/><italic>Appl. Physiol. Nutr. Metab.</italic>
<volume>37</volume>
<fpage>53</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1139/h11-127</pub-id>
<pub-id pub-id-type="pmid">22185592</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leach</surname><given-names>R. N.</given-names></name><name><surname>Brickley</surname><given-names>K.</given-names></name><name><surname>Norman</surname><given-names>R. I.</given-names></name></person-group> (<year>1996</year>). <article-title>Cyclic AMP-dependent protein kinase phosphorylates residues in the C-terminal domain of the cardiac L-type calcium channel alpha1 subunit.</article-title>
<source/><italic>Biochim. Biophys. Acta.</italic>
<volume>11</volume>
<fpage>205</fpage>–<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1016/0005-2736(96)00013-2</pub-id>
<pub-id pub-id-type="pmid">8664319</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leon</surname><given-names>B. M.</given-names></name><name><surname>Maddox</surname><given-names>T. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research.</article-title>
<source/><italic>World J. Diabetes</italic>
<volume>6</volume>
<fpage>1246</fpage>–<lpage>1258</lpage>. <pub-id pub-id-type="doi">10.4239/wjd.v6.i13.1246</pub-id>
<pub-id pub-id-type="pmid">26468341</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Sibrian-Vazquez</surname><given-names>M.</given-names></name><name><surname>Klipp</surname><given-names>R. C.</given-names></name><name><surname>Reynolds</surname><given-names>J. O.</given-names></name><name><surname>Word</surname><given-names>T. A.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Treatment of catecholaminergic polymorphic ventricular tachycardia in mice using novel RyR2-modifying drugs.</article-title>
<source/><italic>Int. J. Cardiol.</italic>
<volume>15</volume>
<fpage>668</fpage>–<lpage>673</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijcard.2016.10.078</pub-id>
<pub-id pub-id-type="pmid">27838126</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Yuan</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Reactive oxygen species mediated oxidative stress links diabetes and atrial fibrillation.</article-title>
<source/><italic>Mol. Med. Rep.</italic>
<volume>17</volume>
<fpage>4933</fpage>–<lpage>4940</lpage>. <pub-id pub-id-type="doi">10.3892/mmr.2018.8472</pub-id>
<pub-id pub-id-type="pmid">29393403</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>1 Walton</surname><given-names>S. D.</given-names></name><name><surname>Ho</surname><given-names>H. T.</given-names></name><name><surname>Belevych</surname><given-names>A. E.</given-names></name><name><surname>Tikunova</surname><given-names>S. B.</given-names></name><name><surname>Bonilla</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Gene transfer of engineered calmodulin alleviates ventricular arrhythmias in a calsequestrin-associated mouse model of catecholaminergic polymorphic ventricular tachycardia.</article-title>
<source/><italic>J. Am. Heart Assoc.</italic>
<volume>7</volume>:<issue>e008155</issue>. <pub-id pub-id-type="doi">10.1161/JAHA.117.008155</pub-id>
<pub-id pub-id-type="pmid">29720499</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>O’Rourke</surname><given-names>B.</given-names></name></person-group> (<year>2013</year>). <article-title>Regulation of the Na + /Ca2 + exchanger by pyridine nucleotide redox potential in ventricular myocytes.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>288</volume>
<fpage>31984</fpage>–<lpage>31992</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M113.496588</pub-id>
<pub-id pub-id-type="pmid">24045952</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Llano-Diez</surname><given-names>M.</given-names></name><name><surname>Sinclair</surname><given-names>J.</given-names></name><name><surname>Yamada</surname><given-names>T.</given-names></name><name><surname>Zong</surname><given-names>M.</given-names></name><name><surname>Fauconnier</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>S. J.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>The role of reactive oxygen species in β-adrenergic signaling in cardiomyocytes from mice with the metabolic syndrome.</article-title>
<source/><italic>PLoS One</italic>
<volume>11</volume>:<issue>e0167090</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0167090</pub-id>
<pub-id pub-id-type="pmid">27907040</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loaiza</surname><given-names>R.</given-names></name><name><surname>Benkusky</surname><given-names>N. A.</given-names></name><name><surname>Powers</surname><given-names>P. P.</given-names></name><name><surname>Hacker</surname><given-names>T.</given-names></name><name><surname>Noujaim</surname><given-names>S.</given-names></name><name><surname>Ackerman</surname><given-names>M. J.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Heterogeneity of ryanodine receptor dysfunction in a mouse model of catecholaminergic polymorphic ventricular tachycardia.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>112</volume>
<fpage>298</fpage>–<lpage>308</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.112.274803</pub-id>
<pub-id pub-id-type="pmid">23152493</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopaschuk</surname><given-names>G. D.</given-names></name><name><surname>Katz</surname><given-names>S.</given-names></name><name><surname>McNeill</surname><given-names>J. H.</given-names></name></person-group> (<year>1983</year>). <article-title>The effect of alloxan- and streptozotocin-induced diabetes on calcium transport in rat cardiac sarcoplasmic reticulum. The possible involvement of long chain acylcarnitines.</article-title>
<source/><italic>Can. J. Physiol. Pharmacol.</italic>
<volume>61</volume>
<fpage>439</fpage>–<lpage>448</lpage>. <pub-id pub-id-type="doi">10.1139/y83-068</pub-id>
<pub-id pub-id-type="pmid">6883199</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Crisosto</surname><given-names>C.</given-names></name><name><surname>Pennanen</surname><given-names>C.</given-names></name><name><surname>Vasquez-Trincado</surname><given-names>C.</given-names></name><name><surname>Morales</surname><given-names>P. E.</given-names></name><name><surname>Bravo-Sagua</surname><given-names>R.</given-names></name><name><surname>Quest</surname><given-names>A. F. G.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Sarcoplasmic reticulum-mitochondria communication in cardiovascular pathophysiology.</article-title>
<source/><italic>Nat. Rev. Cardiol.</italic>
<volume>14</volume>
<fpage>342</fpage>–<lpage>360</lpage>. <pub-id pub-id-type="doi">10.1038/nrcardio.2017.23</pub-id>
<pub-id pub-id-type="pmid">28275246</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Louch</surname><given-names>W. E.</given-names></name><name><surname>Bito</surname><given-names>V.</given-names></name><name><surname>Heinzel</surname><given-names>F. R.</given-names></name><name><surname>Macianskiene</surname><given-names>R.</given-names></name><name><surname>Vanhaecke</surname><given-names>J.</given-names></name><name><surname>Flameng</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Reduced synchrony of Ca2 + release with loss of T-tubules-a comparison to Ca2 + release in human failing cardiomyocytes.</article-title>
<source/><italic>Cardiovasc. Res.</italic>
<volume>62</volume>
<fpage>63</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1016/j.cardiores.2003.12.031</pub-id>
<pub-id pub-id-type="pmid">15023553</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Z.</given-names></name><name><surname>Ballou</surname><given-names>L. M.</given-names></name><name><surname>Jiang</surname><given-names>Y. P.</given-names></name><name><surname>Cohen</surname><given-names>I. S.</given-names></name><name><surname>Lin</surname><given-names>R. Z.</given-names></name></person-group> (<year>2011</year>). <article-title>Restoration of defective L-type Ca2 + current in cardiac myocytes of type 2 diabetic <italic>db/db</italic> mice by Akt and PKC-ι.</article-title>
<source/><italic>J. Cardiovasc. Pharmacol.</italic>
<volume>58</volume>
<fpage>439</fpage>–<lpage>445</lpage>. <pub-id pub-id-type="doi">10.1097/FJC.0b013e318228e68c</pub-id>
<pub-id pub-id-type="pmid">21753738</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Z.</given-names></name><name><surname>Jiang</surname><given-names>Y. P.</given-names></name><name><surname>Xu</surname><given-names>X. H.</given-names></name><name><surname>Ballou</surname><given-names>L. M.</given-names></name><name><surname>Cohen</surname><given-names>I. S.</given-names></name><name><surname>Lin</surname><given-names>R. Z.</given-names></name></person-group> (<year>2007</year>). <article-title>Decreased L-type Ca2 + current in cardiac myocytes of type 1 diabetic Akita mice due to reduced phosphatidylinositol 3-kinase signaling.</article-title>
<source/><italic>Diabetes Metab. Res. Rev.</italic>
<volume>56</volume>
<fpage>2780</fpage>–<lpage>2789</lpage>. <pub-id pub-id-type="doi">10.2337/db06-1629</pub-id>
<pub-id pub-id-type="pmid">17666471</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luczak</surname><given-names>E. D.</given-names></name><name><surname>Anderson</surname><given-names>M. E.</given-names></name></person-group> (<year>2014</year>). <article-title>CaMKII oxidative activation and the pathogenesis of cardiac disease.</article-title>
<source/><italic>J. Mol. Cell. Cardiol.</italic>
<volume>73</volume>
<fpage>112</fpage>–<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2014.02.004</pub-id>
<pub-id pub-id-type="pmid">24530899</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lukyanenko</surname><given-names>V.</given-names></name><name><surname>Györke</surname><given-names>I.</given-names></name><name><surname>Györke</surname><given-names>S.</given-names></name></person-group> (<year>1996</year>). <article-title>Regulation of calcium release by calcium inside the sarcoplasmic reticulum in ventricular myocytes.</article-title>
<source/><italic>Pflugers Arch.</italic>
<volume>432</volume>
<fpage>1047</fpage>–<lpage>1054</lpage>. <pub-id pub-id-type="doi">10.1007/s004240050233</pub-id><pub-id pub-id-type="pmid">8781199</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyon</surname><given-names>A. R.</given-names></name><name><surname>Bannister</surname><given-names>M. L.</given-names></name><name><surname>Collins</surname><given-names>T.</given-names></name><name><surname>Pearce</surname><given-names>E.</given-names></name><name><surname>Sepehripour</surname><given-names>A. H.</given-names></name><name><surname>Dubb</surname><given-names>S. S.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>SERCA2a gene transfer decreases sarcoplasmic reticulum calcium leak and reduces ventricular arrhythmias in a model of chronic heart failure.</article-title>
<source/><italic>Circ. Arrhythm. Electrophysiol.</italic>
<volume>4</volume>
<fpage>362</fpage>–<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCEP.110.961615</pub-id>
<pub-id pub-id-type="pmid">21406682</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makino</surname><given-names>N.</given-names></name><name><surname>Dhalla</surname><given-names>K. S.</given-names></name><name><surname>Elimban</surname><given-names>V.</given-names></name><name><surname>Dhalla</surname><given-names>N. S.</given-names></name></person-group> (<year>1987</year>). <article-title>Sarcolemmal Ca2 + transport in streptozotocin-induced diabetic cardiomyopathy in rats.</article-title>
<source/><italic>Am. J. Physiol.</italic>
<volume>253</volume>(2 Pt 1), <fpage>E202</fpage>–<lpage>E207</lpage>. <pub-id pub-id-type="doi">10.1152/ajpendo.1987.253.2.E202</pub-id>
<pub-id pub-id-type="pmid">2956889</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malhotra</surname><given-names>A.</given-names></name><name><surname>Reich</surname><given-names>D.</given-names></name><name><surname>Reich</surname><given-names>D.</given-names></name><name><surname>Nakouzi</surname><given-names>A.</given-names></name><name><surname>Sanghi</surname><given-names>V.</given-names></name><name><surname>Geenen</surname><given-names>D. L.</given-names></name><etal></etal></person-group> (<year>1997</year>). <article-title>Experimental diabetes is associated with functional activation of protein kinase C epsilon and phosphorylation of troponin I in the heart, which are prevented by angiotensin II receptor blockade.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>81</volume>
<fpage>1027</fpage>–<lpage>1033</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.81.6.1027</pub-id>
<pub-id pub-id-type="pmid">9400384</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mancia</surname><given-names>G.</given-names></name><name><surname>Fagard</surname><given-names>R.</given-names></name><name><surname>Narkiewicz</surname><given-names>K.</given-names></name><name><surname>Redón</surname><given-names>J.</given-names></name><name><surname>Zanchetti</surname><given-names>A.</given-names></name><name><surname>Böhm</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).</article-title>
<source/><italic>J. Hypertens.</italic>
<volume>31</volume>
<fpage>1281</fpage>–<lpage>1357</lpage>. <pub-id pub-id-type="doi">10.1097/01.hjh.0000431740.32696.cc</pub-id>
<pub-id pub-id-type="pmid">23817082</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsman</surname><given-names>R. F.</given-names></name><name><surname>Barc</surname><given-names>J.</given-names></name><name><surname>Beekman</surname><given-names>L.</given-names></name><name><surname>Alders</surname><given-names>M.</given-names></name><name><surname>Dooijes</surname><given-names>D.</given-names></name><name><surname>van den Wijngaard</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>A mutation in CALM1 encoding calmodulin in familial idiopathic ventricular fibrillation in childhood and adolescence.</article-title>
<source/><italic>J. Am. Coll. Cardiol.</italic>
<volume>63</volume>
<fpage>259</fpage>–<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2013.07.091</pub-id>
<pub-id pub-id-type="pmid">24076290</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marx</surname><given-names>S. O.</given-names></name><name><surname>Reiken</surname><given-names>S.</given-names></name><name><surname>Hisamatsu</surname><given-names>Y.</given-names></name><name><surname>Jayaraman</surname><given-names>T.</given-names></name><name><surname>Burkhoff</surname><given-names>D.</given-names></name><name><surname>Rosemblit</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.</article-title>
<source/><italic>Cell</italic>
<volume>101</volume>
<fpage>365</fpage>–<lpage>376</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(00)80847-8</pub-id>
<pub-id pub-id-type="pmid">10830164</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathews</surname><given-names>C. E.</given-names></name><name><surname>Langley</surname><given-names>S. H.</given-names></name><name><surname>Leiter</surname><given-names>E. H.</given-names></name></person-group> (<year>2002</year>). <article-title>New mouse model to study islet transplantation in insulin-dependent diabetes mellitus.</article-title>
<source/><italic>Transplantation</italic>
<volume>73</volume>
<fpage>1333</fpage>–<lpage>1336</lpage>. <pub-id pub-id-type="doi">10.1097/00007890-200204270-00024</pub-id><pub-id pub-id-type="pmid">11981430</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mechmann</surname><given-names>S.</given-names></name><name><surname>Pott</surname><given-names>L.</given-names></name></person-group> (<year>1986</year>). <article-title>Identification of Na-Ca exchange current in single cardiac myocytes.</article-title>
<source/><italic>Nature</italic>
<volume>319</volume>
<fpage>597</fpage>–<lpage>599</lpage>. <pub-id pub-id-type="doi">10.1038/319597a0</pub-id>
<pub-id pub-id-type="pmid">2418367</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meissner</surname><given-names>G.</given-names></name></person-group> (<year>2017</year>). <article-title>The structural basis of ryanodine receptor ion channel function.</article-title>
<source/><italic>J. Gen. Physiol.</italic>
<volume>149</volume>
<fpage>1065</fpage>–<lpage>1089</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.201711878</pub-id>
<pub-id pub-id-type="pmid">29122978</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merchant</surname><given-names>F. M.</given-names></name><name><surname>Armoundas</surname><given-names>A. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Role of substrate and triggers in the genesis of cardiac alternans, from the myocyte to the whole heart: implications for therapy.</article-title>
<source/><italic>Circulation</italic>
<volume>125</volume>
<fpage>539</fpage>–<lpage>549</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.111.033563</pub-id>
<pub-id pub-id-type="pmid">22271847</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mewes</surname><given-names>T.</given-names></name><name><surname>Ravens</surname><given-names>U.</given-names></name></person-group> (<year>1994</year>). <article-title>L-type calcium currents of human myocytes from ventricle of non-failing and failing hearts and from atrium.</article-title>
<source/><italic>J. Mol. Cell. Cardiol.</italic>
<volume>26</volume>
<fpage>1307</fpage>–<lpage>1320</lpage>. <pub-id pub-id-type="doi">10.1006/jmcc.1994.1149</pub-id>
<pub-id pub-id-type="pmid">7869391</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>M.</given-names></name><name><surname>Belke</surname><given-names>D. D.</given-names></name><name><surname>Trost</surname><given-names>S. U.</given-names></name><name><surname>Swanson</surname><given-names>E.</given-names></name><name><surname>Dieterle</surname><given-names>T.</given-names></name><name><surname>Scott</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>A recombinant antibody increases cardiac contractility by mimicking phospholamban phosphorylation.</article-title>
<source/><italic>FASEB J.</italic>
<volume>18</volume>
<fpage>1312</fpage>–<lpage>1314</lpage>. <pub-id pub-id-type="doi">10.1096/fj.03-1231fje</pub-id>
<pub-id pub-id-type="pmid">15180962</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>M.</given-names></name><name><surname>Dillmann</surname><given-names>W. H.</given-names></name></person-group> (<year>1998</year>). <article-title>Sarcoplasmic reticulum Ca(2 + )-ATPase overexpression by adenovirus mediated gene transfer and in transgenic mice.</article-title>
<source/><italic>Cardiovasc. Res.</italic>
<volume>37</volume>
<fpage>360</fpage>–<lpage>366</lpage>. <pub-id pub-id-type="doi">10.1016/S0008-6363(97)00270-8</pub-id><pub-id pub-id-type="pmid">9614493</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mochizuki</surname><given-names>M.</given-names></name><name><surname>Yano</surname><given-names>M.</given-names></name><name><surname>Oda</surname><given-names>T.</given-names></name><name><surname>Tateishi</surname><given-names>H.</given-names></name><name><surname>Kobayashi</surname><given-names>S.</given-names></name><name><surname>Yamamoto</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Scavenging free radicals by low-dose carvedilol prevents redox-dependent Ca2 + leak via stabilization of ryanodine receptor in heart failure.</article-title>
<source/><italic>J. Am. Coll. Cardiol.</italic>
<volume>49</volume>
<fpage>1722</fpage>–<lpage>1732</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2007.01.064</pub-id>
<pub-id pub-id-type="pmid">17448375</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muralidharan</surname><given-names>P.</given-names></name><name><surname>Cserne Szappanos</surname><given-names>H.</given-names></name><name><surname>Ingley</surname><given-names>E.</given-names></name><name><surname>Hool</surname><given-names>L. C.</given-names></name></person-group> (<year>2017</year>). <article-title>The cardiac L-type calcium channel alpha subunit is a target for direct redox modification during oxidative stress-the role of cysteine residues in the alpha interacting domain.</article-title>
<source/><italic>Clin. Exp. Pharmacol. Physiol.</italic>
<volume>44</volume>(Suppl. 1), <fpage>46</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1111/1440-1681.12750</pub-id>
<pub-id pub-id-type="pmid">28306174</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagy</surname><given-names>N.</given-names></name><name><surname>Kormos</surname><given-names>A.</given-names></name><name><surname>Kohajda</surname><given-names>Z.</given-names></name><name><surname>Szebeni</surname><given-names>Á</given-names></name><name><surname>Szepesi</surname><given-names>J.</given-names></name><name><surname>Pollesello</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Selective Na( + ) /Ca(2 + ) exchanger inhibition prevents Ca(2 + ) overload-induced triggered arrhythmias.</article-title>
<source/><italic>Br. J. Pharmacol.</italic>
<volume>171</volume>
<fpage>5665</fpage>–<lpage>5681</lpage>. <pub-id pub-id-type="doi">10.1111/bph.12867</pub-id>
<pub-id pub-id-type="pmid">25073832</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neco</surname><given-names>P.</given-names></name><name><surname>Rose</surname><given-names>B.</given-names></name><name><surname>Huynh</surname><given-names>N.</given-names></name><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Bridge</surname><given-names>J. H.</given-names></name><name><surname>Philipson</surname><given-names>K. D.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Sodium-calcium exchange is essential for effective triggering of calcium release in mouse heart.</article-title>
<source/><italic>Biophys. J.</italic>
<volume>99</volume>
<fpage>755</fpage>–<lpage>764</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpj.2010.04.071</pub-id>
<pub-id pub-id-type="pmid">20682252</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Netticadan</surname><given-names>T.</given-names></name><name><surname>Temsah</surname><given-names>R. M.</given-names></name><name><surname>Kent</surname><given-names>A.</given-names></name><name><surname>Elimban</surname><given-names>V.</given-names></name><name><surname>Dhalla</surname><given-names>N. S.</given-names></name></person-group> (<year>2001</year>). <article-title>Depressed levels of Ca2 + -cycling proteins may underlie sarcoplasmic reticulum dysfunction in the diabetic heart.</article-title>
<source/><italic>Diabetes</italic>
<volume>50</volume>
<fpage>2133</fpage>–<lpage>2138</lpage>. <pub-id pub-id-type="doi">10.2337/diabetes.50.9.2133</pub-id>
<pub-id pub-id-type="pmid">11522681</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niggli</surname><given-names>E.</given-names></name><name><surname>Ullrich</surname><given-names>N. D.</given-names></name><name><surname>Gutierrez</surname><given-names>D.</given-names></name><name><surname>Kyrychenko</surname><given-names>S.</given-names></name><name><surname>Poláková</surname><given-names>E.</given-names></name><name><surname>Shirokova</surname><given-names>N.</given-names></name></person-group> (<year>2013</year>). <article-title>Posttranslational modifications of cardiac ryanodine receptors: Ca(2 + ) signaling and EC-coupling.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1833</volume>
<fpage>866</fpage>–<lpage>875</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2012.08.016</pub-id>
<pub-id pub-id-type="pmid">22960642</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nivala</surname><given-names>M.</given-names></name><name><surname>Qu</surname><given-names>Z.</given-names></name></person-group> (<year>2012</year>). <article-title>Calcium alternans in a couplon network model of ventricular myocytes: role of sarcoplasmic reticulum load.</article-title>
<source/><italic>Am. J. Physiol. Heart Circ. Physiol.</italic>
<volume>303</volume>
<fpage>H341</fpage>–<lpage>H352</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00302.2012</pub-id>
<pub-id pub-id-type="pmid">22661509</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nyegaard</surname><given-names>M.</given-names></name><name><surname>Overgaard</surname><given-names>M. T.</given-names></name><name><surname>Søndergaard</surname><given-names>M. T.</given-names></name><name><surname>Vranas</surname><given-names>M.</given-names></name><name><surname>Behr</surname><given-names>E. R.</given-names></name><name><surname>Hildebrandt</surname><given-names>L. L.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>91</volume>
<fpage>703</fpage>–<lpage>712</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2012.08.015</pub-id>
<pub-id pub-id-type="pmid">23040497</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohishi</surname><given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>Hypertension with diabetes mellitus: physiology and pathology.</article-title>
<source/><italic>Hypertens. Res.</italic>
<volume>41</volume>
<fpage>389</fpage>–<lpage>393</lpage>. <pub-id pub-id-type="doi">10.1038/s41440-018-0034-4</pub-id>
<pub-id pub-id-type="pmid">29556093</pub-id></mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okatan</surname><given-names>E. N.</given-names></name><name><surname>Durak</surname><given-names>A. T.</given-names></name><name><surname>Turan</surname><given-names>B.</given-names></name></person-group> (<year>2016</year>). <article-title>Electrophysiological basis of metabolic-syndrome-induced cardiac dysfunction.</article-title>
<source/><italic>Can. J. Physiol. Pharmacol.</italic>
<volume>94</volume>
<fpage>1064</fpage>–<lpage>1073</lpage>. <pub-id pub-id-type="doi">10.1139/cjpp-2015-0531</pub-id>
<pub-id pub-id-type="pmid">27322594</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okuda</surname><given-names>S.</given-names></name><name><surname>Yano</surname><given-names>M.</given-names></name><name><surname>Doi</surname><given-names>M.</given-names></name><name><surname>Oda</surname><given-names>T.</given-names></name><name><surname>Tokuhisa</surname><given-names>T.</given-names></name><name><surname>Kohno</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Valsartan restores sarcoplasmic reticulum function with no appreciable effect on resting cardiac function in pacing-induced heart failure.</article-title>
<source/><italic>Circulation</italic>
<volume>109</volume>
<fpage>911</fpage>–<lpage>919</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.0000115526.92541.D2</pub-id>
<pub-id pub-id-type="pmid">14757694</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Rourke</surname><given-names>B.</given-names></name><name><surname>Kass</surname><given-names>D. A.</given-names></name><name><surname>Tomaselli</surname><given-names>G. F.</given-names></name><name><surname>Kääb</surname><given-names>S.</given-names></name><name><surname>Tunin</surname><given-names>R.</given-names></name><name><surname>Marbán</surname><given-names>E.</given-names></name></person-group> (<year>1999</year>). <article-title>Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure. I: experimental studies.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>84</volume>
<fpage>562</fpage>–<lpage>570</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.84.5.562</pub-id><pub-id pub-id-type="pmid">10082478</pub-id></mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ottolia</surname><given-names>M.</given-names></name><name><surname>Torres</surname><given-names>N.</given-names></name><name><surname>Bridge</surname><given-names>J. H.</given-names></name><name><surname>Philipson</surname><given-names>K. D.</given-names></name><name><surname>Goldhaber</surname><given-names>J. I.</given-names></name></person-group> (<year>2013</year>). <article-title>Na/Ca exchange and contraction of the heart.</article-title>
<source/><italic>J. Mol. Cell. Cardiol.</italic>
<volume>61</volume>
<fpage>28</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2013.06.001</pub-id>
<pub-id pub-id-type="pmid">23770352</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozdemir</surname><given-names>S.</given-names></name><name><surname>Tandogan</surname><given-names>B.</given-names></name><name><surname>Ulusu</surname><given-names>N. N.</given-names></name><name><surname>Turan</surname><given-names>B.</given-names></name></person-group> (<year>2009</year>). <article-title>Angiotensin II receptor blockage prevents diabetes-induced oxidative damage in rat heart.</article-title>
<source/><italic>Folia Biol.</italic>
<volume>55</volume>
<fpage>11</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="pmid">19445841</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pappone</surname><given-names>C.</given-names></name><name><surname>Santinelli</surname><given-names>V.</given-names></name></person-group> (<year>2010</year>). <article-title>Cardiac electrophysiology in diabetes.</article-title>
<source/><italic>Minerva Cardioangiol.</italic>
<volume>58</volume>
<fpage>269</fpage>–<lpage>276</lpage>.<pub-id pub-id-type="pmid">20440255</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>L.</given-names></name><name><surname>Matthes</surname><given-names>J.</given-names></name><name><surname>Schuster</surname><given-names>I.</given-names></name><name><surname>Valdivia</surname><given-names>H. H.</given-names></name><name><surname>Herzig</surname><given-names>S.</given-names></name><name><surname>Richard</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Mechanisms of [Ca2 + ]i transient decrease in cardiomyopathy of <italic>db/db</italic> type 2 diabetic mice.</article-title>
<source/><italic>Diabetes</italic>
<volume>55</volume>
<fpage>608</fpage>–<lpage>615</lpage>. <pub-id pub-id-type="doi">10.2337/diabetes.55.03.06.db05-1284</pub-id><pub-id pub-id-type="pmid">16505222</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>B. Z.</given-names></name><name><surname>DeMaria</surname><given-names>C. D.</given-names></name><name><surname>Adelman</surname><given-names>J. P.</given-names></name><name><surname>Yue</surname><given-names>D. T.</given-names></name></person-group> (<year>1999</year>). <article-title>Calmodulin is the Ca2 + sensor for Ca2 + -dependent inactivation of L-type calcium channels.</article-title>
<source/><italic>Neuron</italic>
<volume>22</volume>
<fpage>549</fpage>–<lpage>558</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(00)80709-6</pub-id><pub-id pub-id-type="pmid">10197534</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piacentino</surname><given-names>V.</given-names><suffix>III</suffix></name><name><surname>Weber</surname><given-names>C. R.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Weisser-Thomas</surname><given-names>J.</given-names></name><name><surname>Margulies</surname><given-names>K. B.</given-names></name><name><surname>Bers</surname><given-names>D. M.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Cellular basis of abnormal calcium transients of failing human ventricular myocytes.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>92</volume>
<fpage>651</fpage>–<lpage>658</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000062469.83985.9B</pub-id>
<pub-id pub-id-type="pmid">12600875</pub-id></mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierce</surname><given-names>G. N.</given-names></name><name><surname>Ganguly</surname><given-names>P. K.</given-names></name><name><surname>Dzurba</surname><given-names>A.</given-names></name><name><surname>Dhalla</surname><given-names>N. S.</given-names></name></person-group> (<year>1985</year>). <article-title>Modification of the function of cardiac subcellular organelles by insulin.</article-title>
<source/><italic>Adv. Myocardiol.</italic>
<volume>6</volume>
<fpage>113</fpage>–<lpage>125</lpage>.<pub-id pub-id-type="pmid">2581295</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierce</surname><given-names>G. N.</given-names></name><name><surname>Ramjiawan</surname><given-names>B.</given-names></name><name><surname>Dhalla</surname><given-names>N. S.</given-names></name><name><surname>Ferrari</surname><given-names>R.</given-names></name></person-group> (<year>1990</year>). <article-title>Na( + )-H + exchange in cardiac sarcolemmal vesicles isolated from diabetic rats.</article-title>
<source/><italic>Am. J. Physiol.</italic>
<volume>258</volume>(1 Pt 2), <fpage>H255</fpage>–<lpage>H261</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.1990.258.1.H255</pub-id>
<pub-id pub-id-type="pmid">2154133</pub-id></mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pieske</surname><given-names>B.</given-names></name><name><surname>Kretschmann</surname><given-names>B.</given-names></name><name><surname>Meyer</surname><given-names>M.</given-names></name><name><surname>Holubarsch</surname><given-names>C.</given-names></name><name><surname>Weirich</surname><given-names>J.</given-names></name><name><surname>Posival</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>1995</year>). <article-title>Alterations in intracellular calcium handling associated with the inverse force-frequency relation in human dilated cardiomyopathy.</article-title>
<source/><italic>Circulation</italic>
<volume>92</volume>
<fpage>1169</fpage>–<lpage>1178</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.92.5.1169</pub-id>
<pub-id pub-id-type="pmid">7648662</pub-id></mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pogwizd</surname><given-names>S. M.</given-names></name><name><surname>Qi</surname><given-names>M.</given-names></name><name><surname>Yuan</surname><given-names>W.</given-names></name><name><surname>Samarel</surname><given-names>A. M.</given-names></name><name><surname>Bers</surname><given-names>D. M.</given-names></name></person-group> (<year>1999</year>). <article-title>Upregulation of Na( + )/Ca(2 + ) exchanger expression and function in an arrhythmogenic rabbit model of heart failure.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>85</volume>
<fpage>1009</fpage>–<lpage>1019</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.85.11.1009</pub-id>
<pub-id pub-id-type="pmid">10571531</pub-id></mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pogwizd</surname><given-names>S. M.</given-names></name><name><surname>Schlotthauer</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Yuan</surname><given-names>W.</given-names></name><name><surname>Bers</surname><given-names>D. M.</given-names></name></person-group> (<year>2001</year>). <article-title>Arrhythmogenesis and contractile dysfunction in heart failure: roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>88</volume>
<fpage>1159</fpage>–<lpage>1167</lpage>. <pub-id pub-id-type="doi">10.1161/hh1101.091193</pub-id>
<pub-id pub-id-type="pmid">11397782</pub-id></mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pott</surname><given-names>C.</given-names></name><name><surname>Eckardt</surname><given-names>L.</given-names></name><name><surname>Goldhaber</surname><given-names>J. I.</given-names></name></person-group> (<year>2011</year>). <article-title>Triple threat: the Na + /Ca2 + exchanger in the pathophysiology of cardiac arrhythmia, ischemia and heart failure.</article-title>
<source/><italic>Curr. Drug Targets</italic>
<volume>12</volume>
<fpage>737</fpage>–<lpage>747</lpage>. <pub-id pub-id-type="doi">10.2174/138945011795378559</pub-id>
<pub-id pub-id-type="pmid">21291388</pub-id></mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pott</surname><given-names>C.</given-names></name><name><surname>Muszynski</surname><given-names>A.</given-names></name><name><surname>Ruhe</surname><given-names>M.</given-names></name><name><surname>Bögeholz</surname><given-names>N.</given-names></name><name><surname>Schulte</surname><given-names>J. S.</given-names></name><name><surname>Milberg</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Proarrhythmia in a non-failing murine model of cardiac-specific Na + /Ca2 + exchanger overexpression: whole heart and cellular mechanisms.</article-title>
<source/><italic>Basic Res. Cardiol.</italic>
<volume>107</volume>:<issue>247</issue>. <pub-id pub-id-type="doi">10.1007/s00395-012-0247-7</pub-id>
<pub-id pub-id-type="pmid">22327339</pub-id></mixed-citation>
</ref>
<ref id="B197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prestle</surname><given-names>J.</given-names></name><name><surname>Janssen</surname><given-names>P. M.</given-names></name><name><surname>Janssen</surname><given-names>A. P.</given-names></name><name><surname>Zeitz</surname><given-names>O.</given-names></name><name><surname>Lehnart</surname><given-names>S. E.</given-names></name><name><surname>Bruce</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Overexpression of FK506-binding protein FKBP12.6 in cardiomyocytes reduces ryanodine receptor-mediated Ca(2 + ) leak from the sarcoplasmic reticulum and increases contractility.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>88</volume>
<fpage>188</fpage>–<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.88.2.188</pub-id>
<pub-id pub-id-type="pmid">11157671</pub-id></mixed-citation>
</ref>
<ref id="B198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Priori</surname><given-names>S. G.</given-names></name><name><surname>Chen</surname><given-names>S. R.</given-names></name></person-group> (<year>2011</year>). <article-title>Inherited dysfunction of sarcoplasmic reticulum Ca2 + handling and arrhythmogenesis.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>108</volume>
<fpage>871</fpage>–<lpage>883</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.110.226845</pub-id>
<pub-id pub-id-type="pmid">21454795</pub-id></mixed-citation>
</ref>
<ref id="B199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Priori</surname><given-names>S. G.</given-names></name><name><surname>Napolitano</surname><given-names>C.</given-names></name><name><surname>Memmi</surname><given-names>M.</given-names></name><name><surname>Colombi</surname><given-names>B.</given-names></name><name><surname>Drago</surname><given-names>F.</given-names></name><name><surname>Gasparini</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.</article-title>
<source/><italic>Circulation</italic>
<volume>2</volume>
<fpage>69</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.0000020013.73106.D8</pub-id>
<pub-id pub-id-type="pmid">12093772</pub-id></mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Privratsky</surname><given-names>J. R.</given-names></name><name><surname>Wold</surname><given-names>L. E.</given-names></name><name><surname>Sowers</surname><given-names>J. R.</given-names></name><name><surname>Quinn</surname><given-names>M. T.</given-names></name><name><surname>Ren</surname><given-names>J.</given-names></name></person-group> (<year>2003</year>). <article-title>AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase.</article-title>
<source/><italic>Hypertension</italic>
<volume>42</volume>
<fpage>206</fpage>–<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1161/01.HYP.0000082814.62655.85</pub-id>
<pub-id pub-id-type="pmid">12847113</pub-id></mixed-citation>
</ref>
<ref id="B201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prunier</surname><given-names>F.</given-names></name><name><surname>Kawase</surname><given-names>Y.</given-names></name><name><surname>Gianni</surname><given-names>D.</given-names></name><name><surname>Scapin</surname><given-names>C.</given-names></name><name><surname>Danik</surname><given-names>S. B.</given-names></name><name><surname>Ellinor</surname><given-names>P. T.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Prevention of ventricular arrhythmias with sarcoplasmic reticulum Ca2 + ATPase pump overexpression in a porcine model of ischemia reperfusion.</article-title>
<source/><italic>Circulation</italic>
<volume>118</volume>
<fpage>614</fpage>–<lpage>624</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.108.770883</pub-id>
<pub-id pub-id-type="pmid">18645052</pub-id></mixed-citation>
</ref>
<ref id="B202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raimondi</surname><given-names>L.</given-names></name><name><surname>De Paoli</surname><given-names>P.</given-names></name><name><surname>Mannucci</surname><given-names>E.</given-names></name><name><surname>Lonardo</surname><given-names>G.</given-names></name><name><surname>Sartiani</surname><given-names>L.</given-names></name><name><surname>Banchelli</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Restoration of cardiomyocyte functional properties by angiotensin II receptor blockade in diabetic rats.</article-title>
<source/><italic>Diabetes</italic>
<volume>53</volume>
<fpage>1927</fpage>–<lpage>1933</lpage>. <pub-id pub-id-type="doi">10.2337/diabetes.53.7.1927</pub-id>
<pub-id pub-id-type="pmid">15220222</pub-id></mixed-citation>
</ref>
<ref id="B203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rebbeck</surname><given-names>R. T.</given-names></name><name><surname>Essawy</surname><given-names>M. M.</given-names></name><name><surname>Nitu</surname><given-names>F. R.</given-names></name><name><surname>Grant</surname><given-names>B. D.</given-names></name><name><surname>Gillispie</surname><given-names>G. D.</given-names></name><name><surname>Thomas</surname><given-names>D. D.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>High-throughput screens to discover small-molecule modulators of ryanodine receptor calcium release channels.</article-title>
<source/><italic>SLAS Discov.</italic>
<volume>22</volume>
<fpage>176</fpage>–<lpage>186</lpage>. <pub-id pub-id-type="doi">10.1177/1087057116674312</pub-id>
<pub-id pub-id-type="pmid">27760856</pub-id></mixed-citation>
</ref>
<ref id="B204">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rehsia</surname><given-names>N. S.</given-names></name><name><surname>Dhalla</surname><given-names>N. S.</given-names></name></person-group> (<year>2010</year>). <article-title>Exp clin cardiol.</article-title>
<source/><italic>Winter</italic>
<volume>15</volume>
<fpage>e86</fpage>–<lpage>e95</lpage>.</mixed-citation>
</ref>
<ref id="B205">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Respress</surname><given-names>J. L.</given-names></name><name><surname>van Oort</surname><given-names>R. J.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Rolim</surname><given-names>N.</given-names></name><name><surname>Dixit</surname><given-names>S. S.</given-names></name><name><surname>deAlmeida</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Role of RyR2 phosphorylation at S2814 during heart failure progression.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>110</volume>
<fpage>1474</fpage>–<lpage>1483</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.112.268094</pub-id>
<pub-id pub-id-type="pmid">22511749</pub-id></mixed-citation>
</ref>
<ref id="B206">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reuter</surname><given-names>H.</given-names></name><name><surname>Grönke</surname><given-names>S.</given-names></name><name><surname>Adam</surname><given-names>C.</given-names></name><name><surname>Ribati</surname><given-names>M.</given-names></name><name><surname>Brabender</surname><given-names>J.</given-names></name><name><surname>Zobel</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Sarcoplasmic Ca2 + release is prolonged in nonfailing myocardium of diabetic patients.</article-title>
<source/><italic>Mol. Cell. Biochem.</italic>
<volume>308</volume>
<fpage>141</fpage>–<lpage>149</lpage>. <pub-id pub-id-type="doi">10.1007/s11010-007-9622-3</pub-id>
<pub-id pub-id-type="pmid">17952561</pub-id></mixed-citation>
</ref>
<ref id="B207">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ricci</surname><given-names>E.</given-names></name><name><surname>Smallwood</surname><given-names>S.</given-names></name><name><surname>Chouabe</surname><given-names>C.</given-names></name><name><surname>Mertani</surname><given-names>H. C.</given-names></name><name><surname>Raccurt</surname><given-names>M.</given-names></name><name><surname>Morel</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Electrophysiological characterization of left ventricular myocytes from obese Sprague-Dawley rat.</article-title>
<source/><italic>Obesity</italic>
<volume>14</volume>
<fpage>778</fpage>–<lpage>786</lpage>. <pub-id pub-id-type="doi">10.1038/oby.2006.90</pub-id>
<pub-id pub-id-type="pmid">16855186</pub-id></mixed-citation>
</ref>
<ref id="B208">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roux-Buisson</surname><given-names>N.</given-names></name><name><surname>Cacheux</surname><given-names>M.</given-names></name><name><surname>Fourest-Lieuvin</surname><given-names>A.</given-names></name><name><surname>Fauconnier</surname><given-names>J.</given-names></name><name><surname>Brocard</surname><given-names>J.</given-names></name><name><surname>Denjoy</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>21</volume>
<fpage>2759</fpage>–<lpage>2767</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/dds104</pub-id>
<pub-id pub-id-type="pmid">22422768</pub-id></mixed-citation>
</ref>
<ref id="B209">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz-Meana</surname><given-names>M.</given-names></name><name><surname>Fernandez-Sanz</surname><given-names>C.</given-names></name><name><surname>Garcia-Dorado</surname><given-names>D.</given-names></name></person-group> (<year>2010</year>). <article-title>The SR-mitochondria interaction: a new player in cardiac pathophysiology.</article-title>
<source/><italic>Cardiovasc. Res.</italic>
<volume>88</volume>
<fpage>30</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvq225</pub-id>
<pub-id pub-id-type="pmid">20615915</pub-id></mixed-citation>
</ref>
<ref id="B210">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salama</surname><given-names>G.</given-names></name><name><surname>Menshikova</surname><given-names>E. V.</given-names></name><name><surname>Abramson</surname><given-names>J. J.</given-names></name></person-group> (<year>2000</year>). <article-title>Molecular interaction between nitric oxide and ryanodine receptors of skeletal and cardiac sarcoplasmic reticulum.</article-title>
<source/><italic>Antioxid. Redox. Signal.</italic>
<volume>2</volume>
<fpage>5</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2000.2.1-5</pub-id>
<pub-id pub-id-type="pmid">11232600</pub-id></mixed-citation>
</ref>
<ref id="B211">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salem</surname><given-names>K. A.</given-names></name><name><surname>Qureshi</surname><given-names>M. A.</given-names></name><name><surname>Sydorenko</surname><given-names>V.</given-names></name><name><surname>Parekh</surname><given-names>K.</given-names></name><name><surname>Jayaprakash</surname><given-names>P.</given-names></name><name><surname>Iqbal</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Effects of exercise training on excitation-contraction coupling and related mRNA expression in hearts of Goto-Kakizaki type 2 diabetic rats.</article-title>
<source/><italic>Mol. Cell. Biochem.</italic>
<volume>380</volume>
<fpage>83</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1007/s11010-013-1662-2</pub-id>
<pub-id pub-id-type="pmid">23620341</pub-id></mixed-citation>
</ref>
<ref id="B212">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samsó</surname><given-names>M.</given-names></name><name><surname>Wagenknecht</surname><given-names>T.</given-names></name></person-group> (<year>2002</year>). <article-title>Apocalmodulin and Ca2 + -calmodulin bind to neighboring locations on the ryanodine receptor.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>11</volume>
<fpage>1349</fpage>–<lpage>1353</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M109196200</pub-id>
<pub-id pub-id-type="pmid">11694536</pub-id></mixed-citation>
</ref>
<ref id="B213">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sánchez</surname><given-names>G.</given-names></name><name><surname>Araneda</surname><given-names>F.</given-names></name><name><surname>Peña</surname><given-names>J. P.</given-names></name><name><surname>Finkelstein</surname><given-names>J. P.</given-names></name><name><surname>Riquelme</surname><given-names>J. A.</given-names></name><name><surname>Montecinos</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>High-fat-diet-induced obesity produces spontaneous ventricular arrhythmias and increases the activity of ryanodine receptors in mice.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>19</volume>:<issue>E533</issue>. <pub-id pub-id-type="doi">10.3390/ijms19020533</pub-id>
<pub-id pub-id-type="pmid">29439404</pub-id></mixed-citation>
</ref>
<ref id="B214">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satoh</surname><given-names>H.</given-names></name><name><surname>Ginsburg</surname><given-names>K. S.</given-names></name><name><surname>Qing</surname><given-names>K.</given-names></name><name><surname>Terada</surname><given-names>H.</given-names></name><name><surname>Hayashi</surname><given-names>H.</given-names></name><name><surname>Bers</surname><given-names>D. M.</given-names></name></person-group> (<year>2000</year>). <article-title>KB-R7943 block of Ca(2 + ) influx via Na( + )/Ca(2 + ) exchange does not alter twitches or glycoside inotropy but prevents Ca(2 + ) overload in rat ventricular myocytes.</article-title>
<source/><italic>Circulation</italic>
<volume>101</volume>
<fpage>1441</fpage>–<lpage>1446</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.101.12.1441</pub-id>
<pub-id pub-id-type="pmid">10736290</pub-id></mixed-citation>
</ref>
<ref id="B215">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>U.</given-names></name><name><surname>Hajjar</surname><given-names>R. J.</given-names></name><name><surname>Helm</surname><given-names>P. A.</given-names></name><name><surname>Kim</surname><given-names>C. S.</given-names></name><name><surname>Doye</surname><given-names>A. A.</given-names></name><name><surname>Gwathmey</surname><given-names>J. K.</given-names></name></person-group> (<year>1998</year>). <article-title>Contribution of abnormal sarcoplasmic reticulum ATPase activity to systolic and diastolic dysfunction in human heart failure.</article-title>
<source/><italic>J. Mol. Cell. Cardiol.</italic>
<volume>30</volume>
<fpage>1929</fpage>–<lpage>1937</lpage>. <pub-id pub-id-type="doi">10.1006/jmcc.1998.0748</pub-id>
<pub-id pub-id-type="pmid">9799647</pub-id></mixed-citation>
</ref>
<ref id="B216">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>U.</given-names></name><name><surname>Hajjar</surname><given-names>R. J.</given-names></name><name><surname>Kim</surname><given-names>C. S.</given-names></name><name><surname>Lebeche</surname><given-names>D.</given-names></name><name><surname>Doye</surname><given-names>A. A.</given-names></name><name><surname>Gwathmey</surname><given-names>J. K.</given-names></name></person-group> (<year>1999</year>). <article-title>Human heart failure: cAMP stimulation of SR Ca(2 + )-ATPase activity and phosphorylation level of phospholamban.</article-title>
<source/><italic>Am. J. Physiol.</italic>
<volume>277</volume>(2 Pt 2), <fpage>H474</fpage>–<lpage>H480</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.1999.277.2.H474</pub-id>
<pub-id pub-id-type="pmid">10444471</pub-id></mixed-citation>
</ref>
<ref id="B217">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitt</surname><given-names>J. P.</given-names></name><name><surname>Kamisago</surname><given-names>M.</given-names></name><name><surname>Asahi</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>G. H.</given-names></name><name><surname>Ahmad</surname><given-names>F.</given-names></name><name><surname>Mende</surname><given-names>U.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban.</article-title>
<source/><italic>Science</italic>
<volume>299</volume>
<fpage>1410</fpage>–<lpage>1413</lpage>. <pub-id pub-id-type="doi">10.1126/science.1081578</pub-id>
<pub-id pub-id-type="pmid">12610310</pub-id></mixed-citation>
</ref>
<ref id="B218">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwinger</surname><given-names>R. H.</given-names></name><name><surname>Bölck</surname><given-names>B.</given-names></name><name><surname>Münch</surname><given-names>G.</given-names></name><name><surname>Brixius</surname><given-names>K.</given-names></name><name><surname>Müller-Ehmsen</surname><given-names>J.</given-names></name><name><surname>Erdmann</surname><given-names>E.</given-names></name></person-group> (<year>1998</year>). <article-title>cAMP-dependent protein kinase A-stimulated sarcoplasmic reticulum function in heart failure.</article-title>
<source/><italic>Ann. N. Y. Acad. Sci.</italic>
<volume>853</volume>
<fpage>240</fpage>–<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1111/j.1749-6632.1998.tb08272.x</pub-id>
<pub-id pub-id-type="pmid">10603952</pub-id></mixed-citation>
</ref>
<ref id="B219">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwinger</surname><given-names>R. H.</given-names></name><name><surname>Münch</surname><given-names>G.</given-names></name><name><surname>Bölck</surname><given-names>B.</given-names></name><name><surname>Karczewski</surname><given-names>P.</given-names></name><name><surname>Krause</surname><given-names>E. G.</given-names></name><name><surname>Erdmann</surname><given-names>E.</given-names></name></person-group> (<year>1999</year>). <article-title>Reduced Ca(2 + )-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation.</article-title>
<source/><italic>J. Mol. Cell. Cardiol.</italic>
<volume>31</volume>
<fpage>479</fpage>–<lpage>491</lpage>. <pub-id pub-id-type="doi">10.1006/jmcc.1998.0897</pub-id>
<pub-id pub-id-type="pmid">10198180</pub-id></mixed-citation>
</ref>
<ref id="B220">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sechi</surname><given-names>L. A.</given-names></name><name><surname>Griffin</surname><given-names>C. A.</given-names></name><name><surname>Schambelan</surname><given-names>M.</given-names></name></person-group> (<year>1994</year>). <article-title>The cardiac renin-angiotensin system in STZ-induced diabetes.</article-title>
<source/><italic>Diabetes</italic>
<volume>43</volume>
<fpage>1180</fpage>–<lpage>1184</lpage>. <pub-id pub-id-type="doi">10.2337/diab.43.10.1180</pub-id><pub-id pub-id-type="pmid">7926285</pub-id></mixed-citation>
</ref>
<ref id="B221">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sham</surname><given-names>J. S.</given-names></name><name><surname>Song</surname><given-names>L. S.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Deng</surname><given-names>L. H.</given-names></name><name><surname>Stern</surname><given-names>M. D.</given-names></name><name><surname>Lakatta</surname><given-names>E. G.</given-names></name><etal></etal></person-group> (<year>1998</year>). <article-title>Termination of Ca2 + release by a local inactivation of ryanodine receptors in cardiac myocytes.</article-title>
<source/><italic>Proc. Natl Acad. Sci. U.S.A.</italic>
<volume>95</volume>
<fpage>15096</fpage>–<lpage>15101</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.95.25.15096</pub-id><pub-id pub-id-type="pmid">9844021</pub-id></mixed-citation>
</ref>
<ref id="B222">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname><given-names>C. H.</given-names></name><name><surname>Capek</surname><given-names>H. L.</given-names></name><name><surname>Patel</surname><given-names>K. P.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Tang</surname><given-names>K.</given-names></name><name><surname>DeSouza</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Carbonylation contributes to SERCA2a activity loss and diastolic dysfunction in a rat model of type 1 diabetes.</article-title>
<source/><italic>Diabetes</italic>
<volume>60</volume>
<fpage>947</fpage>–<lpage>959</lpage>. <pub-id pub-id-type="doi">10.2337/db10-1145</pub-id>
<pub-id pub-id-type="pmid">21300842</pub-id></mixed-citation>
</ref>
<ref id="B223">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname><given-names>C. H.</given-names></name><name><surname>Rozanski</surname><given-names>G. J.</given-names></name><name><surname>Patel</surname><given-names>K. P.</given-names></name><name><surname>Bidasee</surname><given-names>K. R.</given-names></name></person-group> (<year>2007</year>). <article-title>Dyssynchronous (non-uniform) Ca2 + release in myocytes from streptozotocin-induced diabetic rats.</article-title>
<source/><italic>J. Mol. Cell. Cardiol.</italic>
<volume>42</volume>
<fpage>234</fpage>–<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2006.08.018</pub-id>
<pub-id pub-id-type="pmid">17027851</pub-id></mixed-citation>
</ref>
<ref id="B224">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname><given-names>C. H.</given-names></name><name><surname>Tian</surname><given-names>C.</given-names></name><name><surname>Ouyang</surname><given-names>S.</given-names></name><name><surname>Moore</surname><given-names>C. J.</given-names></name><name><surname>Alomar</surname><given-names>F.</given-names></name><name><surname>Nemet</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Carbonylation induces heterogeneity in cardiac ryanodine receptor function in diabetes mellitus.</article-title>
<source/><italic>Mol. Pharmacol.</italic>
<volume>82</volume>
<fpage>383</fpage>–<lpage>399</lpage>. <pub-id pub-id-type="doi">10.1124/mol.112.078352</pub-id>
<pub-id pub-id-type="pmid">22648972</pub-id></mixed-citation>
</ref>
<ref id="B225">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname><given-names>C. H.</given-names></name><name><surname>Wehrens</surname><given-names>X. H.</given-names></name><name><surname>Wyatt</surname><given-names>T. A.</given-names></name><name><surname>Parbhu</surname><given-names>S.</given-names></name><name><surname>Rozanski</surname><given-names>G. J.</given-names></name><name><surname>Patel</surname><given-names>K. P.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Exercise training during diabetes attenuates cardiac ryanodine receptor dysregulation.</article-title>
<source/><italic>J. Appl. Physiol.</italic>
<volume>106</volume>
<fpage>1280</fpage>–<lpage>1292</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.91280.2008</pub-id>
<pub-id pub-id-type="pmid">19131475</pub-id></mixed-citation>
</ref>
<ref id="B226">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>V. K.</given-names></name><name><surname>Ramesh</surname><given-names>V.</given-names></name><name><surname>Franzini-Armstrong</surname><given-names>C.</given-names></name><name><surname>Sheu</surname><given-names>S. S.</given-names></name></person-group> (<year>2000</year>). <article-title>Transport of Ca2 + from sarcoplasmic reticulum to mitochondria in rat ventricular myocytes.</article-title>
<source/><italic>J. Bioenerg. Biomembr.</italic>
<volume>32</volume>
<fpage>97</fpage>–<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1023/A:1005520714221</pub-id><pub-id pub-id-type="pmid">11768767</pub-id></mixed-citation>
</ref>
<ref id="B227">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>X.</given-names></name><name><surname>Zheng</surname><given-names>S.</given-names></name><name><surname>Thongboonkerd</surname><given-names>V.</given-names></name><name><surname>Xu</surname><given-names>M.</given-names></name><name><surname>Pierce</surname><given-names>W. M.</given-names><suffix>Jr.</suffix></name><name><surname>Klein</surname><given-names>J. B.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes.</article-title>
<source/><italic>Am. J. Physiol. Endocrinol. Metab.</italic>
<volume>287</volume>
<fpage>E896</fpage>–<lpage>E905</lpage>. <pub-id pub-id-type="doi">10.1152/ajpendo.00047.2004</pub-id>
<pub-id pub-id-type="pmid">15280150</pub-id></mixed-citation>
</ref>
<ref id="B228">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shkryl</surname><given-names>V. M.</given-names></name><name><surname>Maxwell</surname><given-names>J. T.</given-names></name><name><surname>Domeier</surname><given-names>T. L.</given-names></name><name><surname>Blatter</surname><given-names>L. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Refractoriness of sarcoplasmic reticulum Ca2 + release determines Ca2 + alternans in atrial myocytes.</article-title>
<source/><italic>Am. J. Physiol. Heart Circ. Physiol.</italic>
<volume>302</volume>
<fpage>H2310</fpage>–<lpage>H2320</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00079.2012</pub-id>
<pub-id pub-id-type="pmid">22467301</pub-id></mixed-citation>
</ref>
<ref id="B229">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simmerman</surname><given-names>H. K.</given-names></name><name><surname>Collins</surname><given-names>J. H.</given-names></name><name><surname>Theibert</surname><given-names>J. L.</given-names></name><name><surname>Wegener</surname><given-names>A. D.</given-names></name><name><surname>Jones</surname><given-names>L. R.</given-names></name></person-group> (<year>1986</year>). <article-title>Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>261</volume>
<fpage>13333</fpage>–<lpage>13341</lpage>. <pub-id pub-id-type="pmid">3759968</pub-id></mixed-citation>
</ref>
<ref id="B230">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>R. M.</given-names></name><name><surname>Waqar</surname><given-names>T.</given-names></name><name><surname>Howarth</surname><given-names>F. C.</given-names></name><name><surname>Adeghate</surname><given-names>E.</given-names></name><name><surname>Bidasee</surname><given-names>K.</given-names></name><name><surname>Singh</surname><given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>Hyperglycemia-induced cardiac contractile dysfunction in the diabetic heart.</article-title>
<source/><italic>Heart Fail. Rev.</italic>
<volume>23</volume>
<fpage>37</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1007/s10741-017-9663-y</pub-id>
<pub-id pub-id-type="pmid">29192360</pub-id></mixed-citation>
</ref>
<ref id="B231">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sipido</surname><given-names>K. R.</given-names></name><name><surname>Vangheluwe</surname><given-names>P.</given-names></name></person-group> (<year>2010</year>). <article-title>Targeting sarcoplasmic reticulum Ca2 + uptake to improve heart failure: hit or miss.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>106</volume>
<fpage>230</fpage>–<lpage>233</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.109.210740</pub-id>
<pub-id pub-id-type="pmid">20133907</pub-id></mixed-citation>
</ref>
<ref id="B232">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siscovick</surname><given-names>D. S.</given-names></name><name><surname>Sotoodehnia</surname><given-names>N.</given-names></name><name><surname>Rea</surname><given-names>T. D.</given-names></name><name><surname>Raghunathan</surname><given-names>T. E.</given-names></name><name><surname>Jouven</surname><given-names>X.</given-names></name><name><surname>Lemaitre</surname><given-names>R. N.</given-names></name></person-group> (<year>2010</year>). <article-title>Type 2 diabetes mellitus and the risk of sudden cardiac arrest in the community.</article-title>
<source/><italic>Rev. Endocr. Metab. Disord.</italic>
<volume>11</volume>
<fpage>53</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1007/s11154-010-9133-5</pub-id>
<pub-id pub-id-type="pmid">20195771</pub-id></mixed-citation>
</ref>
<ref id="B233">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sitsapesan</surname><given-names>R.</given-names></name><name><surname>Williams</surname><given-names>A. J.</given-names></name></person-group> (<year>1994</year>). <article-title>Regulation of the gating of the sheep cardiac sarcoplasmic reticulum Ca(2 + )-release channel by luminal Ca2 +.</article-title>
<source/><italic>J. Membr. Biol.</italic>
<volume>137</volume>
<fpage>215</fpage>–<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1007/BF00232590</pub-id><pub-id pub-id-type="pmid">8182731</pub-id></mixed-citation>
</ref>
<ref id="B234">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smail</surname><given-names>M. M.</given-names></name><name><surname>Qureshi</surname><given-names>M. A.</given-names></name><name><surname>Shmygol</surname><given-names>A.</given-names></name><name><surname>Oz</surname><given-names>M.</given-names></name><name><surname>Singh</surname><given-names>J.</given-names></name><name><surname>Sydorenko</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Regional effects of streptozotocin-induced diabetes on shortening and calcium transport in epicardial and endocardial myocytes from rat left ventricle.</article-title>
<source/><italic>Physiol. Rep.</italic>
<volume>4</volume>:<issue>e13034</issue>. <pub-id pub-id-type="doi">10.14814/phy2.13034</pub-id>
<pub-id pub-id-type="pmid">27884956</pub-id></mixed-citation>
</ref>
<ref id="B235">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sobie</surname><given-names>E. A.</given-names></name><name><surname>Song</surname><given-names>L. S.</given-names></name><name><surname>Lederer</surname><given-names>W. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Restitution of Ca(2 + ) release and vulnerability to arrhythmias.</article-title>
<source/><italic>J. Cardiovasc. Electrophysiol.</italic>
<volume>17</volume>(Suppl. 1), <fpage>S64</fpage>–<lpage>S70</lpage>. <pub-id pub-id-type="doi">10.1111/j.1540-8167.2006.00385.x</pub-id>
<pub-id pub-id-type="pmid">16686684</pub-id></mixed-citation>
</ref>
<ref id="B236">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sommese</surname><given-names>L.</given-names></name><name><surname>Valverde</surname><given-names>C. A.</given-names></name><name><surname>Blanco</surname><given-names>P.</given-names></name><name><surname>Castro</surname><given-names>M. C.</given-names></name><name><surname>Rueda</surname><given-names>O. V.</given-names></name><name><surname>Kaetzel</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Ryanodine receptor phosphorylation by CaMKII promotes spontaneous Ca(2 + ) release events in a rodent model of early stage diabetes: the arrhythmogenic substrate.</article-title>
<source/><italic>Int. J. Cardiol.</italic>
<volume>202</volume>
<fpage>394</fpage>–<lpage>406</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijcard.2015.09.022</pub-id>
<pub-id pub-id-type="pmid">26432489</pub-id></mixed-citation>
</ref>
<ref id="B237">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>Q.</given-names></name><name><surname>Schmidt</surname><given-names>A. G.</given-names></name><name><surname>Hahn</surname><given-names>H. S.</given-names></name><name><surname>Carr</surname><given-names>A. N.</given-names></name><name><surname>Frank</surname><given-names>B.</given-names></name><name><surname>Pater</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>111</volume>
<fpage>859</fpage>–<lpage>867</lpage>. <pub-id pub-id-type="doi">10.1172/JCI16738</pub-id>
<pub-id pub-id-type="pmid">12639992</pub-id></mixed-citation>
</ref>
<ref id="B238">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sossalla</surname><given-names>S.</given-names></name><name><surname>Fluschnik</surname><given-names>N.</given-names></name><name><surname>Schotola</surname><given-names>H.</given-names></name><name><surname>Ort</surname><given-names>K. R.</given-names></name><name><surname>Neef</surname><given-names>S.</given-names></name><name><surname>Schulte</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Inhibition of elevated Ca2 + /calmodulin-dependent protein kinase II improves contractility in human failing myocardium.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>107</volume>
<fpage>1150</fpage>–<lpage>1161</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.110.220418</pub-id>
<pub-id pub-id-type="pmid">20814023</pub-id></mixed-citation>
</ref>
<ref id="B239">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spooner</surname><given-names>P. M.</given-names></name></person-group> (<year>2008</year>). <article-title>Sudden cardiac death: influence of diabetes.</article-title>
<source/><italic>Diabetes Obes. Metab.</italic>
<volume>10</volume>
<fpage>523</fpage>–<lpage>532</lpage>. <pub-id pub-id-type="doi">10.1111/j.1463-1326.2007.00723.x</pub-id>
<pub-id pub-id-type="pmid">17451424</pub-id></mixed-citation>
</ref>
<ref id="B240">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stary</surname><given-names>V.</given-names></name><name><surname>Puppala</surname><given-names>D.</given-names></name><name><surname>Scherrer-Crosbie</surname><given-names>M.</given-names></name><name><surname>Dillmann</surname><given-names>W. H.</given-names></name><name><surname>Armoundas</surname><given-names>A. A.</given-names></name></person-group> (<year>2016</year>). <article-title>SERCA2a upregulation ameliorates cellular alternans induced by metabolic inhibition.</article-title>
<source/><italic>J. Appl. Physiol.</italic>
<volume>120</volume>
<fpage>865</fpage>–<lpage>875</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.00588.2015</pub-id>
<pub-id pub-id-type="pmid">26846549</pub-id></mixed-citation>
</ref>
<ref id="B241">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stølen</surname><given-names>T. O.</given-names></name><name><surname>Høydal</surname><given-names>M. A.</given-names></name><name><surname>Kemi</surname><given-names>O. J.</given-names></name><name><surname>Catalucci</surname><given-names>D.</given-names></name><name><surname>Ceci</surname><given-names>M.</given-names></name><name><surname>Aasum</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Interval training normalizes cardiomyocyte function, diastolic Ca2 + control, and SR Ca2 + release synchronicity in a mouse model of diabetic cardiomyopathy.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>105</volume>
<fpage>527</fpage>–<lpage>536</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.109.199810</pub-id>
<pub-id pub-id-type="pmid">19679837</pub-id></mixed-citation>
</ref>
<ref id="B242">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Studer</surname><given-names>R.</given-names></name><name><surname>Reinecke</surname><given-names>H.</given-names></name><name><surname>Bilger</surname><given-names>J.</given-names></name><name><surname>Eschenhagen</surname><given-names>T.</given-names></name><name><surname>Böhm</surname><given-names>M.</given-names></name><name><surname>Hasenfuss</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>1994</year>). <article-title>Gene expression of the cardiac Na( + )-Ca2 + exchanger in end-stage human heart failure.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>75</volume>
<fpage>443</fpage>–<lpage>453</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.75.3.443</pub-id><pub-id pub-id-type="pmid">8062418</pub-id></mixed-citation>
</ref>
<ref id="B243">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suarez</surname><given-names>J.</given-names></name><name><surname>Belke</surname><given-names>D. D.</given-names></name><name><surname>Gloss</surname><given-names>B.</given-names></name><name><surname>Dieterle</surname><given-names>T.</given-names></name><name><surname>McDonough</surname><given-names>P. M.</given-names></name><name><surname>Kim</surname><given-names>Y. K.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>In vivo adenoviral transfer of sorcin reverses cardiac contractile abnormalities of diabetic cardiomyopathy.</article-title>
<source/><italic>Am. J. Physiol. Heart Circ. Physiol.</italic>
<volume>286</volume>
<fpage>H68</fpage>–<lpage>H75</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00245.2003</pub-id>
<pub-id pub-id-type="pmid">12958030</pub-id></mixed-citation>
</ref>
<ref id="B244">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>B.</given-names></name><name><surname>Wei</surname><given-names>J.</given-names></name><name><surname>Zhong</surname><given-names>X.</given-names></name><name><surname>Guo</surname><given-names>W.</given-names></name><name><surname>Yao</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>The cardiac ryanodine receptor, but not sarcoplasmic reticulum Ca2 + -ATPase, is a major determinant of Ca2 + alternans in intact mouse hearts.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>293</volume>:<issue>jbc</issue>.RA118.003760. <pub-id pub-id-type="doi">10.1074/jbc.RA118.003760</pub-id>
<pub-id pub-id-type="pmid">29986885</pub-id></mixed-citation>
</ref>
<ref id="B245">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szentesi</surname><given-names>P.</given-names></name><name><surname>Pignier</surname><given-names>C.</given-names></name><name><surname>Egger</surname><given-names>M.</given-names></name><name><surname>Kranias</surname><given-names>E. G.</given-names></name><name><surname>Niggli</surname><given-names>E.</given-names></name></person-group> (<year>2004</year>). <article-title>Sarcoplasmic reticulum Ca2 + refilling controls recovery from Ca2 + -induced Ca2 + release refractoriness in heart muscle.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>95</volume>
<fpage>807</fpage>–<lpage>813</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000146029.80463.7d</pub-id>
<pub-id pub-id-type="pmid">15388639</pub-id></mixed-citation>
</ref>
<ref id="B246">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szepesi</surname><given-names>J.</given-names></name><name><surname>Acsai</surname><given-names>K.</given-names></name><name><surname>Sebok</surname><given-names>Z.</given-names></name><name><surname>Prorok</surname><given-names>J.</given-names></name><name><surname>Pollesello</surname><given-names>P.</given-names></name><name><surname>Levijoki</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Comparison of the efficiency of Na + /Ca2 + exchanger or Na + /H + exchanger inhibition and their combination in reducing coronary reperfusion-induced arrhythmias.</article-title>
<source/><italic>J Physiol. Pharmacol.</italic>
<volume>66</volume>
<fpage>215</fpage>–<lpage>226</lpage>.<pub-id pub-id-type="pmid">25903952</pub-id></mixed-citation>
</ref>
<ref id="B247">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szkudelski</surname><given-names>T.</given-names></name></person-group> (<year>2001</year>). <article-title>The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas.</article-title>
<source/><italic>Physiol. Res.</italic>
<volume>50</volume>
<fpage>537</fpage>–<lpage>546</lpage>. <pub-id pub-id-type="pmid">11829314</pub-id></mixed-citation>
</ref>
<ref id="B248">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terentyev</surname><given-names>D.</given-names></name><name><surname>Belevych</surname><given-names>A. E.</given-names></name><name><surname>Terentyeva</surname><given-names>R.</given-names></name><name><surname>Martin</surname><given-names>M. M.</given-names></name><name><surname>Malana</surname><given-names>G. E.</given-names></name><name><surname>Kuhn</surname><given-names>D. E.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>miR-1 overexpression enhances Ca(2 + ) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>104</volume>
<fpage>514</fpage>–<lpage>521</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.108.181651</pub-id>
<pub-id pub-id-type="pmid">19131648</pub-id></mixed-citation>
</ref>
<ref id="B249">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terentyev</surname><given-names>D.</given-names></name><name><surname>Hamilton</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>Regulation of sarcoplasmic reticulum Ca2 + release by serine-threonine phosphatases in the heart.</article-title>
<source/><italic>J. Mol. Cell. Cardiol.</italic>
<volume>101</volume>
<fpage>156</fpage>–<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2016.08.020</pub-id>
<pub-id pub-id-type="pmid">27585747</pub-id></mixed-citation>
</ref>
<ref id="B250">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terentyev</surname><given-names>D.</given-names></name><name><surname>Kubalova</surname><given-names>Z.</given-names></name><name><surname>Valle</surname><given-names>G.</given-names></name><name><surname>Nori</surname><given-names>A.</given-names></name><name><surname>Vedamoorthyrao</surname><given-names>S.</given-names></name><name><surname>Terentyeva</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Modulation of SR Ca release by luminal Ca and calsequestrin in cardiac myocytes: effects of CASQ2 mutations linked to sudden cardiac death.</article-title>
<source/><italic>Biophys. J.</italic>
<volume>95</volume>
<fpage>2037</fpage>–<lpage>2048</lpage>. <pub-id pub-id-type="doi">10.1529/biophysj.107.128249</pub-id>
<pub-id pub-id-type="pmid">18469084</pub-id></mixed-citation>
</ref>
<ref id="B251">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terentyev</surname><given-names>D.</given-names></name><name><surname>Nori</surname><given-names>A.</given-names></name><name><surname>Santoro</surname><given-names>M.</given-names></name><name><surname>Viatchenko-Karpinski</surname><given-names>S.</given-names></name><name><surname>Kubalova</surname><given-names>Z.</given-names></name><name><surname>Györke</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>98</volume>
<fpage>1151</fpage>–<lpage>1158</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000220647.93982.08</pub-id>
<pub-id pub-id-type="pmid">16601229</pub-id></mixed-citation>
</ref>
<ref id="B252">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terentyev</surname><given-names>D.</given-names></name><name><surname>Viatchenko-Karpinski</surname><given-names>S.</given-names></name><name><surname>Valdivia</surname><given-names>H. H.</given-names></name><name><surname>Escobar</surname><given-names>A. L.</given-names></name><name><surname>Györke</surname><given-names>S.</given-names></name></person-group> (<year>2002</year>). <article-title>Luminal Ca<sup>2+</sup> controls termination and refractory behavior of Ca<sup>2+</sup> -induced Ca<sup>2+</sup> release in cardiac myocytes.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>6</volume>
<fpage>414</fpage>–<lpage>420</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000032490.04207.BD</pub-id></mixed-citation>
</ref>
<ref id="B253">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teshima</surname><given-names>Y.</given-names></name><name><surname>Takahashi</surname><given-names>N.</given-names></name><name><surname>Nishio</surname><given-names>S.</given-names></name><name><surname>Saito</surname><given-names>S.</given-names></name><name><surname>Kondo</surname><given-names>H.</given-names></name><name><surname>Fukui</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Production of reactive oxygen species in the diabetic heart. Roles of mitochondria and NADPH oxidase.</article-title>
<source/><italic>Circ. J.</italic>
<volume>78</volume>
<fpage>300</fpage>–<lpage>306</lpage>. <pub-id pub-id-type="doi">10.1253/circj.CJ-13-1187</pub-id><pub-id pub-id-type="pmid">24334638</pub-id></mixed-citation>
</ref>
<ref id="B254">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teshima</surname><given-names>Y.</given-names></name><name><surname>Takahashi</surname><given-names>N.</given-names></name><name><surname>Saikawa</surname><given-names>T.</given-names></name><name><surname>Hara</surname><given-names>M.</given-names></name><name><surname>Yasunaga</surname><given-names>S.</given-names></name><name><surname>Hidaka</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Diminished expression of sarcoplasmic reticulum Ca(2 + )-ATPase and ryanodine sensitive Ca(2 + )Channel mRNA in streptozotocin-induced diabetic rat heart.</article-title>
<source/><italic>J. Mol. Cell. Cardiol.</italic>
<volume>32</volume>
<fpage>655</fpage>–<lpage>664</lpage>. <pub-id pub-id-type="doi">10.1006/jmcc.2000.1107</pub-id>
<pub-id pub-id-type="pmid">10756121</pub-id></mixed-citation>
</ref>
<ref id="B255">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tester</surname><given-names>D. J.</given-names></name><name><surname>Kopplin</surname><given-names>L. J.</given-names></name><name><surname>Will</surname><given-names>M. L.</given-names></name><name><surname>Ackerman</surname><given-names>M. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing.</article-title>
<source/><italic>Heart Rhythm.</italic>
<volume>2</volume>
<fpage>1099</fpage>–<lpage>1105</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2005.07.012</pub-id>
<pub-id pub-id-type="pmid">16188589</pub-id></mixed-citation>
</ref>
<ref id="B256">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>C.</given-names></name><name><surname>Shao</surname><given-names>C. H.</given-names></name><name><surname>Moore</surname><given-names>C. J.</given-names></name><name><surname>Kutty</surname><given-names>S.</given-names></name><name><surname>Walseth</surname><given-names>T.</given-names></name><name><surname>DeSouza</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Gain of function of cardiac ryanodine receptor in a rat model of type 1 diabetes.</article-title>
<source/><italic>Cardiovasc. Res.</italic>
<volume>91</volume>
<fpage>300</fpage>–<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvr076</pub-id>
<pub-id pub-id-type="pmid">21421556</pub-id></mixed-citation>
</ref>
<ref id="B257">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trost</surname><given-names>S. U.</given-names></name><name><surname>Belke</surname><given-names>D. D.</given-names></name><name><surname>Bluhm</surname><given-names>W. F.</given-names></name><name><surname>Meyer</surname><given-names>M.</given-names></name><name><surname>Swanson</surname><given-names>E.</given-names></name><name><surname>Dillmann</surname><given-names>W. H.</given-names></name></person-group> (<year>2002</year>). <article-title>Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy.</article-title>
<source/><italic>Diabetes</italic>
<volume>51</volume>
<fpage>1166</fpage>–<lpage>1171</lpage>. <pub-id pub-id-type="doi">10.2337/diabetes.51.4.1166</pub-id>
<pub-id pub-id-type="pmid">11916940</pub-id></mixed-citation>
</ref>
<ref id="B258">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tse</surname><given-names>G.</given-names></name><name><surname>Lai</surname><given-names>E. T.</given-names></name><name><surname>Tse</surname><given-names>V.</given-names></name><name><surname>Yeo</surname><given-names>J. M.</given-names></name></person-group> (<year>2016</year>). <article-title>Molecular and electrophysiological mechanisms underlying cardiac arrhythmogenesis in diabetes mellitus.</article-title>
<source/><italic>J. Diabetes Res.</italic>
<volume>2016</volume>:<issue>2848759</issue>. <pub-id pub-id-type="doi">10.1155/2016/2848759</pub-id>
<pub-id pub-id-type="pmid">27642609</pub-id></mixed-citation>
</ref>
<ref id="B259">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsujimoto</surname><given-names>T.</given-names></name><name><surname>Sugiyama</surname><given-names>T.</given-names></name><name><surname>Shapiro</surname><given-names>M. F.</given-names></name><name><surname>Noda</surname><given-names>M.</given-names></name><name><surname>Kajio</surname><given-names>H.</given-names></name></person-group> (<year>2017</year>). <article-title>Risk of cardiovascular events in patients with diabetes mellitus on β-blockers.</article-title>
<source/><italic>Hypertension</italic>
<volume>70</volume>
<fpage>103</fpage>–<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.117.09259</pub-id>
<pub-id pub-id-type="pmid">28559400</pub-id></mixed-citation>
</ref>
<ref id="B260">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuncay</surname><given-names>E.</given-names></name><name><surname>Okatan</surname><given-names>E. N.</given-names></name><name><surname>Toy</surname><given-names>A.</given-names></name><name><surname>Turan</surname><given-names>B.</given-names></name></person-group> (<year>2014</year>). <article-title>Enhancement of cellular antioxidant-defence preserves diastolic dysfunction via regulation of both diastolic Zn2 + and Ca2 + and prevention of RyR2-leak in hyperglycemic cardiomyocytes.</article-title>
<source/><italic>Oxid. Med. Cell. Longev.</italic>
<volume>2014</volume>:<issue>290381</issue>. <pub-id pub-id-type="doi">10.1155/2014/290381</pub-id>
<pub-id pub-id-type="pmid">24693334</pub-id></mixed-citation>
</ref>
<ref id="B261">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tunwell</surname><given-names>R. E.</given-names></name><name><surname>Wickenden</surname><given-names>C.</given-names></name><name><surname>Bertrand</surname><given-names>B. M.</given-names></name><name><surname>Shevchenko</surname><given-names>V. I.</given-names></name><name><surname>Walsh</surname><given-names>M. B.</given-names></name><name><surname>Allen</surname><given-names>P. D.</given-names></name><etal></etal></person-group> (<year>1996</year>). <article-title>The human cardiac muscle ryanodine receptor-calcium release channel: identification, primary structure and topological analysis.</article-title>
<source/><italic>Biochem. J.</italic>
<volume>318</volume>( Pt 2), <fpage>477</fpage>–<lpage>487</lpage>. <pub-id pub-id-type="doi">10.1042/bj3180477</pub-id>
<pub-id pub-id-type="pmid">8809036</pub-id></mixed-citation>
</ref>
<ref id="B262">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tzimas</surname><given-names>C.</given-names></name><name><surname>Terrovitis</surname><given-names>J.</given-names></name><name><surname>Lehnart</surname><given-names>S. E.</given-names></name><name><surname>Kranias</surname><given-names>E. G.</given-names></name><name><surname>Sanoudou</surname><given-names>D.</given-names></name></person-group> (<year>2015</year>). <article-title>Calcium/calmodulin-dependent protein kinase II (CaMKII) inhibition ameliorates arrhythmias elicited by junctin ablation under stress conditions.</article-title>
<source/><italic>Heart Rhythm.</italic>
<volume>12</volume>
<fpage>1599</fpage>–<lpage>1610</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2015.03.043</pub-id>
<pub-id pub-id-type="pmid">25814413</pub-id></mixed-citation>
</ref>
<ref id="B263">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uchinoumi</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Oda</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Alsina</surname><given-names>K. M.</given-names></name><name><surname>Puglisi</surname><given-names>J. L.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>CaMKII-dependent phosphorylation of RyR2 promotes targetable pathological RyR2 conformational shift.</article-title>
<source/><italic>J. Mol. Cell. Cardiol.</italic>
<volume>98</volume>
<fpage>62</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2016.06.007</pub-id>
<pub-id pub-id-type="pmid">27318036</pub-id></mixed-citation>
</ref>
<ref id="B264">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uehara</surname><given-names>A.</given-names></name><name><surname>Murayama</surname><given-names>T.</given-names></name><name><surname>Yasukochi</surname><given-names>M.</given-names></name><name><surname>Fill</surname><given-names>M.</given-names></name><name><surname>Horie</surname><given-names>M.</given-names></name><name><surname>Okamoto</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Extensive Ca2 + leak through K4750Q cardiac ryanodine receptors caused by cytosolic and luminal Ca2 + hypersensitivity.</article-title>
<source/><italic>J. Gen. Physiol.</italic>
<volume>149</volume>
<fpage>199</fpage>–<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.201611624</pub-id>
<pub-id pub-id-type="pmid">28082361</pub-id></mixed-citation>
</ref>
<ref id="B265">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasiliadis</surname><given-names>I.</given-names></name><name><surname>Kolovou</surname><given-names>G.</given-names></name><name><surname>Mavrogeni</surname><given-names>S.</given-names></name><name><surname>Nair</surname><given-names>D. R.</given-names></name><name><surname>Mikhailidis</surname><given-names>D. P.</given-names></name></person-group> (<year>2014</year>). <article-title>Sudden cardiac death and diabetes mellitus.</article-title>
<source/><italic>J. Diabetes Complications</italic>
<volume>28</volume>
<fpage>573</fpage>–<lpage>579</lpage>. <pub-id pub-id-type="doi">10.1016/j.jdiacomp.2014.02.003</pub-id>
<pub-id pub-id-type="pmid">24666923</pub-id></mixed-citation>
</ref>
<ref id="B266">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venetucci</surname><given-names>L.</given-names></name><name><surname>Denegri</surname><given-names>M.</given-names></name><name><surname>Napolitano</surname><given-names>C.</given-names></name><name><surname>Priori</surname><given-names>S. G.</given-names></name></person-group> (<year>2012</year>). <article-title>Inherited calcium channelopathies in the pathophysiology of arrhythmias.</article-title>
<source/><italic>Nat. Rev. Cardiol.</italic>
<volume>9</volume>
<fpage>561</fpage>–<lpage>575</lpage>. <pub-id pub-id-type="doi">10.1038/nrcardio.2012.93</pub-id>
<pub-id pub-id-type="pmid">22733215</pub-id></mixed-citation>
</ref>
<ref id="B267">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vervliet</surname><given-names>T.</given-names></name><name><surname>Robinson</surname><given-names>E. L.</given-names></name><name><surname>Roderick</surname><given-names>H. L.</given-names></name></person-group> (<year>2018</year>). <article-title>Lnc’ing Ca2 +. SERCA and cardiac disease.</article-title>
<source/><italic>Cell Calcium</italic>
<volume>72</volume>
<fpage>132</fpage>–<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceca.2018.05.005</pub-id>
<pub-id pub-id-type="pmid">29793762</pub-id></mixed-citation>
</ref>
<ref id="B268">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vetter</surname><given-names>R.</given-names></name><name><surname>Rehfeld</surname><given-names>U.</given-names></name><name><surname>Reissfelder</surname><given-names>C.</given-names></name><name><surname>Weiss</surname><given-names>W.</given-names></name><name><surname>Wagner</surname><given-names>K. D.</given-names></name><name><surname>Günther</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Transgenic overexpression of the sarcoplasmic reticulum Ca2 + ATPase improves reticular Ca2 + handling in normal and diabetic rat hearts.</article-title>
<source/><italic>FASEB J.</italic>
<volume>16</volume>
<fpage>1657</fpage>–<lpage>1659</lpage>. <pub-id pub-id-type="doi">10.1096/fj.01-1019fje</pub-id>
<pub-id pub-id-type="pmid">12206992</pub-id></mixed-citation>
</ref>
<ref id="B269">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waller</surname><given-names>A. P.</given-names></name><name><surname>Kalyanasundaram</surname><given-names>A.</given-names></name><name><surname>Hayes</surname><given-names>S.</given-names></name><name><surname>Periasamy</surname><given-names>M.</given-names></name><name><surname>Lacombe</surname><given-names>V. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Sarcoplasmic reticulum Ca2 + ATPase pump is a major regulator of glucose transport in the healthy and diabetic heart.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1852</volume>
<fpage>873</fpage>–<lpage>881</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2015.01.009</pub-id>
<pub-id pub-id-type="pmid">25615793</pub-id></mixed-citation>
</ref>
<ref id="B270">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>C. R.</given-names></name><name><surname>Piacentino</surname><given-names>V.</given-names><suffix>III</suffix></name><name><surname>Houser</surname><given-names>S. R.</given-names></name><name><surname>Bers</surname><given-names>D. M.</given-names></name></person-group> (<year>2003</year>). <article-title>Dynamic regulation of sodium/calcium exchange function in human heart failure.</article-title>
<source/><italic>Circulation</italic>
<volume>108</volume>
<fpage>2224</fpage>–<lpage>2229</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.0000095274.72486.94</pub-id>
<pub-id pub-id-type="pmid">14557358</pub-id></mixed-citation>
</ref>
<ref id="B271">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wehrens</surname><given-names>X. H.</given-names></name><name><surname>Lehnart</surname><given-names>S. E.</given-names></name><name><surname>Huang</surname><given-names>F.</given-names></name><name><surname>Vest</surname><given-names>J. A.</given-names></name><name><surname>Reiken</surname><given-names>S. R.</given-names></name><name><surname>Mohler</surname><given-names>P. J.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death.</article-title>
<source/><italic>Cell</italic>
<volume>27</volume>
<fpage>829</fpage>–<lpage>840</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(03)00434-3</pub-id>
<pub-id pub-id-type="pmid">12837242</pub-id></mixed-citation>
</ref>
<ref id="B272">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wehrens</surname><given-names>X. H.</given-names></name><name><surname>Lehnart</surname><given-names>S. E.</given-names></name><name><surname>Reiken</surname><given-names>S.</given-names></name><name><surname>van der Nagel</surname><given-names>R.</given-names></name><name><surname>Morales</surname><given-names>R.</given-names></name><name><surname>Sun</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failure.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>102</volume>
<fpage>9607</fpage>–<lpage>9612</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0500353102</pub-id>
<pub-id pub-id-type="pmid">15972811</pub-id></mixed-citation>
</ref>
<ref id="B273">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wehrens</surname><given-names>X. H.</given-names></name><name><surname>Lehnart</surname><given-names>S. E.</given-names></name><name><surname>Reiken</surname><given-names>S.</given-names></name><name><surname>Vest</surname><given-names>J. A.</given-names></name><name><surname>Wronska</surname><given-names>A.</given-names></name><name><surname>Marks</surname><given-names>A. R.</given-names></name></person-group> (<year>2006</year>). <article-title>Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>103</volume>
<fpage>511</fpage>–<lpage>518</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0510113103</pub-id>
<pub-id pub-id-type="pmid">16407108</pub-id></mixed-citation>
</ref>
<ref id="B274">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wehrens</surname><given-names>X. H.</given-names></name><name><surname>Lehnart</surname><given-names>S. E.</given-names></name><name><surname>Reiken</surname><given-names>S. R.</given-names></name><name><surname>Deng</surname><given-names>S. X.</given-names></name><name><surname>Vest</surname><given-names>J. A.</given-names></name><name><surname>Cervantes</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2004a</year>). <article-title>Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2.</article-title>
<source/><italic>Science</italic>
<volume>304</volume>
<fpage>292</fpage>–<lpage>296</lpage>. <pub-id pub-id-type="doi">10.1126/science.1094301</pub-id>
<pub-id pub-id-type="pmid">15073377</pub-id></mixed-citation>
</ref>
<ref id="B275">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wehrens</surname><given-names>X. H.</given-names></name><name><surname>Lehnart</surname><given-names>S. E.</given-names></name><name><surname>Reiken</surname><given-names>S. R.</given-names></name><name><surname>Marks</surname><given-names>A. R.</given-names></name></person-group> (<year>2004b</year>). <article-title>Ca2 + /calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>94</volume>
<fpage>e61</fpage>–<lpage>e70</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000125626.33738.E2</pub-id>
<pub-id pub-id-type="pmid">15016728</pub-id></mixed-citation>
</ref>
<ref id="B276">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>S.</given-names></name><name><surname>Guo</surname><given-names>A.</given-names></name><name><surname>Chen</surname><given-names>B.</given-names></name><name><surname>Kutschke</surname><given-names>W.</given-names></name><name><surname>Xie</surname><given-names>Y. P.</given-names></name><name><surname>Zimmerman</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>T-tubule remodeling during transition from hypertrophy to heart failure.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>107</volume>
<fpage>520</fpage>–<lpage>531</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.109.212324</pub-id>
<pub-id pub-id-type="pmid">20576937</pub-id></mixed-citation>
</ref>
<ref id="B277">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>J. N.</given-names></name><name><surname>Garfinkel</surname><given-names>A.</given-names></name><name><surname>Karagueuzian</surname><given-names>H. S.</given-names></name><name><surname>Chen</surname><given-names>P. S.</given-names></name><name><surname>Qu</surname><given-names>Z.</given-names></name></person-group> (<year>2010</year>). <article-title>Early afterdepolarizations and cardiac arrhythmias.</article-title>
<source/><italic>Heart Rhythm.</italic>
<volume>7</volume>
<fpage>1891</fpage>–<lpage>1899</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2010.09.017</pub-id>
<pub-id pub-id-type="pmid">20868774</pub-id></mixed-citation>
</ref>
<ref id="B278">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wickley</surname><given-names>P. J.</given-names></name><name><surname>Shiga</surname><given-names>T.</given-names></name><name><surname>Murray</surname><given-names>P. A.</given-names></name><name><surname>Damron</surname><given-names>D. S.</given-names></name></person-group> (<year>2007</year>). <article-title>Propofol modulates Na + -Ca2 + exchange activity via activation of protein kinase C in diabetic cardiomyocytes.</article-title>
<source/><italic>Anesthesiology</italic>
<volume>106</volume>
<fpage>302</fpage>–<lpage>311</lpage>. <pub-id pub-id-type="doi">10.1097/00000542-200702000-00019</pub-id>
<pub-id pub-id-type="pmid">17264725</pub-id></mixed-citation>
</ref>
<ref id="B279">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>A. J.</given-names></name><name><surname>Gill</surname><given-names>E. K.</given-names></name><name><surname>Abudalo</surname><given-names>R. A.</given-names></name><name><surname>Edgar</surname><given-names>K. S.</given-names></name><name><surname>Watson</surname><given-names>C. J.</given-names></name><name><surname>Grieve</surname><given-names>D. J.</given-names></name></person-group> (<year>2018</year>). <article-title>Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting.</article-title>
<source/><italic>Heart</italic>
<volume>104</volume>
<fpage>293</fpage>–<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1136/heartjnl-2017-311448</pub-id>
<pub-id pub-id-type="pmid">28954833</pub-id></mixed-citation>
</ref>
<ref id="B280">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winnick</surname><given-names>J. J.</given-names></name><name><surname>Sherman</surname><given-names>W. M.</given-names></name><name><surname>Habash</surname><given-names>D. L.</given-names></name><name><surname>Stout</surname><given-names>M. B.</given-names></name><name><surname>Failla</surname><given-names>M. L.</given-names></name><name><surname>Belury</surname><given-names>M. A.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Short-term aerobic exercise training in obese humans with type 2 diabetes mellitus improves whole-body insulin sensitivity through gains in peripheral, not hepatic insulin sensitivity.</article-title>
<source/><italic>J. Clin. Endocrinol. Metab.</italic>
<volume>93</volume>
<fpage>771</fpage>–<lpage>778</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2007-1524</pub-id>
<pub-id pub-id-type="pmid">18073312</pub-id></mixed-citation>
</ref>
<ref id="B281">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winslow</surname><given-names>R. L.</given-names></name><name><surname>Rice</surname><given-names>J.</given-names></name><name><surname>Jafri</surname><given-names>S.</given-names></name><name><surname>Marbán</surname><given-names>E.</given-names></name><name><surname>O’Rourke</surname><given-names>B.</given-names></name></person-group> (<year>1999</year>). <article-title>Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure. II: model studies.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>19</volume>
<fpage>571</fpage>–<lpage>586</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.84.5.571</pub-id>
<pub-id pub-id-type="pmid">10082479</pub-id></mixed-citation>
</ref>
<ref id="B282">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Witcher</surname><given-names>D. R.</given-names></name><name><surname>Kovacs</surname><given-names>R. J.</given-names></name><name><surname>Schulman</surname><given-names>H.</given-names></name><name><surname>Cefali</surname><given-names>D. C.</given-names></name><name><surname>Jones</surname><given-names>L. R.</given-names></name></person-group> (<year>1991</year>). <article-title>Unique phosphorylation site on the cardiac ryanodine receptor regulates calcium channel activity.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>15</volume>
<fpage>11144</fpage>–<lpage>11152</lpage>. <pub-id pub-id-type="pmid">1645727</pub-id></mixed-citation>
</ref>
<ref id="B283">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wold</surname><given-names>L. E.</given-names></name><name><surname>Dutta</surname><given-names>K.</given-names></name><name><surname>Mason</surname><given-names>M. M.</given-names></name><name><surname>Ren</surname><given-names>J.</given-names></name><name><surname>Cala</surname><given-names>S. E.</given-names></name><name><surname>Schwanke</surname><given-names>M. L.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Impaired SERCA function contributes to cardiomyocyte dysfunction in insulin resistant rats.</article-title>
<source/><italic>J. Mol. Cell. Cardiol.</italic>
<volume>39</volume>
<fpage>297</fpage>–<lpage>307</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2005.03.014</pub-id>
<pub-id pub-id-type="pmid">15878173</pub-id></mixed-citation>
</ref>
<ref id="B284">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>B.</given-names></name><name><surname>Jiang</surname><given-names>M. T.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>D.</given-names></name><name><surname>Sutherland</surname><given-names>C.</given-names></name><name><surname>Lai</surname><given-names>F. A.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Characterization of a novel PKA phosphorylation site, serine-2030, reveals no PKA hyperphosphorylation of the cardiac ryanodine receptor in canine heart failure.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>96</volume>
<fpage>847</fpage>–<lpage>855</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000163276.26083.e8</pub-id>
<pub-id pub-id-type="pmid">15790957</pub-id></mixed-citation>
</ref>
<ref id="B285">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>B.</given-names></name><name><surname>Sutherland</surname><given-names>C.</given-names></name><name><surname>Walsh</surname><given-names>M. P.</given-names></name><name><surname>Chen</surname><given-names>S. R.</given-names></name></person-group> (<year>2004</year>). <article-title>Protein kinase A phosphorylation at serine-2808 of the cardiac Ca2 + -release channel (ryanodine receptor) does not dissociate 12.6-kDa FK506-binding protein (FKBP12.6).</article-title>
<source/><italic>Circ. Res.</italic>
<volume>94</volume>
<fpage>487</fpage>–<lpage>495</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000115945.89741.22</pub-id>
<pub-id pub-id-type="pmid">14715536</pub-id></mixed-citation>
</ref>
<ref id="B286">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>C.</given-names></name><name><surname>Biary</surname><given-names>N.</given-names></name><name><surname>Tocchetti</surname><given-names>C. G.</given-names></name><name><surname>Aon</surname><given-names>M. A.</given-names></name><name><surname>Paolocci</surname><given-names>N.</given-names></name><name><surname>Kauffman</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Glutathione oxidation unmasks proarrhythmic vulnerability of chronically hyperglycemic guinea pigs.</article-title>
<source/><italic>Am. J. Physiol. Heart Circ. Physiol.</italic>
<volume>304</volume>
<fpage>H916</fpage>–<lpage>H926</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00026.2012</pub-id>
<pub-id pub-id-type="pmid">23376824</pub-id></mixed-citation>
</ref>
<ref id="B287">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>L. H.</given-names></name><name><surname>Chen</surname><given-names>F.</given-names></name><name><surname>Karagueuzian</surname><given-names>H. S.</given-names></name><name><surname>Weiss</surname><given-names>J. N.</given-names></name></person-group> (<year>2009</year>). <article-title>Oxidative-stress-induced afterdepolarizations and calmodulin kinase II signaling.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>104</volume>
<fpage>79</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.108.183475</pub-id>
<pub-id pub-id-type="pmid">19038865</pub-id></mixed-citation>
</ref>
<ref id="B288">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>K. Y.</given-names></name><name><surname>Zweier</surname><given-names>J. L.</given-names></name><name><surname>Becker</surname><given-names>L. C.</given-names></name></person-group> (<year>1997</year>). <article-title>Hydroxyl radical inhibits sarcoplasmic reticulum Ca(2 + )-ATPase function by direct attack on the ATP binding site.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>80</volume>
<fpage>76</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.80.1.76</pub-id>
<pub-id pub-id-type="pmid">8978325</pub-id></mixed-citation>
</ref>
<ref id="B289">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>L.</given-names></name><name><surname>Eu</surname><given-names>J. P.</given-names></name><name><surname>Meissner</surname><given-names>G.</given-names></name><name><surname>Stamler</surname><given-names>J. S.</given-names></name></person-group> (<year>1998</year>). <article-title>Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation.</article-title>
<source/><italic>Science</italic>
<volume>9</volume>
<fpage>234</fpage>–<lpage>237</lpage>. <pub-id pub-id-type="doi">10.1126/science.279.5348.234</pub-id>
<pub-id pub-id-type="pmid">9422697</pub-id></mixed-citation>
</ref>
<ref id="B290">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>D.</given-names></name><name><surname>Zhu</surname><given-names>W. Z.</given-names></name><name><surname>Xiao</surname><given-names>B.</given-names></name><name><surname>Brochet</surname><given-names>D. X.</given-names></name><name><surname>Chen</surname><given-names>S. R.</given-names></name><name><surname>Lakatta</surname><given-names>E. G.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Ca2 + /calmodulin kinase II-dependent phosphorylation of ryanodine receptors suppresses Ca2 + sparks and Ca2 + waves in cardiac myocytes.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>100</volume>
<fpage>399</fpage>–<lpage>407</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000258022.13090.55</pub-id>
<pub-id pub-id-type="pmid">17234969</pub-id></mixed-citation>
</ref>
<ref id="B291">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Qiu</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Liang</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Xanthine oxidase inhibitor allopurinol prevents oxidative stress-mediated atrial remodeling in alloxan-induced diabetes mellitus rabbits.</article-title>
<source/><italic>J. Am. Heart Assoc.</italic>
<volume>7</volume>:<issue>e008807</issue>. <pub-id pub-id-type="doi">10.1161/JAHA.118.008807</pub-id>
<pub-id pub-id-type="pmid">29720500</pub-id></mixed-citation>
</ref>
<ref id="B292">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yano</surname><given-names>K.</given-names></name><name><surname>Zarain-Herzberg</surname><given-names>A.</given-names></name></person-group> (<year>1994</year>). <article-title>Sarcoplasmic reticulum calsequestrins: structural and functional properties.</article-title>
<source/><italic>Mol. Cell. Biochem.</italic>
<volume>15</volume>
<fpage>61</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1007/BF00925961</pub-id>
<pub-id pub-id-type="pmid">7816057</pub-id></mixed-citation>
</ref>
<ref id="B293">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yaras</surname><given-names>N.</given-names></name><name><surname>Bilginoglu</surname><given-names>A.</given-names></name><name><surname>Vassort</surname><given-names>G.</given-names></name><name><surname>Turan</surname><given-names>B.</given-names></name></person-group> (<year>2007</year>). <article-title>Restoration of diabetes-induced abnormal local Ca2 + release in cardiomyocytes by angiotensin II receptor blockade.</article-title>
<source/><italic>Am. J. Physiol. Heart Circ. Physiol.</italic>
<volume>292</volume>
<fpage>H912</fpage>–<lpage>H920</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00824.2006</pub-id>
<pub-id pub-id-type="pmid">17012347</pub-id></mixed-citation>
</ref>
<ref id="B294">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yaras</surname><given-names>N.</given-names></name><name><surname>Ugur</surname><given-names>M.</given-names></name><name><surname>Ozdemir</surname><given-names>S.</given-names></name><name><surname>Gurdal</surname><given-names>H.</given-names></name><name><surname>Purali</surname><given-names>N.</given-names></name><name><surname>Lacampagne</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Effects of diabetes on ryanodine receptor Ca release channel (RyR2) and Ca2 + homeostasis in rat heart.</article-title>
<source/><italic>Diabetes Metab. Res. Rev.</italic>
<volume>54</volume>
<fpage>3082</fpage>–<lpage>3088</lpage>. <pub-id pub-id-type="doi">10.2337/diabetes.54.11.3082</pub-id>
<pub-id pub-id-type="pmid">16249429</pub-id></mixed-citation>
</ref>
<ref id="B295">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>D.</given-names></name><name><surname>Tester</surname><given-names>D. J.</given-names></name><name><surname>Zhou</surname><given-names>W.</given-names></name><name><surname>Papagiannis</surname><given-names>J.</given-names></name><name><surname>Ackerman</surname><given-names>M. J.</given-names></name></person-group> (<year>2018</year>). <article-title>A pore-localizing CACNA1C-E1115K missense mutation, identified in a patient with idiopathic qt prolongation, bradycardia, and autism spectrum disorder, converts the l-type calcium channel into a hybrid non-selective monovalent cation channel.</article-title>
<source/><italic>Heart Rhythm.</italic>
<pub-id pub-id-type="doi">10.1016/j.hrthm.2018.08.030</pub-id> [Epub ahead of print]. <pub-id pub-id-type="pmid">30172029</pub-id></mixed-citation>
</ref>
<ref id="B296">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ying</surname><given-names>J.</given-names></name><name><surname>Sharov</surname><given-names>V.</given-names></name><name><surname>Xu</surname><given-names>S.</given-names></name><name><surname>Jiang</surname><given-names>B.</given-names></name><name><surname>Gerrity</surname><given-names>R.</given-names></name><name><surname>Schöneich</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Cysteine-674 oxidation and degradation of sarcoplasmic reticulum Ca(2 + ) ATPase in diabetic pig aorta.</article-title>
<source/><italic>Free Radic. Biol. Med.</italic>
<volume>45</volume>
<fpage>756</fpage>–<lpage>762</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2008.05.029</pub-id>
<pub-id pub-id-type="pmid">18590812</pub-id></mixed-citation>
</ref>
<ref id="B297">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Z.</given-names></name><name><surname>Tibbits</surname><given-names>G. F.</given-names></name><name><surname>McNeill</surname><given-names>J. H.</given-names></name></person-group> (<year>1994</year>). <article-title>Cellular functions of diabetic cardiomyocytes: contractility, rapid-cooling contracture, and ryanodine binding.</article-title>
<source/><italic>Am. J Physiol.</italic>
<volume>266</volume>(5 Pt 2), <fpage>H2082</fpage>–<lpage>H2089</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.1994.266.5.H2082</pub-id>
<pub-id pub-id-type="pmid">8203606</pub-id></mixed-citation>
</ref>
<ref id="B298">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarain-Herzberg</surname><given-names>A.</given-names></name><name><surname>García-Rivas</surname><given-names>G.</given-names></name><name><surname>Estrada-Avilés</surname><given-names>R.</given-names></name></person-group> (<year>2014</year>). <article-title>Regulation of SERCA pumps expression in diabetes.</article-title>
<source/><italic>Cell Calcium</italic>
<volume>56</volume>
<fpage>302</fpage>–<lpage>310</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceca.2014.09.005</pub-id>
<pub-id pub-id-type="pmid">25270119</pub-id></mixed-citation>
</ref>
<ref id="B299">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Zhou</surname><given-names>Q.</given-names></name><name><surname>Smith</surname><given-names>C. D.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Tan</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Non-β-blocking R-carvedilol enantiomer suppresses Ca2 + waves and stress-induced ventricular tachyarrhythmia without lowering heart rate or blood pressure.</article-title>
<source/><italic>Biochem. J.</italic>
<volume>470</volume>
<fpage>233</fpage>–<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20150548</pub-id>
<pub-id pub-id-type="pmid">26348911</pub-id></mixed-citation>
</ref>
<ref id="B300">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P.</given-names></name></person-group> (<year>2017</year>). <article-title>CaMKII: the molecular villain that aggravates cardiovascular disease.</article-title>
<source/><italic>Exp. Ther. Med.</italic>
<volume>13</volume>
<fpage>815</fpage>–<lpage>820</lpage>. <pub-id pub-id-type="doi">10.3892/etm.2017.4034</pub-id>
<pub-id pub-id-type="pmid">28450904</pub-id></mixed-citation>
</ref>
<ref id="B301">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Khoo</surname><given-names>M. S.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Grueter</surname><given-names>C. E.</given-names></name><name><surname>Ni</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Calmodulin kinase II inhibition protects against structural heart disease.</article-title>
<source/><italic>Nat Med.</italic>
<volume>11</volume>
<fpage>409</fpage>–<lpage>417</lpage>. <pub-id pub-id-type="doi">10.1038/nm1215</pub-id>
<pub-id pub-id-type="pmid">15793582</pub-id></mixed-citation>
</ref>
<ref id="B302">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>T.</given-names></name><name><surname>Guo</surname><given-names>T.</given-names></name><name><surname>Mishra</surname><given-names>S.</given-names></name><name><surname>Dalton</surname><given-names>N. D.</given-names></name><name><surname>Kranias</surname><given-names>E. G.</given-names></name><name><surname>Peterson</surname><given-names>K. L.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Phospholamban ablation rescues sarcoplasmic reticulum Ca(2 + ) handling but exacerbates cardiac dysfunction in CaMKIIdelta(C) transgenic mice.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>106</volume>
<fpage>354</fpage>–<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.109.207423</pub-id>
<pub-id pub-id-type="pmid">19959778</pub-id></mixed-citation>
</ref>
<ref id="B303">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Jiang</surname><given-names>N.</given-names></name><name><surname>Qiu</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Alogliptin, a dipeptidyl peptidase-4 inhibitor, alleviates atrial remodeling and improves mitochondrial function and biogenesis in diabetic rabbits.</article-title>
<source/><italic>J. Am. Heart Assoc.</italic>
<volume>6</volume>:<issue>e005945</issue>. <pub-id pub-id-type="doi">10.1161/JAHA.117.005945</pub-id>
<pub-id pub-id-type="pmid">28507060</pub-id></mixed-citation>
</ref>
<ref id="B304">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>S. M.</given-names></name><name><surname>Wang</surname><given-names>Y. L.</given-names></name><name><surname>Guo</surname><given-names>C. Y.</given-names></name><name><surname>Chen</surname><given-names>J. L.</given-names></name><name><surname>Wu</surname><given-names>Y. Q.</given-names></name></person-group> (<year>2014</year>). <article-title>Progressive decay of Ca2 + homeostasis in the development of diabetic cardiomyopathy.</article-title>
<source/><italic>Cardiovasc. Diabetol.</italic>
<volume>13</volume>:<issue>75</issue>. <pub-id pub-id-type="doi">10.1186/1475-2840-13-75</pub-id>
<pub-id pub-id-type="pmid">24712865</pub-id></mixed-citation>
</ref>
<ref id="B305">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y. T.</given-names></name><name><surname>Valdivia</surname><given-names>C. R.</given-names></name><name><surname>Gurrola</surname><given-names>G. B.</given-names></name><name><surname>Powers</surname><given-names>P. P.</given-names></name><name><surname>Willis</surname><given-names>B. C.</given-names></name><name><surname>Moss</surname><given-names>R. L.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine receptor function.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>112</volume>
<fpage>E1669</fpage>–<lpage>E1677</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1419795112</pub-id>
<pub-id pub-id-type="pmid">25775566</pub-id></mixed-citation>
</ref>
<ref id="B306">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>M.</given-names></name><name><surname>Rees</surname><given-names>C. M.</given-names></name><name><surname>Terentyev</surname><given-names>D.</given-names></name><name><surname>Choi</surname><given-names>B. R.</given-names></name><name><surname>Koren</surname><given-names>G.</given-names></name><name><surname>Karma</surname><given-names>A.</given-names></name></person-group> (<year>2018</year>). <article-title>NCX-mediated subcellular Ca2 + dynamics underlying early afterdepolarizations in LQT2 cardiomyocytes.</article-title>
<source/><italic>Biophys. J.</italic>
<volume>115</volume>
<fpage>1019</fpage>–<lpage>1032</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpj.2018.08.004</pub-id>
<pub-id pub-id-type="pmid">30173888</pub-id></mixed-citation>
</ref>
<ref id="B307">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Q.</given-names></name><name><surname>Xiao</surname><given-names>J.</given-names></name><name><surname>Jiang</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>R.</given-names></name><name><surname>Vembaiyan</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2 + release.</article-title>
<source/><italic>Nat. Med.</italic>
<volume>17</volume>
<fpage>1003</fpage>–<lpage>1009</lpage>. <pub-id pub-id-type="doi">10.1038/nm.2406</pub-id>
<pub-id pub-id-type="pmid">21743453</pub-id></mixed-citation>
</ref>
<ref id="B308">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zima</surname><given-names>A. V.</given-names></name><name><surname>Blatter</surname><given-names>L. A.</given-names></name></person-group> (<year>2006</year>). <article-title>Redox regulation of cardiac calcium channels and transporters.</article-title>
<source/><italic>Cardiovasc. Res.</italic>
<volume>71</volume>
<fpage>310</fpage>–<lpage>321</lpage>. <pub-id pub-id-type="doi">10.1016/j.cardiores.2006.02.019</pub-id>
<pub-id pub-id-type="pmid">16581043</pub-id></mixed-citation>
</ref>
<ref id="B309">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zima</surname><given-names>A. V.</given-names></name><name><surname>Bovo</surname><given-names>E.</given-names></name><name><surname>Mazurek</surname><given-names>S. R.</given-names></name><name><surname>Rochira</surname><given-names>J. A.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Terentyev</surname><given-names>D.</given-names></name></person-group> (<year>2014</year>). <article-title>Ca handling during excitation-contraction coupling in heart failure.</article-title>
<source/><italic>Pflugers Arch.</italic>
<volume>466</volume>
<fpage>1129</fpage>–<lpage>1137</lpage>. <pub-id pub-id-type="doi">10.1007/s00424-014-1469-3</pub-id>
<pub-id pub-id-type="pmid">24515294</pub-id></mixed-citation>
</ref>
<ref id="B310">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zima</surname><given-names>A. V.</given-names></name><name><surname>Mazurek</surname><given-names>S. R.</given-names></name></person-group> (<year>2016</year>). <article-title>Functional impact of ryanodine receptor oxidation on intracellular calcium regulation in the heart.</article-title>
<source/><italic>Rev. Physiol. Biochem. Pharmacol.</italic>
<volume>171</volume>
<fpage>39</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1007/112_2016_2</pub-id>
<pub-id pub-id-type="pmid">27251471</pub-id></mixed-citation>
</ref>
<ref id="B311">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zima</surname><given-names>A. V.</given-names></name><name><surname>Picht</surname><given-names>E.</given-names></name><name><surname>Bers</surname><given-names>D. M.</given-names></name><name><surname>Blatter</surname><given-names>L. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Termination of cardiac Ca2 + sparks: role of intra-SR [Ca2 + ], release flux, and intra-SR Ca2 + diffusion.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>103</volume>
<fpage>e105</fpage>–<lpage>e115</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.107.183236</pub-id>
<pub-id pub-id-type="pmid">18787194</pub-id></mixed-citation>
</ref>
<ref id="B312">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zsebo</surname><given-names>K.</given-names></name><name><surname>Yaroshinsky</surname><given-names>A.</given-names></name><name><surname>Rudy</surname><given-names>J. J.</given-names></name><name><surname>Wagner</surname><given-names>K.</given-names></name><name><surname>Greenberg</surname><given-names>B.</given-names></name><name><surname>Jessup</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Long-term effects of AAV1/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>114</volume>
<fpage>101</fpage>–<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.113.302421</pub-id>
<pub-id pub-id-type="pmid">24065463</pub-id></mixed-citation>
</ref>
<ref id="B313">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zühlke</surname><given-names>R. D.</given-names></name><name><surname>Pitt</surname><given-names>G. S.</given-names></name><name><surname>Deisseroth</surname><given-names>K.</given-names></name><name><surname>Tsien</surname><given-names>R. W.</given-names></name><name><surname>Reuter</surname><given-names>H.</given-names></name></person-group> (<year>1999</year>). <article-title>Calmodulin supports both inactivation and facilitation of L-type calcium channels.</article-title>
<source/><italic>Nature</italic>
<volume>399</volume>
<fpage>159</fpage>–<lpage>162</lpage>. <pub-id pub-id-type="doi">10.1038/20200</pub-id>
<pub-id pub-id-type="pmid">10335846</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>